syndrome	score	normalized_score
ANGIOEDEMA, HEREDITARY, TYPE I; HAE1	2.2	100.0
%210500 BILIARY ATRESIA, EXTRAHEPATIC; EHBA	2.04170431	92.80474136363635
DIAPHANOSPONDYLODYSOSTOSIS	2.000843882	90.94744918181816
LYMPHEDEMA, HEREDITARY, III	1.6938263820000001	76.99210827272728
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	1.6369386810000002	74.40630368181819
MYOCLONIC EPILEPSY OF LAFORA	1.5181308	69.00594545454545
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	1.5025641	68.29836818181818
MARTINEZ-FRIAS SYNDROME	1.5	68.18181818181817
#600803 GALLBLADDER DISEASE 1; GBD1;;CHOLELITHIASIS, LOW PHOSPHOLIPID-ASSOCIATED; LPAC	1.3060683	59.3667409090909
EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3	1.3055556	59.34343636363636
ANGIOEDEMA, HEREDITARY, TYPE III	1.3	59.09090909090908
SECKEL SYNDROME 10; SCKL10	1.2688679	57.675813636363635
Lymphatic malformation 1	1.2666667	57.57575909090909
HEPATOCELLULAR CARCINOMA	1.2016805	54.6218409090909
#215140 GREENBERG DYSPLASIA; GRBGD;;HYDROPS-ECTOPIC CALCIFICATION-MOTH-EATEN SKELETAL DYSPLASIA;;HEM SKELETAL DYSPLASIA;;MOTH-EATEN SKELETAL DYSPLASIA;;CHONDRODYSTROPHY, HYDROPIC AND PRENATALLY LETHAL TYPE	1.19485141	54.31142772727272
ALAGILLE SYNDROME 1; ALGS1	1.1597486	52.71584545454545
METACHROMATIC LEUKODYSTROPHY	1.159729851	52.71499322727272
#613470 HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO GLUCOSE PHOSPHATE ISOMERASEDEFICIENCY	1.1375641	51.70745909090909
3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY	1.1188679000000001	50.85763181818182
#615207 IL21R IMMUNODEFICIENCY	1.1151515	50.68870454545454
CYSTIC FIBROSIS WITH HELICOBACTER PYLORI GASTRITIS, MEGALOBLASTIC ANEMIA, AND MENTAL RETARDATION	1.111111	50.50504545454545
Congenital disorder of glycosylation, type IIh	1.110634012	50.48336418181818
CRANIOECTODERMAL DYSPLASIA 1	1.08894051	49.4972959090909
MECKEL SYNDROME, TYPE 6; MKS6	1.0788114	49.03688181818182
WILSON DISEASE	1.0771597099999999	48.96180499999999
CHOLESTASIS-LYMPHEDEMA SYNDROME	1.0624645099999999	48.29384136363635
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	1.036787662	47.12671190909091
MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY; MADD	1.03205261	46.91148227272727
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	1.02986511	46.81205045454545
MEVALONIC ACIDURIA; MEVA	1.028831002	46.76504554545454
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	1.019653592	46.34789054545455
#264470 PEROXISOMAL ACYL-CoA OXIDASE DEFICIENCY;;STRAIGHT-CHAIN ACYL-CoA OXIDASE DEFICIENCY;;PSEUDONEONATAL ADRENOLEUKODYSTROPHY	1.011912961	45.99604368181818
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	1.01	45.90909090909091
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	1.008433112	45.83786872727273
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE III; ALPS3	1.00318471	45.599304999999994
3-METHYLCROTONYL-CoA CARBOXYLASE 1 DEFICIENCY; MCC1D	1.001759633	45.53452877272727
COFFIN-SIRIS SYNDROME 1; CSS1	1.001759633	45.53452877272727
#158350 COWDEN SYNDROME 1; CWS1;;CS; CD;;MULTIPLE HAMARTOMA SYNDROME; MHAMDYSPLASTIC GANGLIOCYTOMA OF THE CEREBELLUM, INCLUDED;;CEREBELLOPARENCHYMAL DISORDER VI, INCLUDED; CPD6, INCLUDED;;CEREBELLAR GRANULE CELL HYPERTROPHY AND MEGALENCEPHALY, INCLUDED;;LHERMITTE-DUCLOS DISEASE, INCLUDED; LDD, INCLUDED;;PROTEUS-LIKE SYNDROME, INCLUDED	1.001759633	45.53452877272727
#116860 CEREBRAL CAVERNOUS MALFORMATIONS; CCM;;CAVERNOUS ANGIOMA, FAMILIAL;;CAVERNOUS ANGIOMATOUS MALFORMATIONS; CAM;;CEREBRAL CAPILLARY MALFORMATIONSCEREBRAL CAVERNOUS MALFORMATIONS 1, INCLUDED; CCM1, INCLUDED;;CAVERNOUS MALFORMATIONS OF CNS AND RETINA, INCLUDED;;HYPERKERATOTIC CUTANEOUS CAPILLARY-VENOUS MALFORMATIONS ASSOCIATEDWITH CEREBRAL CAPILLARY MALFORMATIONS, INCLUDED	1.000915751	45.49617049999999
268040 RETINOHEPATOENDOCRINOLOGIC SYNDROME;;RHE SYNDROME	1.0	45.45454545454545
AUTOIMMUNE INTERSTITIAL LUNG, JOINT, AND KIDNEY DISEASE; AILJK	1.0	45.45454545454545
ENTEROKINASE DEFICIENCY	1.0	45.45454545454545
PORTAL VEIN, CAVERNOUS TRANSFORMATION OF	1.0	45.45454545454545
CHONDROITIN-6-SULFATURIA, DEFECTIVE CELLULAR IMMUNITY, NEPHROTIC SYNDROME	1.0	45.45454545454545
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	1.0	45.45454545454545
HEPATIC ADENOMAS, FAMILIAL	1.0	45.45454545454545
CARDIAC-UROGENITAL SYNDROME; CUGS	1.0	45.45454545454545
CHOLANGIOCARCINOMA	1.0	45.45454545454545
EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	0.9484125999999999	43.109663636363635
%265300 LYMPHANGIECTASIA, PULMONARY, CONGENITAL; CPL;;LYMPHANGIOMATOSIS, PULMONARY;;PULMONARY CYSTIC LYMPHANGIECTASIS	0.8666667	39.39394090909091
CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC 1	0.83651771	38.023532272727266
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.831685692	37.80389509090909
PERIODIC FEVER, FAMILIAL, AUTOSOMAL DOMINANT	0.6394928	29.06785454545454
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.6388886	29.040390909090906
#608836 CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LETHAL NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, ANTENATAL;;CPT II DEFICIENCY, LETHAL NEONATAL;;CPT2 DEFICIENCY, LETHAL NEONATAL	0.6369129609999999	28.95058913636363
PETERS-PLUS SYNDROME; PTRPLS	0.6267596329999999	28.48907422727272
LATHOSTEROLOSIS	0.617061551	28.048252318181817
MITCHELL-RILEY SYNDROME; MTCHRS	0.6166670000000001	28.03031818181818
HALOTHANE HEPATITIS	0.61	27.727272727272723
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.6073725130000001	27.607841500000003
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.6011458000000001	27.324809090909092
IMMUNE DEFICIENCY DISEASE	0.6	27.27272727272727
BARE LYMPHOCYTE SYNDROME, TYPE II	0.6	27.27272727272727
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.5933333000000001	26.969695454545455
TRICHOHEPATOENTERIC SYNDROME 1	0.58492531	26.587514090909092
#300868 MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 2; MCAHS2	0.575544522	26.16111463636363
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 1; CBAS1	0.56948201	25.885545909090908
#218600 BALLER-GEROLD SYNDROME; BGS;;CRANIOSYNOSTOSIS WITH RADIAL DEFECTS;;CRANIOSYNOSTOSIS-RADIAL APLASIA SYNDROME	0.5675824509999999	25.799202318181813
ANEMIA, SIDEROBLASTIC, 3, PYRIDOXINE-REFRACTORY; SIDBA3	0.56114871	25.506759545454543
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.548704792	24.941126909090908
POTOCKI-LUPSKI SYNDROME	0.5402211330000001	24.555506045454546
SPLENOPORTAL VASCULAR ANOMALIES	0.5384073	24.473059090909093
#121200 SEIZURES, BENIGN FAMILIAL NEONATAL, 1; BFNS1EPILEPSY, BENIGN NEONATAL, 1, AND/OR MYOKYMIA, INCLUDED;;SEIZURES, BENIGN FAMILIAL NEONATAL, 1, AND/OR MYOKYMIA, INCLUDED	0.537771982	24.444180999999997
GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME; GIDID	0.5357143	24.350649999999995
NUCHAL BLEB, FAMILIAL	0.5357143	24.350649999999995
#274000 THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME; TAR;;TAR SYNDROME;;CHROMOSOME 1q21.1 DELETION SYNDROME, 200-KB	0.532441453	24.20188422727273
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.530764243	24.12564740909091
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.52936458	24.06202636363636
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.5292445	24.05656818181818
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 1	0.52833621	24.01528227272727
SCLEROSING CHOLANGITIS, NEONATAL	0.5282117099999999	24.009623181818174
AICARDI SYNDROME; AIC	0.525	23.863636363636363
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.516067251	23.457602318181813
EPILEPSY, BENIGN NEONATAL, 2	0.5147059	23.395722727272727
GLYCOGEN STORAGE DISEASE VI	0.51099721	23.227145909090908
LAMBERT SYNDROME	0.51	23.18181818181818
IMMUNODEFICIENCY WITH HYPER-IGM, TYPE 1	0.50886653	23.13029681818182
LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1; XLP1	0.5088665299999999	23.130296818181815
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.505869012	22.994045999999997
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.5034798509999999	22.885447772727268
COMBINED SAPOSIN DEFICIENCY	0.50318471	22.872032272727267
GLYCOGEN STORAGE DISEASE IXB	0.50318471	22.872032272727267
#300755 AGAMMAGLOBULINEMIA, X-LINKED; XLA;;BRUTON-TYPE AGAMMAGLOBULINEMIA;;AGAMMAGLOBULINEMIA, X-LINKED, TYPE 1; AGMX1;;IMMUNODEFICIENCY 1; IMD1HYPOGAMMAGLOBULINEMIA, X-LINKED, INCLUDED	0.50304878	22.865853636363635
KETOADIPICACIDURIA	0.501759633	22.807256045454547
PEHO SYNDROME; PEHO	0.501759633	22.807256045454547
CHROMOSOME 10q22.3-q23.2 DELETION SYNDROME	0.5008438820000001	22.765631000000003
#614265 COMBINED MALONIC AND METHYLMALONIC ACIDURIA; CMAMMA	0.500843882	22.765631
MENTAL RETARDATION, BUENOS AIRES TYPE	0.5	22.727272727272727
APOLIPOPROTEIN A-I; APOA1	0.5	22.727272727272727
PSEUDOXANTHOMA ELASTICUM; PXE	0.5	22.727272727272727
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.5	22.727272727272727
IMMUNODEFICIENCY 36; IMD36	0.5	22.727272727272727
CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 1	0.5	22.727272727272727
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.5	22.727272727272727
EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7	0.5	22.727272727272727
PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE	0.5	22.727272727272727
#613270 CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 6; FECD6;;CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, LATE-ONSET	0.5	22.727272727272727
PTERYGIUM COLLI AND MENTAL RETARDATION WITH FACIAL AND DIGITAL ANOMALIES	0.5	22.727272727272727
#307200 ISOLATED GROWTH HORMONE DEFICIENCY, TYPE III; IGHD3;;IGHD III;;GROWTH HORMONE DEFICIENCY WITH HYPOGAMMAGLOBULINEMIA;;HYPOGAMMAGLOBULINEMIA AND ISOLATED GROWTH HORMONE DEFICIENCY, X-LINKED;;AGAMMAGLOBULINEMIA AND ISOLATED GROWTH HORMONE DEFICIENCY, X-LINKED;;FLEISHER SYNDROME	0.5	22.727272727272727
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 2	0.49382601	22.446636818181815
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.48869108200000005	22.213231
#300672 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2; EIEE2;;INFANTILE SPASM SYNDROME, X-LINKED 2; ISSX2	0.47571763300000003	21.623528772727273
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.4732773430000001	21.5126065
#613812 BILE ACID SYNTHESIS DEFECT, CONGENITAL, 3; CBAS3	0.46948201	21.34009136363636
#604403 GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 2; GEFSP2;;GEFS+, TYPE 2; GEFS+2FEBRILE SEIZURES, FAMILIAL, 3A, INCLUDED; FEB3A, INCLUDED	0.4663689	21.19858636363636
CENTRALOPATHIC EPILEPSY	0.4484126	20.38239090909091
SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	0.44841259999999994	20.382390909090905
SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	0.44841259999999994	20.382390909090905
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.447433461	20.337884590909088
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.425915451	19.359793227272725
FIBROSCLEROSIS, MULTIFOCAL	0.4242421	19.283731818181817
SHORT-RIB THORACIC DYSPLASIA 1 WITH OR WITHOUT POLYDACTYLY; SRTD1	0.39436699999999997	17.925772727272722
LYMPHATIC MALFORMATION 7; LMPHM7	0.3929825	17.862840909090906
#267000 PERLMAN SYNDROME; PRLMNS;;RENAL HAMARTOMAS, NEPHROBLASTOMATOSIS, AND FETAL GIGANTISM;;NEPHROBLASTOMATOSIS, FETAL ASCITES, MACROSOMIA, AND WILMS TUMOR	0.38713118199999996	17.596871909090904
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.386858882	17.584494636363633
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.38532338200000005	17.514699181818184
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.38532338200000005	17.514699181818184
HEMOCHROMATOSIS, NEONATAL	0.3830351	17.410686363636362
#605751 SEIZURES, BENIGN FAMILIAL INFANTILE, 2; BFIS2;;CONVULSIONS, BENIGN FAMILIAL INFANTILE, 2; BFIC2	0.3824787	17.385395454545453
#602066 CONVULSIONS, FAMILIAL INFANTILE, WITH PAROXYSMAL CHOREOATHETOSIS;ICCA;;INFANTILE CONVULSIONS AND PAROXYSMAL CHOREOATHETOSIS, FAMILIAL;;ICCA SYNDROME;;PAROXYSMAL KINESIGENIC DYSKINESIA WITH INFANTILE CONVULSIONS; PKD/IC	0.3824787	17.385395454545453
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.380911761	17.314170954545453
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.37922393	17.23745136363636
EPILEPSY WITH GRAND MAL SEIZURES ON AWAKENING	0.3752738	17.057899999999997
EPILEPSY, JUVENILE ABSENCE	0.3752738	17.057899999999997
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 3; PFIC3	0.37503760999999997	17.04716409090909
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA SYNDROME; HLTS	0.3666667	16.66666818181818
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.362568782	16.48039918181818
EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2	0.3613516	16.425072727272727
#607682 EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 9; EIG9EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 6, INCLUDED; EJM6,INCLUDED	0.3596488	16.347672727272723
#230600 GM1-GANGLIOSIDOSIS, TYPE II;;GANGLIOSIDOSIS, GENERALIZED GM1, JUVENILE TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE II;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 2GANGLIOSIDOSIS, GENERALIZED GM1, LATE-INFANTILE TYPE, INCLUDED	0.35909820000000003	16.322645454545455
ARGININOSUCCINIC ACIDURIA	0.35768734300000005	16.25851559090909
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.351585251	15.981147772727272
CAROLI DISEASE, ISOLATED	0.35080371	15.945623181818181
DIARRHEA 10, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR10	0.35	15.909090909090907
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.349801882	15.900085545454544
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.349400251	15.881829590909089
#187300 TELANGIECTASIA, HEREDITARY HEMORRHAGIC, OF RENDU, OSLER, AND WEBER;HHT;;OSLER-RENDU-WEBER DISEASE;;ORW DISEASETELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 1, INCLUDED; HHT1, INCLUDED	0.349400251	15.881829590909089
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.3480389	15.819949999999999
PANCREATITIS, SCLEROSING CHOLANGITIS, AND SICCA COMPLEX	0.34651771	15.750804999999998
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 4	0.33780881	15.354945909090908
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ic; CDG1C	0.337656733	15.348033318181816
ALSTROM SYNDROME; ALMS	0.336264592	15.28475418181818
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.33509263300000003	15.231483318181818
JUVENILE POLYPOSIS/HEREDITARY HEMORRHAGIC TELANGIECTASIA SYNDROME; JPHT	0.333333	15.151499999999999
BLEPHAROCHALASIS, SUPERIOR	0.333333	15.151499999999999
RED CELL PHOSPHOLIPID DEFECT WITH HEMOLYSIS	0.333333	15.151499999999999
#225410 EHLERS-DANLOS SYNDROME, TYPE VII, AUTOSOMAL RECESSIVE;;EHLERS-DANLOS SYNDROME, DERMATOSPARAXIS TYPE;;DERMATOSPARAXIS;;EDS VIIC;;EDS7C	0.333333	15.151499999999999
601165 CLEFT LIP/PALATE WITH CHARACTERISTIC FACIES, INTESTINAL MALROTATION,AND LETHAL CONGENITAL HEART DISEASE	0.333333	15.151499999999999
BLEPHAROCHALASIS AND DOUBLE LIP	0.333333	15.151499999999999
NAVAJO NEUROHEPATOPATHY	0.331368292	15.06219509090909
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.330749782	15.034080999999999
TUBEROUS SCLEROSIS	0.32591575100000003	14.814352318181816
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIl; CDG2L	0.320778463	14.580839227272726
#607208 DRAVET SYNDROME;;EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 6; EIEE6;;SEVERE MYOCLONIC EPILEPSY OF INFANCY; SMEI	0.319772282	14.535103727272727
POLYCYSTIC KIDNEY DISEASE 4 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD4	0.31330371	14.241077727272728
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.3073294	13.96951818181818
#208540 RENAL-HEPATIC-PANCREATIC DYSPLASIA; RHPD	0.30524141	13.874609545454545
SCALP-EAR-NIPPLE SYNDROME; SENS	0.30000000000000004	13.636363636363638
LYMPHEDEMA, HEREDITARY, II	0.30000000000000004	13.636363636363638
MICROGASTRIA-LIMB REDUCTION DEFECTS ASSOCIATION; MLRD	0.291667	13.257590909090908
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I	0.29	13.18181818181818
JOHANSON-BLIZZARD SYNDROME; JBS	0.2844828	12.93103636363636
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.280208462	12.736748272727272
%211890 CAMPOMELIA, CUMMING TYPE;;CERVICAL LYMPHOCELE WITH BOWED LONG BONES;;CUMMING SYNDROME	0.2763158	12.559809090909091
#267010 MECKEL SYNDROME, TYPE 7; MKS7;;RENAL-HEPATIC-PANCREATIC DYSPLASIA WITH DANDY-WALKER CYST;;GOLDSTON SYNDROME	0.27376839999999997	12.44401818181818
CEREBELLAR VERMIS APLASIA WITH ASSOCIATED FEATURES SUGGESTING SMITH-LEMLI-OPITZSYNDROME AND MECKEL SYNDROME	0.2714286	12.337663636363636
#610984 COMPLEMENT FACTOR I DEFICIENCY; CFID;;COMPLEMENT COMPONENT 3 INACTIVATOR DEFICIENCY;;C3 INACTIVATOR DEFICIENCY	0.2714286	12.337663636363636
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.27001668199999995	12.273485545454541
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.26775467999999997	12.17066727272727
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.266468882	12.11222190909091
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.265971613	12.089618772727272
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.265549782	12.070444636363636
118900 CIRRHOSIS, FAMILIAL	0.2651515	12.052340909090907
#236700 MCKUSICK-KAUFMAN SYNDROME; MKKS;;HYDROMETROCOLPOS SYNDROME;;HYDROMETROCOLPOS, POSTAXIAL POLYDACTYLY, AND CONGENITAL HEART MALFORMATION;HMCS;;KAUFMAN-MCKUSICK SYNDROME	0.2644928	12.022399999999998
%152800 LYMPHANGIECTASIA, INTESTINAL	0.2644928	12.022399999999998
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.264100461	12.004566409090907
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.263053643	11.956983772727272
GLYCOGEN STORAGE DISEASE Ic; GSD1C	0.26200821	11.90946409090909
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.259710412	11.805018727272726
CEPHALIN LIPIDOSIS	0.25408163	11.549164999999999
CHOLESTASIS WITH GALLSTONE, ATAXIA, AND VISUAL DISTURBANCE	0.2525641	11.480186363636363
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.252231551	11.4650705
FRYNS SYNDROME; FRNS	0.250915751	11.40526140909091
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.250915751	11.40526140909091
AXIAL OSTEOMALACIA	0.25	11.363636363636363
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.25	11.363636363636363
TUFTSIN DEFICIENCY	0.25	11.363636363636363
CEROID STORAGE DISEASE	0.25	11.363636363636363
%123550 CRYOGLOBULINEMIA, FAMILIAL MIXED;;MELTZER SYNDROME	0.25	11.363636363636363
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.25	11.363636363636363
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.25	11.363636363636363
DISTICHIASIS WITH CONGENITAL ANOMALIES OF THE HEART AND PERIPHERAL	0.25	11.363636363636363
#604364 EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI; FFEVF;;EPILEPSY, PARTIAL, WITH VARIABLE FOCI; FPEVF	0.25	11.363636363636363
HYPEREKPLEXIA 1; HKPX1	0.25	11.363636363636363
#614379 COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD ;;C4B DEFICIENCY	0.25	11.363636363636363
PANCREATIC INSUFFICIENCY, COMBINED EXOCRINE	0.25	11.363636363636363
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.24819026300000002	11.281375590909091
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.24819026300000002	11.281375590909091
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.246619033	11.209956045454545
LIVER FAILURE, INFANTILE, TRANSIENT	0.24599721000000002	11.181691363636363
PYRUVATE KINASE DEFICIENCY OF RED CELLS	0.2416667	10.98485
NEPHRONOPHTHISIS 18; NPHP18	0.23448280000000002	10.658309090909091
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.234177582	10.644435545454545
LYMPHEDEMA-DISTICHIASIS SYNDROME; LPHDST	0.2263158	10.287081818181818
%153300 YELLOW NAIL SYNDROME;;YNS;;LYMPHEDEMA AND YELLOW NAILS	0.2263158	10.287081818181818
BLAU SYNDROME	0.225	10.227272727272727
FEBRILE SEIZURES, FAMILIAL, 5; FEB5	0.2244281	10.201277272727271
FEBRILE SEIZURES, FAMILIAL, 4; FEB4	0.2244281	10.201277272727271
FEBRILE SEIZURES, FAMILIAL, 2; FEB2	0.2244281	10.201277272727271
FEBRILE SEIZURES, FAMILIAL, 6; FEB6	0.2244281	10.201277272727271
%121210 FEBRILE SEIZURES, FAMILIAL, 1; FEB1;;CONVULSIONS, FAMILIAL FEBRILE;  1	0.2244281	10.201277272727271
ACYL-COA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF	0.22205261	10.093300454545455
BARDET-BIEDL SYNDROME 1; BBS1	0.221379262	10.062693727272725
CHROMOSOME 1P36 DELETION SYNDROME	0.219730913	9.987768772727271
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.2188679	9.948540909090909
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.21767751000000002	9.894432272727274
TRANSALDOLASE DEFICIENCY	0.21513083	9.778674090909089
ENHANCED S-CONE SYNDROME	0.2144928	9.749672727272728
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.209386192	9.517554181818182
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.204944343	9.315651954545453
LEIGH SYNDROME; LS	0.204323733	9.28744240909091
XANTHINURIA, TYPE I	0.20408163	9.276437727272727
JOUBERT SYNDROME 2	0.203407982	9.245817363636363
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE I; CDG1	0.20318471000000002	9.235668636363636
BECKWITH-WIEDEMANN SYNDROME	0.20318471000000002	9.235668636363636
GRANULOMATOUS DISEASE, CHRONIC, X-LINKED; CDGX	0.20318471000000002	9.235668636363636
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE II; CDG2	0.20318471000000002	9.235668636363636
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-NEGATIVE	0.20318471000000002	9.235668636363636
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4; CMH4	0.20318471000000002	9.235668636363636
LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 2; XLP2	0.20318471	9.235668636363634
REFSUM DISEASE	0.20256410000000002	9.207459090909092
#604901 NORTH AMERICAN INDIAN CHILDHOOD CIRRHOSIS; NAIC	0.20220829999999998	9.191286363636362
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.201759633	9.170892409090909
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.200915751	9.132534136363637
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.200915751	9.132534136363637
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.200915751	9.132534136363637
NETHERTON SYNDROME; NETH	0.200843882	9.129267363636364
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.200843882	9.129267363636364
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.200843882	9.129267363636364
#115470 CAT EYE SYNDROME; CES;;SCHMID-FRACCARO SYNDROME;;CHROMOSOME 22 PARTIAL TETRASOMY;;INV DUP(22)(q11)	0.2	9.090909090909092
CARBOXYPEPTIDASE N DEFICIENCY	0.2	9.090909090909092
HAND-FOOT-GENITAL SYNDROME; HFG	0.2	9.090909090909092
ACQUIRED ANGIOEDEMA	0.2	9.090909090909092
PULMONARY EDEMA OF MOUNTAINEERS	0.2	9.090909090909092
FANCONI ANEMIA, COMPLEMENTATION GROUP Q; FANCQ	0.2	9.090909090909092
RETINITIS PIGMENTOSA 11	0.2	9.090909090909092
RETINITIS PIGMENTOSA 27; RP27	0.2	9.090909090909092
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.2	9.090909090909092
FAMILIAL ADENOMATOUS POLYPOSIS 1; FAP1	0.2	9.090909090909092
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.2	9.090909090909092
TORTICOLLIS, KELOIDS, CRYPTORCHIDISM, AND RENAL DYSPLASIA; TKCR	0.2	9.090909090909092
#267450 RESPIRATORY DISTRESS SYNDROME IN PREMATURE INFANTS;;RDS OF PREMATURITY;;HYALINE MEMBRANE DISEASE, FORMERLY	0.2	9.090909090909092
#180104 RETINITIS PIGMENTOSA 9; RP9	0.2	9.090909090909092
T-CELL LYMPHOMA, SUBCUTANEOUS PANNICULITIS-LIKE; SPTCL	0.2	9.090909090909092
HETEROTAXY, VISCERAL, 1, X-LINKED; HTX1	0.2	9.090909090909092
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.19441408200000002	8.837003727272727
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.192708073	8.759457863636364
MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY	0.19041742	8.655337272727271
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 4	0.18977580000000002	8.626172727272728
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.185052462	8.411475545454545
HEMOCHROMATOSIS, TYPE 1	0.18497221	8.407827727272727
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.18214338200000002	8.279244636363636
#613863 GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 7; GEFSP7;;GEFS+, TYPE 7; GEFS+7FEBRILE SEIZURES, FAMILIAL, 3B, INCLUDED; FEB3B, INCLUDED	0.18129950000000003	8.240886363636363
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.18040505099999998	8.200229590909089
ERYTHROCYTOSIS, FAMILIAL, 8; ECYT8	0.17908163000000002	8.140074090909092
#235700 HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO HEXOKINASE DEFICIENCY	0.17908163000000002	8.140074090909092
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.175843882	7.992903727272727
#611881 GLYCOGEN STORAGE DISEASE XII; GSD12;;GSD XII;;ALDOLASE A DEFICIENCY;;ALDOA DEFICIENCY;;ALDOLASE DEFICIENCY, RED CELL;;RED CELL ALDOLASE DEFICIENCY	0.17500000000000002	7.954545454545454
NEPHROPATHY, PROGRESSIVE TUBULOINTERSTITIAL, WITH CHOLESTATIC LIVERDISEASE	0.1744795	7.930886363636364
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.17147541300000002	7.7943369545454555
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.170559662	7.752711909090909
HARDIKAR SYNDROME	0.16861621	7.66437318181818
#117550 SOTOS SYNDROME 1; SOTOS1;;SOTOS SYNDROME;;CEREBRAL GIGANTISM;;CHROMOSOME 5q35 DELETION SYNDROME	0.168426633	7.655756045454544
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.167582751	7.617397772727272
%300712 CRANIOFACIOSKELETAL SYNDROME	0.167510882	7.614130999999999
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 2; ADMIO2	0.166667	7.575772727272727
ALAGILLE SYNDROME 2	0.166667	7.575772727272727
184705 STEINFELD SYNDROME	0.166667	7.575772727272727
SHORT-RIB THORACIC DYSPLASIA 20 WITH POLYDACTYLY; SRTD20	0.166667	7.575772727272727
SPECIFIC LANGUAGE IMPAIRMENT 2; SLI2	0.166667	7.575772727272727
FLOATING-HARBOR SYNDROME	0.166667	7.575772727272727
DYSPHASIA, FAMILIAL DEVELOPMENTAL	0.166667	7.575772727272727
NEPHROTIC SYNDROME, TYPE 15; NPHS15	0.166667	7.575772727272727
FAMILIAL IDIOPATHIC STEROID-RESISTANT NEPHROTIC SYNDROME	0.166667	7.575772727272727
#603471 CITRULLINEMIA, TYPE II, ADULT-ONSET; CTLN2;;CITRIN DEFICIENCY	0.162427	7.383045454545453
DEHYDRATED HEREDITARY STOMATOCYTOSIS 1 WITH OR WITHOUT PSEUDOHYPERKALEMIA AND/OR PERINATAL EDEMA; DHS1	0.15318471000000003	6.962941363636364
CIRRHOSIS, FAMILIAL	0.152857	6.948045454545454
MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS, X-LINKED	0.14693863	6.679028636363634
#615369 EPILEPTIC ENCEPHALOPATHY, CHILDHOOD-ONSET; EEOC	0.14637478199999998	6.65339918181818
IMMUNODEFICIENCY 23; IMD23	0.146264982	6.648408272727272
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.14370088199999997	6.531858272727272
LIPODYSTROPHY, PARTIAL, ACQUIRED, WITH LOW COMPLEMENT COMPONENT C3, WITH OR WITHOUT GLOMERULONEPHRITIS; APLDC3	0.14285699999999998	6.493499999999999
#613652 C1q DEFICIENCY; C1QD	0.14285699999999998	6.493499999999999
#608709 LIPODYSTROPHY, PARTIAL, ACQUIRED, SUSCEPTIBILITY TO; APLD;;APLD, SUSCEPTIBILITY TO;;BARRAQUER-SIMONS SYNDROME;;LIPODYSTROPHY, CEPHALOTHORACIC TYPE;;LIPODYSTROPHY, PARTIAL, PROGRESSIVE	0.14285699999999998	6.493499999999999
COMPLEMENT COMPONENT 3 DEFICIENCY, AUTOSOMAL RECESSIVE; C3D	0.14285699999999998	6.493499999999999
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.14182756300000002	6.44670740909091
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3; PRAAS3	0.14167903	6.4399559090909095
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.140535261	6.387966409090909
NEURAMINIDASE DEFICIENCY	0.139814761	6.355216409090909
GLYCOGEN STORAGE DISEASE IV	0.1379776	6.2717090909090905
COACH SYNDROME	0.137061543	6.230070136363636
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.136912961	6.223316409090908
CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC, 2; BRIC2	0.13651801000000002	6.205364090909091
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.1357143	6.168831818181818
219400 CYANOSIS AND HEPATIC DISEASE	0.1357143	6.168831818181818
DUBIN-JOHNSON SYNDROME	0.135	6.136363636363637
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.134710412	6.123200545454545
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.1344828	6.112854545454546
#613060 EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 10; EIG10GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 5, SUSCEPTIBILITYTO, INCLUDED; GEFS5, INCLUDED;;GEFS+, TYPE 5, SUSCEPTIBILITY TO, INCLUDED;;GEFS+5, SUSCEPTIBILITY TO, INCLUDED;;GEFSP5, SUSCEPTIBILITY TO, INCLUDED;;EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 7, INCLUDED; EJM7,INCLUDED	0.1344245	6.110204545454545
MITOCHONDRIAL DNA DEPLETION SYNDROME 15 (HEPATOCEREBRAL TYPE); MTDPS15	0.132964	6.043818181818182
RENAL CYSTS AND DIABETES SYNDROME; RCAD	0.1328125	6.0369318181818175
#613722 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 12; EIEE12	0.1324787	6.021759090909091
REYNOLDS SYNDROME	0.13210821	6.004918636363636
#272200 MULTIPLE SULFATASE DEFICIENCY; MSD;;MUCOSULFATIDOSIS;;SULFATIDOSIS, JUVENILE, AUSTIN TYPE	0.131592692	5.981485999999999
PHELAN-MCDERMID SYNDROME; PHMDS	0.131124213	5.960191499999999
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.130869012	5.948591454545454
#615473 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 17; EIEE17	0.13086901199999998	5.948591454545453
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 2; PRAAS2	0.13068182	5.940082727272727
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIx;;CDG-x	0.129997381	5.908971863636363
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.12908163	5.867346818181818
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.129028592	5.864935999999999
OSTEOMYELITIS, STERILE MULTIFOCAL, WITH PERIOSTITIS AND PUSTULOSIS; OMPP	0.12818471	5.826577727272727
#228000 FARBER LIPOGRANULOMATOSIS;;FARBER DISEASE;;CERAMIDASE DEFICIENCY;;ACID CERAMIDASE DEFICIENCY;;AC DEFICIENCY;;N-LAURYLSPHINGOSINE DEACYLASE DEFICIENCY	0.12818471	5.826577727272727
COMPLEMENT HYPERACTIVATION, ANGIOPATHIC THROMBOSIS, AND PROTEIN-LOSING ENTEROPATHY; CHAPLE	0.12818471	5.826577727272727
MECKEL SYNDROME, TYPE 5	0.12698420000000002	5.7720090909090915
#194190 WOLF-HIRSCHHORN SYNDROME; WHS;;CHROMOSOME 4p16.3 DELETION SYNDROME;;PITT-ROGERS-DANKS SYNDROME; PRDS;;PITT SYNDROME	0.126759633	5.7618015
#614921 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE It; CDG1T;;CDG It; CDGIt;;PHOSPHOGLUCOMUTASE 1 DEFICIENCY;;PGM1 DEFICIENCY;;GLYCOGEN STORAGE DISEASE XIV; GSD14;;GSD XIV	0.1266804	5.7581999999999995
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 3; HKLLS3	0.1263158	5.741627272727272
TUBEROUS SCLEROSIS 2; TSC2	0.125915751	5.7234432272727265
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.125915751	5.7234432272727265
#604233 GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 1; GEFSP1;;GEFS+, TYPE 1; GEFS+1	0.12574390000000002	5.715631818181818
AUTOINFLAMMATION, PANNICULITIS, AND DERMATOSIS SYNDROME; AIPDS	0.125	5.681818181818182
SPINAL MUSCULAR ATROPHY, TYPE I, WITH CONGENITAL BONE FRACTURES	0.125	5.681818181818182
PEUTZ-JEGHERS SYNDROME	0.125	5.681818181818182
#608898 HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 3; FHL3;;HPLH3;;HLH3	0.125	5.681818181818182
APLASIA CUTIS CONGENITA WITH INTESTINAL LYMPHANGIECTASIA	0.125	5.681818181818182
#613101 HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 5; FHL5	0.125	5.681818181818182
POPLITEAL CYST	0.125	5.681818181818182
STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME	0.125	5.681818181818182
#256520 NEU-LAXOVA SYNDROME; NLS	0.125	5.681818181818182
LACRIMAL DUCT DEFECT	0.125	5.681818181818182
ROBERTS SYNDROME; RBS	0.125	5.681818181818182
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.125	5.681818181818182
127820 DYSPLASIA EPIPHYSEALIS HEMIMELICA WITH CHONDROMAS AND OSTEOCHONDROMAS;;OSTEOCHONDROMATOSIS, DOMINANT CARPOTARSAL	0.125	5.681818181818182
ARTHROPATHY, PROGRESSIVE PSEUDORHEUMATOID, OF CHILDHOOD	0.125	5.681818181818182
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia; CDG1A	0.124111343	5.641424681818181
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.121663143	5.530142863636364
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.11971178200000002	5.441444636363637
TRICHOHEPATOENTERIC SYNDROME 2	0.11833621	5.378918636363636
NEPHRONOPHTHISIS 19; NPHP19	0.11647891	5.294495909090909
%153880 MACULAR EDEMA, CYSTOID;;CYSTOID MACULAR DYSTROPHY; CYMD;;MACULAR DYSTROPHY, DOMINANT CYSTOID; MDDC;;DCMD	0.1144928	5.204218181818181
ICHTHYOSIS, LEUKOCYTE VACUOLES, ALOPECIA, AND SCLEROSING CHOLANGITIS; ILVASC	0.11318471	5.144759545454545
RETINITIS PIGMENTOSA 59; RP59	0.111912961	5.0869527727272725
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.11165295100000001	5.075134136363637
BILIARY CIRRHOSIS, PRIMARY	0.11111099999999999	5.050499999999999
CYSTIC FIBROSIS	0.11111099999999999	5.050499999999999
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.110915751	5.041625045454545
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.110626163	5.028461954545453
#225750 AICARDI-GOUTIERES SYNDROME 1; AGS1;;AGS;;ENCEPHALOPATHY, FAMILIAL INFANTILE, WITH INTRACRANIAL CALCIFICATIONAND CHRONIC CEREBROSPINAL FLUID LYMPHOCYTOSIS;;CREE ENCEPHALITIS;;PSEUDOTOXOPLASMOSIS SYNDROMEAICARDI-GOUTIERES SYNDROME 1, AUTOSOMAL DOMINANT, INCLUDED	0.110172763	5.007852863636363
SMITH-MAGENIS SYNDROME; SMS	0.10957031300000003	4.980468772727273
LYSINURIC PROTEIN INTOLERANCE; LPI	0.10886653	4.948478636363636
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.10854784300000002	4.933992863636364
MYOCLONIC EPILEPSY, FAMILIAL INFANTILE	0.1081087	4.914031818181818
#615395 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 16; COXPD16	0.1078125	4.900568181818182
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.107687343	4.894879227272727
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.10480841300000002	4.7640187727272725
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 2	0.10433051	4.742295909090909
LISSENCEPHALY 2; LIS2	0.10408278200000001	4.731035545454546
#252500 MUCOLIPIDOSIS II ALPHA/BETA;;MUCOLIPIDOSIS II; ML II;;ML II ALPHA/BETA;;I-CELL DISEASE; ICD	0.104028592	4.7285723636363635
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.10365875100000001	4.711761409090909
LYMPHOPROLIFERATIVE SYNDROME 2; LPFS2	0.10318471	4.69021409090909
MCLEOD SYNDROME; MCLDS	0.10192310000000002	4.632868181818182
GAUCHER DISEASE, PERINATAL LETHAL	0.10144898100000001	4.611317318181818
#262600 PITUITARY HORMONE DEFICIENCY, COMBINED, 2; CPHD2;;PANHYPOPITUITARISM;;ATELIOTIC DWARFISM WITH HYPOGONADISM;;PITUITARY DWARFISM III;;HANHART DWARFISM	0.10091575100000001	4.587079590909092
GRISCELLI SYNDROME, TYPE 2; GS2	0.10091575100000001	4.587079590909092
FOUNTAIN SYNDROME	0.10091575100000001	4.587079590909092
WHITE-SUTTON SYNDROME; WHSUS	0.10084388200000001	4.583812818181818
RETINITIS PIGMENTOSA 76; RP76	0.1	4.545454545454546
MELKERSSON-ROSENTHAL SYNDROME	0.1	4.545454545454546
RETINITIS PIGMENTOSA 83; RP83	0.1	4.545454545454546
MICROPHTHALMIA, ISOLATED 5	0.1	4.545454545454546
#256450 HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1; HHF1;;PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA OF INFANCY; PHHI;;HYPOGLYCEMIA, HYPERINSULINEMIC, OF INFANCY;;HYPERINSULINEMIC HYPOGLYCEMIA DUE TO FOCAL ADENOMATOUS HYPERPLASIA;;NESIDIOBLASTOSIS OF PANCREAS;;HYPERINSULINISM, FAMILIAL, WITH PANCREATIC NESIDIOBLASTOSIS;;HYPERINSULINISM, CONGENITAL	0.1	4.545454545454546
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.1	4.545454545454546
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.1	4.545454545454546
NOONAN SYNDROME 8; NS8	0.1	4.545454545454546
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.1	4.545454545454546
MACS SYNDROME	0.1	4.545454545454546
RETINITIS PIGMENTOSA 78; RP78	0.1	4.545454545454546
HEPATITIS B VACCINE, RESPONSE TO	0.1	4.545454545454546
RETINITIS PIGMENTOSA 77; RP77	0.1	4.545454545454546
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.1	4.545454545454546
#610198 3-@METHYLGLUTACONIC ACIDURIA, TYPE V; MGCA5;;CARDIOMYOPATHY, DILATED, WITH ATAXIA; DCMA;;MGA, TYPE V; MGA5	0.1	4.545454545454546
#613582 RETINITIS PIGMENTOSA 57; RP57	0.1	4.545454545454546
PSORIASIS 14, PUSTULAR	0.1	4.545454545454546
PANCREATITIS, HEREDITARY	0.1	4.545454545454546
RETINITIS PIGMENTOSA 13; RP13	0.1	4.545454545454546
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.1	4.545454545454546
#613783 COMPLEMENT COMPONENT C1s DEFICIENCY; C1SD;;C1s DEFICIENCY	0.1	4.545454545454546
%602248 MALIGNANT ATROPHIC PAPULOSIS;;DEGOS DISEASE;;PAPULOSIS, MALIGNANT ATROPHIC	0.1	4.545454545454546
CITRULLINEMIA, CLASSIC	0.09958304300000001	4.526501954545455
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.099271812	4.51235509090909
#605814 CITRULLINEMIA, TYPE II, NEONATAL-ONSET;;CHOLESTASIS, NEONATAL INTRAHEPATIC, CAUSED BY CITRIN DEFICIENCY; NICCD	0.09848480000000001	4.476581818181819
SILVER-RUSSELL SYNDROME; SRS	0.098128882	4.460403727272727
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.096634882	4.392494636363637
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.09659092000000001	4.390496363636364
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 1; AHMIO1	0.09499073000000001	4.317760454545454
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.09225978200000001	4.193626454545455
#276710 TYROSINEMIA, TYPE III; TYRSN3;;4-@HYDROXYPHENYLPYRUVIC ACID OXIDASE DEFICIENCY;;4-@HYDROXYPHENYLPYRUVATE DIOXYGENASE DEFICIENCY	0.09182485100000001	4.173856863636364
#614018 EPILEPSY, PROGRESSIVE MYOCLONIC, 6; EPM6	0.0913799	4.153631818181818
HYPERVITAMINOSIS A, SUSCEPTIBILITY TO	0.0909091	4.132231818181818
ATRANSFERRINEMIA	0.0909091	4.132231818181818
RCAD (renal cysts and diabetes)	0.0909091	4.132231818181818
HEPATIC VENOOCCLUSIVE DISEASE WITH IMMUNODEFICIENCY	0.0909091	4.132231818181818
SITOSTEROLEMIA	0.0909091	4.132231818181818
#193300 VON HIPPEL-LINDAU SYNDROME; VHLVON HIPPEL-LINDAU SYNDROME, MODIFIERS OF, INCLUDED	0.0909091	4.132231818181818
IMMUNODEFICIENCY 47	0.089410661	4.064120954545454
OROFACIODIGITAL SYNDROME I; OFD1	0.086671551	3.939615954545454
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.08605299200000001	3.9114996363636365
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.08578963	3.899528636363636
LYSOSOMAL ACID LIPASE DEFICIENCY	0.08545991	3.8845413636363633
TYROSINEMIA, TYPE I; TYRSN1	0.08497220999999999	3.862373181818181
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.082715282	3.759785545454545
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.08260492000000001	3.754769090909091
JOUBERT SYNDROME 6	0.08221938200000001	3.737244636363636
ALPHA-1-ANTITRYPSIN DEFICIENCY; A1ATD	0.0817875	3.717613636363636
GLYCOGEN STORAGE DISEASE IXC	0.08170431	3.7138322727272723
#311250 ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO;;ORNITHINE CARBAMOYLTRANSFERASE DEFICIENCY;;OTC DEFICIENCYVALPROATE SENSITIVITY, INCLUDED	0.08124683300000002	3.693037863636364
#237300 CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY, HYPERAMMONEMIA DUE TO;;CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY;;CPS I DEFICIENCY	0.08124683300000002	3.693037863636364
MAPLE SYRUP URINE DISEASE; MSUD	0.08040295100000001	3.6546795909090912
MYOCLONUS AND ATAXIA	0.07948720000000001	3.6130545454545455
#224120 ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE Ia; CDAN1A;;DYSERYTHROPOIETIC ANEMIA, CONGENITAL, TYPE Ia;;CDA Ia;;ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE I	0.0791926	3.599663636363636
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14	0.0788689	3.58495
#607361 MECKEL SYNDROME, TYPE 3; MKS3;;MECKEL-GRUBER SYNDROME, TYPE 3	0.0788114	3.5823363636363634
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.078621682	3.573712818181818
#612437 EPILEPSY, PROGRESSIVE MYOCLONIC 1B; EPM1B	0.078125	3.5511363636363633
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.07783885100000001	3.5381295909090915
#608033 ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 3; IIAE3;;ENCEPHALOPATHY, ACUTE NECROTIZING, SUSCEPTIBILITY TO; ANE	0.07783885100000001	3.5381295909090915
IMMUNODEFICIENCY, COMMON VARIABLE, 6; CVID6	0.07711042000000001	3.5050190909090917
NEPHROTIC SYNDROME, TYPE 7; NPHS7	0.07711042000000001	3.5050190909090917
THROMBOCYTOPENIA WITH ELEVATED SERUM IGA AND RENAL DISEASE	0.07711042000000001	3.5050190909090917
CANAVAN DISEASE	0.07692310000000001	3.496504545454546
#615604 L-FERRITIN DEFICIENCY; LFTD	0.07692310000000001	3.496504545454546
KOOLEN-DE VRIES SYNDROME; KDVS	0.07623701300000002	3.4653187727272736
ALKAPTONURIA	0.07551023000000001	3.432283181818182
#230500 GM1-GANGLIOSIDOSIS, TYPE I;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE I;;GANGLIOSIDOSIS, GENERALIZED GM1, INFANTILE FORM;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 1;;BETA-GALACTOSIDASE-1 DEFICIENCY;;GLB1 DEFICIENCYGM1-GANGLIOSIDOSIS, TYPE I, WITH CARDIAC INVOLVEMENT, INCLUDED;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE I, WITH CARDIAC INVOLVEMENT,INCLUDED	0.07461331	3.391514090909091
HYPERBILIVERDINEMIA; HBLVD	0.0744828	3.385581818181818
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.0744235	3.3828863636363637
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.0744235	3.3828863636363637
LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD	0.07399270000000001	3.363304545454546
BUDD-CHIARI SYNDROMEMEMBRANOUS OBSTRUCTION OF INFERIOR VENA CAVA, INCLUDED	0.073975	3.3624999999999994
PORPHYRIA CUTANEA TARDA	0.073975	3.3624999999999994
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.073733982	3.351544636363636
MOWAT-WILSON SYNDROME; MOWS	0.072607581	3.3003445909090905
KAPUR-TORIELLO SYNDROME	0.07234435100000002	3.2883795909090914
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.07169183	3.258719545454545
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ik; CDG1K	0.071611043	3.255047409090909
VISCERAL STEATOSIS, CONGENITAL	0.071450351	3.2477432272727267
GLUCOCORTICOID-REMEDIABLE ALDOSTERONISM	0.07142860000000001	3.2467545454545457
Split hand/foot malformation 1 (SHFM1)	0.07142860000000001	3.2467545454545457
#600208 MACROTHROMBOCYTOPENIA AND PROGRESSIVE SENSORINEURAL DEAFNESS	0.07142860000000001	3.2467545454545457
%247800 LYMPHOPENIC HYPERGAMMAGLOBULINEMIA, ANTIBODY DEFICIENCY, AUTOIMMUNEHEMOLYTIC ANEMIA, AND GLOMERULONEPHRITIS	0.07142860000000001	3.2467545454545457
GOODPASTURE SYNDROME	0.07142860000000001	3.2467545454545457
#614380 COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD;;C4A DEFICIENCY	0.07142860000000001	3.2467545454545457
248760 MARFANOID HABITUS WITH MICROCEPHALY AND GLOMERULONEPHRITIS	0.07142860000000001	3.2467545454545457
#104200 ALPORT SYNDROME, AUTOSOMAL DOMINANT	0.07142860000000001	3.2467545454545457
#614809 CFHR5 DEFICIENCY	0.07142860000000001	3.2467545454545457
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IV; MEN4	0.07142860000000001	3.2467545454545457
TUBULOINTERSTITIAL NEPHRITIS WITH UVEITIS; TINU	0.07142860000000001	3.2467545454545457
NAIL-PATELLA SYNDROME	0.07142860000000001	3.2467545454545457
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASEDEFICIENCY	0.07142860000000001	3.2467545454545457
#267430 RENAL TUBULAR DYSGENESIS; RTD;;PRIMITIVE RENAL TUBULE SYNDROMERENAL TUBULAR DYSGENESIS WITH CHOANAL ATRESIA AND ATHELIA, INCLUDED	0.07142860000000001	3.2467545454545457
%174770 ACTINIC PRURIGOPOLYMORPHIC LIGHT ERUPTION, HEREDITARY; HPLE;;JUVENILE SPRING ERUPTION OF EARS, INCLUDED	0.07142860000000001	3.2467545454545457
SHORT-RIB THORACIC DYSPLASIA 5 WITH OR WITHOUT POLYDACTYLY; SRTD5	0.07142860000000001	3.2467545454545457
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.07141779200000001	3.2462632727272727
ADAMS-OLIVER SYNDROME 6; AOS6	0.0708748	3.221581818181818
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.07063123099999999	3.2105104999999994
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.0702615	3.1937045454545454
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.0702615	3.1937045454545454
MENTAL RETARDATION, X-LINKED 98; MRX98	0.070157563	3.1889801363636368
RETINAL VENOUS BEADING	0.07004840000000001	3.1840181818181823
GLYCOGEN STORAGE DISEASE IB	0.06982071000000001	3.1736686363636366
GLYCOGEN STORAGE DISEASE IA	0.06982071000000001	3.1736686363636366
CRI-DU-CHAT SYNDROME	0.06971548	3.1688854545454537
CHROMOSOME 16p13.3 DELETION SYNDROME	0.068426333	3.110287863636364
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.067510582	3.068662818181818
HYDROPS FETALIS, NONIMMUNE	0.0666667	3.030304545454545
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.0666667	3.030304545454545
#263750 POSTAXIAL ACROFACIAL DYSOSTOSIS; POADS;;MILLER SYNDROME;;GENEE-WIEDEMANN SYNDROME	0.0666667	3.030304545454545
BARDET-BIEDL SYNDROME 12; BBS12	0.0666667	3.030304545454545
HYDROPS FETALIS, NONIMMUNE, WITH GRACILE BONES AND DYSMORPHIC FEATURES	0.0666667	3.030304545454545
NIPPLES, SUPERNUMERARY	0.0666667	3.030304545454545
#608980 BIFID NOSE WITH OR WITHOUT ANORECTAL AND RENAL ANOMALIES; BNAR	0.0666667	3.030304545454545
BARDET-BIEDL SYNDROME 11; BBS11	0.0666667	3.030304545454545
CHROMOSOME 17q12 DELETION SYNDROME	0.06641688000000001	3.0189490909090915
POLYCYSTIC LIVER DISEASE 2	0.06568471	2.9856686363636356
THYROCEREBRORETINAL SYNDROME	0.064717271	2.9416941363636364
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.06453013299999999	2.933187863636363
EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10	0.064163	2.9164999999999996
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.06348741	2.885791363636363
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.063415751	2.8825341363636365
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1	0.0632439	2.874722727272727
FEBRILE SEIZURES, FAMILIAL, 8; FEB8	0.0632439	2.874722727272727
POLYCYSTIC LIVER DISEASE 3 WITH OR WITHOUT KIDNEY CYSTS; PCLD3	0.0625	2.840909090909091
POLYCYSTIC KIDNEY DISEASE 3	0.0625	2.840909090909091
SHORT-RIB THORACIC DYSPLASIA 4 WITH OR WITHOUT POLYDACTYLY; SRTD4	0.0625	2.840909090909091
NEPHRONOPHTHISIS 13	0.0625	2.840909090909091
SENIOR-LOKEN SYNDROME 8; SLSN8	0.0625	2.840909090909091
POLYCYSTIC KIDNEY DISEASE 6 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD6	0.0625	2.840909090909091
POLYCYSTIC KIDNEY DISEASE 2	0.0625	2.840909090909091
POLYCYSTIC KIDNEYS	0.0625	2.840909090909091
%263630 POLYSYNDACTYLY WITH CARDIAC MALFORMATION;;BONNEAU SYNDROME	0.0625	2.840909090909091
POLYCYSTIC LIVER DISEASE 4 WITH OR WITHOUT KIDNEY CYSTS; PCLD4	0.0625	2.840909090909091
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.06215317100000001	2.8251441363636367
SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6	0.062018880000000005	2.81904
300270 ADRENOMYODYSTROPHY	0.06137848199999999	2.7899309999999993
FECHTNER SYNDROME	0.06123742	2.7835190909090906
ALPORT SYNDROME, X-LINKED; ATS	0.06123742	2.7835190909090906
Polyarteritis nodosa, childhood-onset	0.06118031	2.780923181818182
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.06092331	2.7692413636363633
RENAL-HEPATIC-PANCREATIC DYSPLASIA 2; RHPD2	0.06092331	2.7692413636363633
ATYPICAL MYCOBACTERIOSIS, FAMILIAL	0.060714300000000006	2.759740909090909
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.060580730000000006	2.753669545454546
#254770 EPILEPSY, MYOCLONIC JUVENILE; EJM;;MYOCLONIC EPILEPSY, JUVENILE; JME;;PETIT MAL, IMPULSIVE;;JANZ SYNDROMEMYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 1, INCLUDED; EJM1,INCLUDED	0.0598896	2.7222545454545455
#176000 PORPHYRIA, ACUTE INTERMITTENT;;AIP;;PORPHYRIA, SWEDISH TYPE;;PORPHOBILINOGEN DEAMINASE DEFICIENCY;;PBGD DEFICIENCY;;UROPORPHYRINOGEN SYNTHASE DEFICIENCY;;UPS DEFICIENCYPORPHYRIA, ACUTE INTERMITTENT, NONERYTHROID VARIANT, INCLUDED;;PORPHYRIA, CHESTER TYPE, INCLUDED; PORC, INCLUDED	0.059739251	2.7154204999999996
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.059637230000000006	2.710783181818182
#274150 THROMBOTIC THROMBOCYTOPENIC PURPURA, CONGENITAL; TTP;;MICROANGIOPATHIC HEMOLYTIC ANEMIA;;THROMBOTIC MICROANGIOPATHY, FAMILIAL;;UPSHAW-SCHULMAN SYNDROME; USS;;SCHULMAN-UPSHAW SYNDROME;;UPSHAW FACTOR, DEFICIENCY OF;;MICROANGIOPATHIC HEMOLYTIC ANEMIA, CONGENITAL;;THROMBOTIC THROMBOCYTOPENIC PURPURA, FAMILIAL	0.059160120000000004	2.6890963636363634
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.058970100000000004	2.680459090909091
RUIJS-AALFS SYNDROME; RJALS	0.0588235	2.6737954545454543
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IIA	0.058740310000000004	2.6700140909090906
SENIOR-LOKEN SYNDROME 9	0.058582482	2.6628400909090906
#615382 NEPHRONOPHTHISIS 16; NPHP16	0.0577386	2.624481818181818
#246200 DONOHUE SYNDROME;;LEPRECHAUNISMINSULIN RECEPTOR, DEFECT IN, INCLUDED	0.0577386	2.624481818181818
#170100 PROLIDASE DEFICIENCY	0.057270342	2.6031973636363634
EPILEPSY, PYRIDOXINE-DEPENDENT	0.057173092	2.598776909090909
EPILEPSY, IDIOPATHIC GENERALIZED	0.0566467	2.5748499999999996
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.056471351	2.5668795909090907
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.056399482	2.563612818181818
EDEMA, FAMILIAL IDIOPATHIC, PREPUBERTAL	0.056159499999999994	2.552704545454545
#229600 FRUCTOSE INTOLERANCE, HEREDITARY;;FRUCTOSEMIA;;FRUCTOSE-1-PHOSPHATE ALDOLASE DEFICIENCY;;FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE B DEFICIENCY;;ALDOLASE B DEFICIENCY;;ALDOB DEFICIENCY	0.055932361	2.5423800454545455
COMPLEMENT COMPONENT C1R DEFICIENCY	0.055555600000000004	2.5252545454545454
EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8	0.055555600000000004	2.5252545454545454
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.055555600000000004	2.5252545454545454
%613944 IgA NEPHROPATHY, SUSCEPTIBILITY TO, 2; IGAN2	0.055555600000000004	2.5252545454545454
IgA NEPHROPATHY, SUSCEPTIBILITY TO, 1; IGAN1	0.055555600000000004	2.5252545454545454
#300491 EPILEPSY, X-LINKED, WITH VARIABLE LEARNING DISABILITIES AND BEHAVIORDISORDERS	0.055555600000000004	2.5252545454545454
#300643 ROLANDIC EPILEPSY, MENTAL RETARDATION, AND SPEECH DYSPRAXIA, X-LINKED;RESDX	0.055555600000000004	2.5252545454545454
HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 1; HNFJ1	0.055555600000000004	2.5252545454545454
%161900 RENAL FAILURE, PROGRESSIVE, WITH HYPERTENSION; RFH1;;NEPHROPATHY, FAMILIAL;;NEPHRITIS, FAMILIAL, WITHOUT DEAFNESS OR OCULAR DEFECT;;RENAL FAILURE, ADULT-ONSET; AORF	0.055555600000000004	2.5252545454545454
#603194 MECKEL SYNDROME, TYPE 2; MKS2;;MECKEL-GRUBER SYNDROME, TYPE 2	0.055555600000000004	2.5252545454545454
MECKEL SYNDROME, TYPE 1; MKS1	0.055555600000000004	2.5252545454545454
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.055555600000000004	2.5252545454545454
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.055555600000000004	2.5252545454545454
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.055555600000000004	2.5252545454545454
MECKEL SYNDROME, TYPE 4; MKS4	0.055555600000000004	2.5252545454545454
APNEA, OBSTRUCTIVE SLEEP	0.055555600000000004	2.5252545454545454
DYSCHONDROSTEOSIS AND NEPHRITIS	0.055555600000000004	2.5252545454545454
#614420 SYSTEMIC LUPUS ERYTHEMATOSUS 16; SLEB16	0.055555600000000004	2.5252545454545454
#609057 NEPHROPATHY WITH PRETIBIAL EPIDERMOLYSIS BULLOSA AND DEAFNESS	0.055555600000000004	2.5252545454545454
ALPORT SYNDROME, AUTOSOMAL RECESSIVE	0.055555600000000004	2.5252545454545454
#615506 TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 5; HHT5	0.0554315	2.519613636363636
LISSENCEPHALY 5; LIS5	0.055421551	2.519161409090909
#601277 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4A; ARCI4A;;ICHTHYOSIS CONGENITA IIB; ICR2B;;ICHTHYOSIS, LAMELLAR, 2, FORMERLY; LI2, FORMERLY	0.054582200000000004	2.481009090909091
%300660 LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD	0.0545058	2.4775363636363634
#221820 LEUKOENCEPHALOPATHY, DIFFUSE HEREDITARY, WITH SPHEROIDS; HDLS;;LEUKOENCEPHALOPATHY WITH NEUROAXONAL SPHEROIDS, AUTOSOMAL DOMINANT;;GLIOSIS, FAMILIAL PROGRESSIVE SUBCORTICAL; GPSC;;DEMENTIA, FAMILIAL, NEUMANN TYPE;;SUBCORTICAL GLIOSIS OF NEUMANN	0.0545058	2.4775363636363634
PROTOPORPHYRIA, ERYTHROPOIETIC	0.0544928	2.4769454545454543
FUMARASE DEFICIENCY; FMRD	0.054194582	2.463390090909091
PITUITARY HORMONE DEFICIENCY, COMBINED, 1	0.053478300000000006	2.4308318181818183
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.053346413	2.4248369545454547
SICKLE CELL ANEMIA	0.05318471	2.417486818181818
#614480 HYPERTRIGLYCERIDEMIA, TRANSIENT INFANTILE; HTGTI	0.05312091	2.4145868181818178
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.052979582	2.4081628181818178
RHEUMATOID ARTHRITIS	0.0522012	2.372781818181818
AMYLOIDOSIS, FAMILIAL VISCERAL	0.05216031	2.3709231818181817
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.051934762	2.360671
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.050986743	2.317579227272727
NIEMANN-PICK DISEASE, TYPE C2	0.050986743	2.317579227272727
PORTAL HYPERTENSION, NONCIRRHOTIC	0.05080371	2.3092595454545455
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.050263063000000004	2.284684681818182
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.050207100000000005	2.282140909090909
CARDIAC VALVULAR DEFECT, DEVELOPMENTAL; CVDD	0.050207100000000005	2.282140909090909
#200610 ACHONDROGENESIS, TYPE II; ACG2;;ACHONDROGENESIS, LANGER-SALDINO TYPE;;CHONDROGENESIS IMPERFECTA;;ACHONDROGENESIS, TYPE IB, FORMERLYHYPOCHONDROGENESIS, INCLUDED	0.050207100000000005	2.282140909090909
#600972 ACHONDROGENESIS, TYPE IB; ACG1B;;ACHONDROGENESIS, FRACCARO TYPE	0.050207100000000005	2.282140909090909
CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS 2	0.0501831	2.2810499999999996
GLYCOGEN STORAGE DISEASE VII	0.05	2.272727272727273
SPHEROCYTOSIS, TYPE 1; SPH1	0.05	2.272727272727273
ANEMIA, DYSERYTHROPOIETIC CONGENITAL, TYPE II	0.05	2.272727272727273
HEMOGLOBIN--BETA LOCUS	0.05	2.272727272727273
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.049688663	2.258575590909091
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.049632143000000004	2.2560065000000002
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.049572133	2.2532787727272723
ARIMA SYNDROME	0.048716392	2.2143814545454545
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.048590312000000004	2.208650545454545
%614280 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9	0.048538	2.2062727272727267
FEBRILE CONVULSIONS, FAMILIAL, 9	0.048538	2.2062727272727267
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.04828671300000001	2.194850590909091
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.048209840000000004	2.1913563636363635
#300752 PROTOPORPHYRIA, ERYTHROPOIETIC, X-LINKED; XLEPP;;PROTOPORPHYRIA, ERYTHROPOIETIC, X-LINKED DOMINANT; XLDPP;;ERYTHROHEPATIC PROTOPORPHYRIA, X-LINKED;	0.0478125	2.1732954545454546
WILLIAMS-BEUREN SYNDROME; WBS	0.047619	2.1645
NIEMANN-PICK DISEASE, TYPE A	0.047506892	2.1594041818181817
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 5	0.0474568	2.157127272727273
DK PHOCOMELIA SYNDROME	0.04734851999999999	2.1522054545454536
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 3; CGL3	0.04705261	2.1387549999999997
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.046400422999999996	2.109110136363636
HEMOGLOBIN--ALPHA LOCUS 1; HBA1	0.045714300000000006	2.0779227272727274
PORPHYRIA, CONGENITAL ERYTHROPOIETIC; CEP	0.04568182	2.076446363636363
HYPERLYSINEMIA, TYPE I	0.045631230999999994	2.074146863636363
Lipodystrophy, congenital generalized, type 1	0.04501661	2.0462095454545453
Lipodystrophy, congenital generalized, type 2	0.04501661	2.0462095454545453
INTERSTITIAL LUNG AND LIVER DISEASE; ILLD	0.04501661	2.0462095454545453
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.044914362	2.041561909090909
DIGEORGE SYNDROME; DGS	0.044808413	2.0367460454545454
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.04465201	2.0296368181818183
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Il; CDG1L	0.044437143	2.019870136363636
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.044394051000000004	2.017911409090909
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.044370682	2.016849181818182
PEROXISOME BIOGENESIS DISORDER 10B	0.044322182	2.014644636363636
#616278 BILE ACID SYNTHESIS DEFECT, CONGENITAL, 5; CBAS5	0.04425301	2.0115004545454545
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	0.0435858	1.9811727272727273
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.043479851	1.9763568636363633
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, DUE TO G6PD DEFICIENCY	0.043478300000000004	1.9762863636363637
GALACTOKINASE DEFICIENCY	0.043478300000000004	1.9762863636363637
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ih; CDG1H	0.04334933	1.9704240909090909
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.042784682000000004	1.9447582727272725
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.042594781	1.936126409090909
#309520 LUJAN-FRYNS SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH MARFANOID HABITUS	0.04258245099999999	1.935565954545454
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.041865582	1.9029809999999998
%193250 VOLVULUS OF MIDGUT;;INTESTINAL MALROTATION, FAMILIAL	0.041666699999999994	1.8939409090909087
ADENOMYOSIS	0.041666699999999994	1.8939409090909087
GENITOURINARY TRACT ANOMALIES	0.041666699999999994	1.8939409090909087
FRYNS MICROPHTHALMIA SYNDROME	0.041666699999999994	1.8939409090909087
LABIA MINORA, INCOMPLETE ADHESION OF	0.041666699999999994	1.8939409090909087
URINARY BLADDER, ATONY OF	0.041666699999999994	1.8939409090909087
#193400 VON WILLEBRAND DISEASE, TYPE 1; VWD1;;VON WILLEBRAND DISEASE, TYPE I;;VWD, TYPE 1	0.041666699999999994	1.8939409090909087
SPLENOGONADAL FUSION WITH LIMB DEFECTS AND MICROGNATHIA	0.041666699999999994	1.8939409090909087
OVARIAN HYPERSTIMULATION SYNDROME	0.041666699999999994	1.8939409090909087
TESTICULAR TORSION	0.041666699999999994	1.8939409090909087
HYDATIDIFORM MOLE, RECURRENT, 1; HYDM1	0.041666699999999994	1.8939409090909087
NATHALIE SYNDROME	0.041666699999999994	1.8939409090909087
GALACTORRHEA	0.041666699999999994	1.8939409090909087
#226730 EPIDERMOLYSIS BULLOSA JUNCTIONALIS WITH PYLORIC ATRESIA;;EPIDERMOLYSIS BULLOSA, JUNCTIONAL, WITH PYLORIC ATRESIA;;JUNCTIONAL EPIDERMOLYSIS BULLOSA WITH PYLORIC ATRESIA;;JEB-PA;;EPIDERMYLOSIS BULLOSA, JUNCTIONAL, WITH PYLORIC ATRESIA AND APLASIACUTIS CONGENITA;;EB-PA-ACC;;CARMI SYNDROME;;APLASIA CUTIS CONGENITA WITH GASTROINTESTINAL ATRESIA	0.041666699999999994	1.8939409090909087
PEYRONIE DISEASE	0.041666699999999994	1.8939409090909087
138790 GOITER, MULTINODULAR, CYSTIC RENAL DISEASE, AND DIGITAL ANOMALIES;;MULTINODULAR GOITER/CYSTIC RENAL DISEASE/DIGITAL ANOMALIES;;MNG/CRD/DA	0.041666699999999994	1.8939409090909087
LEUKEMIA, ACUTE MYELOCYTIC, WITH POLYPOSIS COLI AND COLON CANCER	0.041666699999999994	1.8939409090909087
207620 APHALANGY WITH HEMIVERTEBRAE	0.041666699999999994	1.8939409090909087
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ib; CDG1B	0.04159201	1.890545909090909
MUCOLIPIDOSIS IV; ML4	0.041583312000000004	1.8901505454545455
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.041346483	1.8793855909090909
LETTERER-SIWE DISEASE	0.04068182	1.8491736363636362
INFANTILE SIALIC ACID STORAGE DISEASE	0.040658643	1.8481201363636364
#611465 GALLBLADDER DISEASE 4; GBD4	0.04	1.8181818181818181
MYOTONIC DYSTROPHY 1	0.04	1.8181818181818181
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.039906382000000004	1.8139264545454545
PELVIC LIPOMATOSIS WITH CROSSED RENAL ECTOPIA	0.03979593000000001	1.8089059090909094
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.03979593000000001	1.8089059090909094
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.03979593000000001	1.8089059090909094
ASPLENIA, ISOLATED CONGENITAL; ICAS	0.03979593000000001	1.8089059090909094
MYELOCEREBELLAR DISORDER	0.039495920000000004	1.7952690909090911
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.039442812	1.7928550909090908
HYPOADRENOCORTICISM, FAMILIAL	0.039377251	1.7898750454545456
COWDEN SYNDROME 5; CWS5	0.039377251	1.7898750454545456
COWDEN SYNDROME 6; CWS6	0.039377251	1.7898750454545456
PEHO-LIKE SYNDROME; PEHOL	0.039229712	1.783168727272727
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.038899010000000005	1.7681368181818182
#613673 ANEMIA, DYSERYTHROPOIETIC CONGENITAL, TYPE IV; CDAN4	0.038899010000000005	1.7681368181818182
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.038664351	1.7574705
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.038622513	1.7555687727272724
#609060 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 1; COXPD1;;HEPATOENCEPHALOPATHY, EARLY FATAL PROGRESSIVE	0.038583261	1.7537845909090906
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.03849432	1.7497418181818178
SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS	0.0384615	1.74825
%113950 BUNDLE BRANCH BLOCK, FAMILIAL ISOLATED COMPLETE RIGHT	0.0384615	1.74825
ARTERIES, ANOMALIES OF	0.0384615	1.74825
140450 HEART-HAND SYNDROME, SPANISH TYPE	0.0384615	1.74825
HEMANGIOPERICYTOMA, MALIGNANT	0.0384615	1.74825
150590 LEG ULCERS, FAMILIAL, OF JUVENILE ONSET	0.0384615	1.74825
VENULAR INSUFFICIENCY, SYSTEMIC	0.0384615	1.74825
NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT	0.0384615	1.74825
PREPAPILLARY VASCULAR LOOPS	0.0384615	1.74825
WATSON SYNDROME	0.0384615	1.74825
#214700 DIARRHEA 1, SECRETORY CHLORIDE, CONGENITAL; DIAR1;;CHLORIDE DIARRHEA, CONGENITAL, FINNISH TYPE;;CHLORIDORRHEA, CONGENITAL	0.0384615	1.74825
ATROPHODERMA VERMICULATA; AVA	0.0384615	1.74825
ACRORENAL-MANDIBULAR SYNDROME	0.0384615	1.74825
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.0384615	1.74825
THUMB DEFORMITY	0.0384615	1.74825
MUSCULAR HYPERTONIA, LETHAL	0.0384615	1.74825
BETHLEM MYOPATHY 1	0.0384615	1.74825
#608358 MYOPATHY, MYOSIN STORAGE;;MYOPATHY, HYALINE BODY, AUTOSOMAL DOMINANT	0.0384615	1.74825
#206920 MICROPHTHALMIA WITH LIMB ANOMALIES;;WAARDENBURG ANOPHTHALMIA SYNDROME;;ANOPHTHALMIA-SYNDACTYLY;;OPHTHALMOACROMELIC SYNDROME; OAS	0.0384615	1.74825
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.0379617	1.725531818181818
BLOOD GROUP, DUFFY SYSTEM; FY	0.037414930000000006	1.7006786363636364
#261000 INTRINSIC FACTOR DEFICIENCY; IFD;;PERNICIOUS ANEMIA, CONGENITAL, DUE TO DEFECT OF INTRINSIC FACTOR	0.037414930000000006	1.7006786363636364
INOSINE PHOSPHORYLASE DEFICIENCY, IMMUNE DEFECT DUE TO	0.037414930000000006	1.7006786363636364
MYELOPEROXIDASE DEFICIENCY	0.037414930000000006	1.7006786363636364
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.037190881	1.6904945909090907
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.037119012	1.6872278181818179
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4	0.0369281	1.6785499999999998
FEBRILE SEIZURES, FAMILIAL, 11; FEB11	0.0369281	1.6785499999999998
SHORT SYNDROME	0.036382080000000004	1.6537309090909094
#616341 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 30; EIEE30	0.036199912	1.6454505454545454
3-HYDROXY-3-METHYLGLUTARYL-CoA LYASE DEFICIENCY; HMGCLD	0.036194343	1.6451974090909087
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.036058413	1.6390187727272725
#215045 CHONDRODYSPLASIA, BLOMSTRAND TYPE; BOCD	0.035714300000000004	1.6233772727272728
#200600 ACHONDROGENESIS, TYPE IA; ACG1A;;ACHONDROGENESIS, HOUSTON-HARRIS TYPE	0.035714300000000004	1.6233772727272728
LETHAL CONGENITAL CONTRACTURE SYNDROME 10; LCCS10	0.035714300000000004	1.6233772727272728
PANCREATIC BETA CELL AGENESIS WITH NEONATAL DIABETES MELLITUS	0.035714300000000004	1.6233772727272728
ULNAR AGENESIS AND ENDOCARDIAL FIBROELASTOSIS	0.035714300000000004	1.6233772727272728
PARANA HARD-SKIN SYNDROME	0.035714300000000004	1.6233772727272728
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.035714300000000004	1.6233772727272728
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC 27; CMH27	0.035714300000000004	1.6233772727272728
#255320 MINICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA;;MINICORE MYOPATHY;;MULTICORE MYOPATHY;;MULTIMINICORE MYOPATHY MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA;;MULTIMINICORE DISEASE WITH EXTERNAL OPHTHALMOPLEGIA	0.035714300000000004	1.6233772727272728
MISMATCH REPAIR CANCER SYNDROME; MMRCS	0.035714300000000004	1.6233772727272728
FRASER SYNDROME 3; FRASRS3	0.035714300000000004	1.6233772727272728
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.035714300000000004	1.6233772727272728
YUNIS-VARON SYNDROME	0.035714300000000004	1.6233772727272728
SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY	0.035714300000000004	1.6233772727272728
POLYPOSIS SYNDROME, HEREDITARY MIXED, 1	0.035714300000000004	1.6233772727272728
TERATOMA, PINEAL	0.035714300000000004	1.6233772727272728
%243600 JEJUNAL ATRESIA;;APPLE PEEL SYNDROME;;APPLE PEEL SMALL BOWEL SYNDROME; APSB	0.035714300000000004	1.6233772727272728
GASTRIC SNEEZING	0.035714300000000004	1.6233772727272728
HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	0.035714300000000004	1.6233772727272728
SCLERODERMA, FAMILIAL PROGRESSIVE	0.035714300000000004	1.6233772727272728
AMYLOIDOSIS, FINNISH TYPE	0.035714300000000004	1.6233772727272728
MESOMELIA-SYNOSTOSES SYNDROME	0.035714300000000004	1.6233772727272728
AURAL ATRESIA, MULTIPLE CONGENITAL ANOMALIES, AND MENTAL RETARDATION	0.035714300000000004	1.6233772727272728
METHANE PRODUCTION	0.035714300000000004	1.6233772727272728
FIBROCHONDROGENESIS 1; FBCG1	0.035714300000000004	1.6233772727272728
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.035714300000000004	1.6233772727272728
GALLBLADDER, AGENESIS OF	0.035714300000000004	1.6233772727272728
BLUE DIAPER SYNDROME	0.035714300000000004	1.6233772727272728
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.035573732999999996	1.6169878636363635
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.03533163	1.6059831818181818
#222748 DIHYDROPYRIMIDINASE DEFICIENCY;;DIHYDROPYRIMIDINURIA;;DPYS DEFICIENCY;;DPH DEFICIENCY	0.035214531	1.6006605
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.035142662	1.5973937272727272
GABRIELE-DE VRIES SYNDROME; GADEVS	0.035142662	1.5973937272727272
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.03509293300000001	1.5951333181818184
RETICULOENDOTHELIOSIS, X-LINKED	0.035	1.590909090909091
HYPERLIPOPROTEINEMIA, TYPE I	0.035	1.590909090909091
MEGALENCEPHALY WITH DYSMYELINATION	0.034729851	1.5786295909090908
OCULODENTODIGITAL DYSPLASIA; ODDD	0.034729851	1.5786295909090908
PEROXISOME BIOGENESIS DISORDER 6B	0.034657982	1.575362818181818
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIj; CDG2J	0.034653691	1.5751677727272726
#603358 GRACILE SYNDROME;;GROWTH RETARDATION, AMINO ACIDURIA, CHOLESTASIS, IRON OVERLOAD, LACTICACIDOSIS, AND EARLY DEATH;;FINNISH LETHAL NEONATAL METABOLIC SYNDROME; FLNMS;;LACTIC ACIDOSIS, FINNISH, WITH HEPATIC HEMOSIDEROSIS;;FELLMAN SYNDROME	0.0344828	1.5674000000000001
#613721 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 11; EIEE11	0.034417682	1.5644400909090905
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.034281382	1.5582446363636362
#232400 GLYCOGEN STORAGE DISEASE III;;GSD III; GSD3;;FORBES DISEASE;;CORI DISEASE;;LIMIT DEXTRINOSIS;;AMYLO-1,6-GLUCOSIDASE DEFICIENCY;;AGL DEFICIENCY;;GLYCOGEN DEBRANCHER DEFICIENCY;;GDE DEFICIENCYGLYCOGEN STORAGE DISEASE IIIa, INCLUDED; GSD IIIa, INCLUDED;;GLYCOGEN STORAGE DISEASE IIIb, INCLUDED; GSD IIIb, INCLUDED;;GLYCOGEN STORAGE DISEASE IIIc, INCLUDED; GSD IIIc, INCLUDED;;GLYCOGEN STORAGE DISEASE IIId, INCLUDED; GSD IIId, INCLUDED	0.03425301	1.5569549999999999
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.034188843	1.5540383181818178
#604367 LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 3; FPLD3;;LIPODYSTROPHY, FAMILIAL PARTIAL, ASSOCIATED WITH PPARG MUTATIONS	0.0340194	1.5463363636363634
OSTEOPETROSIS,  AUTOSOMAL RECESSIVE 4; OPTB4	0.03386653	1.5393877272727272
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	0.0338141	1.5370045454545453
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.0335738	1.526081818181818
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.03351561	1.523436818181818
#614652 COENZYME Q10 DEFICIENCY, PRIMARY, 3; COQ10D3	0.0333607	1.5163954545454545
RHEUMATIC FEVER-RELATED ANTIGENRHEUMATIC FEVER, ACUTE, SUSCEPTIBILITY TO, INCLUDED	0.0333333	1.51515
RAGWEED SENSITIVITY	0.0333333	1.51515
SUSCEPTIBILITY TO LYSIS BY ALLOREACTIVE NATURAL KILLER CELLS	0.0333333	1.51515
#254300 MYASTHENIA, LIMB-GIRDLE, FAMILIAL;;LGM;;CONGENITAL MYASTHENIC SYNDROME TYPE Ib; CMS1B;;CMS Ib;;MYASTHENIC MYOPATHY, FORMERLY	0.0333333	1.51515
IMMUNOGLOBULIN D LEVEL IN PLASMA, LOW	0.0333333	1.51515
#250460 METAPHYSEAL DYSPLASIA WITHOUT HYPOTRICHOSIS;;CARTILAGE-HAIR HYPOPLASIA-LIKE SKELETAL DYSPLASIA WITHOUT HYPOTRICHOSISOR IMMUNODEFICIENCY;;CARTILAGE-HAIR HYPOPLASIA VARIANT, SKELETAL MANIFESTATIONS ONLY; CHHV	0.0333333	1.51515
IMMUNE SUPPRESSION	0.0333333	1.51515
DEFECTIVE INTERFERING PARTICLE INDUCTION, CONTROL OF	0.0333333	1.51515
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.0333333	1.51515
MYASTHENIA GRAVIS; MG	0.0333333	1.51515
#246300 LEPROSY, SUSCEPTIBILITY TO, 3; LPRS3	0.0333333	1.51515
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.0333333	1.51515
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.0333333	1.51515
GLOBULIN ANOMALY INVOLVING BETA (2A)-GLOBULIN	0.0333333	1.51515
ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS	0.0333333	1.51515
RADIATION SENSITIVITY OF NATURAL KILLER ACTIVITY	0.0333333	1.51515
ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA	0.0333333	1.51515
SCHISTOSOMA MANSONI INFECTION, SUSCEPTIBILITY/RESISTANCE TO	0.0333333	1.51515
Growth hormone deficiency, isolated, type IA	0.0333333	1.51515
ECHO VIRUS 11 SENSITIVITY	0.0333333	1.51515
LISSENCEPHALY 1; LIS1	0.033009633	1.5004378636363633
HAREL-YOON SYNDROME; HAYOS	0.032772562	1.489661909090909
#612199 CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS; CRMCC;;COATS PLUS SYNDROME	0.032417471	1.473521409090909
Adrenoleukodystrophy	0.032165751	1.4620795909090907
CHROMOSOME 18Q DELETION SYNDROME	0.032165751	1.4620795909090907
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.032093882	1.4588128181818178
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.032093882	1.4588128181818178
INFANTILE LIVER FAILURE SYNDROME 1	0.031624743	1.437488318181818
#610539 GAUCHER DISEASE, ATYPICAL, DUE TO SAPOSIN C DEFICIENCY	0.031597571000000005	1.4362532272727273
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.03125	1.4204545454545454
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5; MDDGA5	0.03125	1.4204545454545454
#302800 CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 1; CMTX1;;CMTX;;CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY, X-LINKED;;HEREDITARY MOTOR AND SENSORY NEUROPATHY, X-LINKED;;HMSN, X-LINKED;;CHARCOT-MARIE-TOOTH NEUROPATHY, X-LINKED, 1;;CMT2, FORMERLY	0.03125	1.4204545454545454
#606612 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH OR WITHOUTMENTAL RETARDATION), TYPE B, 5; MDDGB5;;MUSCULAR DYSTROPHY, CONGENITAL, 1C; MDC1C;;MUSCULAR DYSTROPHY, CONGENITAL, FKRP-RELATED	0.03125	1.4204545454545454
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.030780861	1.3991300454545452
#259710 OSTEOPETROSIS, AUTOSOMAL RECESSIVE 2; OPTB2;;OSTEOPETROSIS, OSTEOCLAST-POOR;;OSTEOPETROSIS, MILD AUTOSOMAL RECESSIVE FORM	0.030681820000000002	1.3946281818181818
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.0303309	1.3786772727272727
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.0303309	1.3786772727272727
MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4	0.0303309	1.3786772727272727
#257300 MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 1; MVA1;;MVA SYNDROME	0.0303309	1.3786772727272727
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.030040563	1.3654801363636362
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.02986511	1.3575049999999997
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.02986511	1.3575049999999997
MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME; MDPL	0.02986511	1.3575049999999997
#612951 LEUKOENCEPHALOPATHY, CYSTIC, WITHOUT MEGALENCEPHALY	0.029784431	1.3538377727272726
AICARDI-GOUTIERES SYNDROME 5	0.029781502	1.3537046363636362
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.02950051	1.3409322727272726
OPTIC ATROPHY 11; OPA11	0.029124812	1.323855090909091
THANATOPHORIC DYSPLASIA, GLASGOW VARIANT	0.02908163	1.3218922727272726
HURLER SYNDROME	0.029028592000000002	1.3194814545454545
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 1; DKCB1	0.02893762	1.3153463636363636
PREECLAMPSIA/ECLAMPSIA 1	0.028902871	1.3137668636363635
MYOCLONIC-ATONIC EPILEPSY	0.0288799	1.312722727272727
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.028837373	1.3107896818181817
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.028750831	1.3068559545454546
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.028440033	1.2927287727272725
#251290 BAND-LIKE CALCIFICATION WITH SIMPLIFIED GYRATION AND POLYMICROGYRIA;BLCPMG;;PSEUDO-TORCH SYNDROME	0.028438663	1.2926665
#606367 IMMUNODEFICIENCY 41 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY; IMD41;;INTERLEUKIN 2 RECEPTOR, ALPHA, DEFICIENCY OF;;IL2RA DEFICIENCY;;CD25 DEFICIENCY	0.02818471	1.2811231818181819
LEUKOCYTE ADHESION DEFICIENCY, TYPE III	0.02818471	1.2811231818181819
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.028075433	1.2761560454545453
OCULOECTODERMAL SYNDROME; OES	0.028075433	1.2761560454545453
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.027579533	1.2536151363636363
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.027579533	1.2536151363636363
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.027579533	1.2536151363636363
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.027579533	1.2536151363636363
SANDHOFF DISEASE	0.0275641	1.2529136363636364
ICHTHYOSIS, HEPATOSPLENOMEGALY, AND CEREBELLAR DEGENERATION	0.0275641	1.2529136363636364
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.027524282	1.2511037272727272
Fabry disease	0.027231551	1.2377977727272726
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.027231551	1.2377977727272726
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.027231551	1.2377977727272726
MENTAL RETARDATION, X-LINKED 41	0.027159682	1.234531
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.027159682	1.234531
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.027148462	1.2340209999999998
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIc; CDG2C	0.027147712	1.233986909090909
#231000 GAUCHER DISEASE, TYPE III;;GD III;;GAUCHER DISEASE, SUBACUTE NEURONOPATHIC TYPE;;GAUCHER DISEASE, CHRONIC NEURONOPATHIC TYPE;;GAUCHER DISEASE, JUVENILE AND ADULT, CEREBRALGAUCHER DISEASE, TYPE IIIA, INCLUDED;;GAUCHER DISEASE, TYPE IIIB, INCLUDED;;GAUCHER DISEASE, NORRBOTTNIAN TYPE, INCLUDED	0.02705563	1.2298013636363636
#615516 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 38; MRT38	0.027030613000000002	1.2286642272727273
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.026735651	1.2152568636363634
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2EE; CMT2EE	0.0266804	1.2127454545454543
JOUBERT SYNDROME 1	0.026663782	1.2119900909090908
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21	0.02644051	1.2018413636363636
ACROCEPHALOPOLYDACTYLOUS DYSPLASIA	0.02644051	1.2018413636363636
LYMPHEDEMA, HEREDITARY, IB	0.0263158	1.1961727272727272
#163950 NOONAN SYNDROME 1; NS1;;NOONAN SYNDROME;;MALE TURNER SYNDROME;;FEMALE PSEUDO-TURNER SYNDROME;;TURNER PHENOTYPE WITH NORMAL KARYOTYPEPTERYGIUM COLLI SYNDROME, INCLUDED	0.0263158	1.1961727272727272
LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA	0.0263158	1.1961727272727272
LYMPHEDEMA AND CEREBRAL ARTERIOVENOUS ANOMALY	0.0263158	1.1961727272727272
#616006 HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 2; HKLLS2	0.0263158	1.1961727272727272
#300301 ECTODERMAL DYSPLASIA, ANHIDROTIC, WITH IMMUNODEFICIENCY, OSTEOPETROSIS,AND LYMPHEDEMA; OLEDAID	0.0263158	1.1961727272727272
#613611 CHOANAL ATRESIA AND LYMPHEDEMA	0.0263158	1.1961727272727272
GERMAN SYNDROME	0.0263158	1.1961727272727272
#612269 EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 5; ECA5	0.0263158	1.1961727272727272
AL-GAZALI-BAKALINOVA SYNDROME; AGBK	0.0263158	1.1961727272727272
CHROMOSOME Xp11.23-p11.22 DUPLICATION SYNDROME	0.0263158	1.1961727272727272
LYMPHEDEMA-HYPOPARATHYROIDISM SYNDROME	0.0263158	1.1961727272727272
DOHLE BODIES AND LEUKEMIA	0.0263158	1.1961727272727272
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.0263158	1.1961727272727272
#613480 LYMPHEDEMA, HEREDITARY, IC;;LMPH1C	0.0263158	1.1961727272727272
CAPILLARY MALFORMATION OF THE LOWER LIP, LYMPHATIC MALFORMATION OF FACE AND NECK, ASYMMETRY OF FACE AND LIMBS, AND PARTIAL/GENERALIZED OVERGROWTH	0.0263158	1.1961727272727272
LYMPHEDEMA, HEREDITARY, ID; LMPH1D	0.0263158	1.1961727272727272
#609242 KANZAKI DISEASE;;ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY, TYPE II;;ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY, ADULT-ONSET;;NAGA DEFICIENCY, TYPE II;;SCHINDLER DISEASE, TYPE II	0.0263158	1.1961727272727272
HYPERPROLINEMIA, TYPE I	0.026240413	1.1927460454545453
HYPERMANGANESEMIA WITH DYSTONIA 1; HMNDYT1	0.02614871	1.1885777272727271
HEMOCHROMATOSIS, TYPE 2B	0.02614871	1.1885777272727271
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.026114862000000003	1.1870391818181818
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.026114862000000003	1.1870391818181818
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.026114862000000003	1.1870391818181818
LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION; LBSL	0.0258199	1.1736318181818182
CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	0.0258199	1.1736318181818182
#610127 CEROID LIPOFUSCINOSIS, NEURONAL, 10; CLN10;;CEROID LIPOFUSCINOSIS, NEURONAL, CATHEPSIN D-DEFICIENT;;NEURONAL CEROID LIPOFUSCINOSIS DUE TO CATHEPSIN D DEFICIENCYNEURONAL CEROID LIPOFUSCINOSIS, CONGENITAL, INCLUDED	0.02551363	1.1597104545454544
RETINITIS PIGMENTOSA 71; RP71	0.02535408	1.1524581818181818
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.025270980000000002	1.1486809090909091
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.025015433	1.1370651363636364
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.025015433	1.1370651363636364
NEUTROPHILIA, HEREDITARY	0.025	1.1363636363636365
ANEMIA, SIDEROBLASTIC, PYRIDOXINE-RESPONSIVE, AUTOSOMAL RECESSIVE	0.025	1.1363636363636365
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3; OPTB3	0.025	1.1363636363636365
IMMUNE DEFECT DUE TO ABSENCE OF THYMUS	0.025	1.1363636363636365
RENAL TUBULAR ACIDOSIS, DISTAL, WITH HEMOLYTIC ANEMIA	0.025	1.1363636363636365
HEMOLYTIC ANEMIA, LETHAL CONGENITAL NONSPHEROCYTIC, WITH GENITAL AND OTHER ABNORMALITIES	0.025	1.1363636363636365
BENT BONE DYSPLASIA SYNDROME; BBDS	0.025	1.1363636363636365
#156200 MENTAL RETARDATION, AUTOSOMAL DOMINANT 1; MRD1CHROMOSOME 2q23.1 DELETION SYNDROME, INCLUDED	0.0247863	1.12665
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.0247863	1.12665
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.024736912	1.1244050909090908
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.024736912	1.1244050909090908
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.024736912	1.1244050909090908
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.024736912	1.1244050909090908
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.024736912	1.1244050909090908
CHANARIN-DORFMAN SYNDROME	0.02461671	1.1189413636363637
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.024241302	1.1018773636363635
#236792 L-2-HYDROXYGLUTARIC ACIDURIA;;L-2-HYDROXYGLUTARIC ACIDEMIA	0.024171551	1.0987068636363635
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.024171551	1.0987068636363635
#125310 CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTSAND LEUKOENCEPHALOPATHY; CADASIL;;DEMENTIA, HEREDITARY MULTI-INFARCT TYPE;;CASIL	0.024171551	1.0987068636363635
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.024171551	1.0987068636363635
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.024171551	1.0987068636363635
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.024171551	1.0987068636363635
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.024171551	1.0987068636363635
NEPHRONOPHTHISIS 11; NPHP11	0.024099682	1.095440090909091
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.024099682	1.095440090909091
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.02389303	1.086046818181818
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.02389303	1.086046818181818
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.02389303	1.086046818181818
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.023812243	1.0823746818181819
#127550 DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT, 1; DKCA1;;DYSKERATOSIS CONGENITA, SCOGGINS TYPE	0.02339742	1.0635190909090908
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 3; SCAN3	0.0232558	1.057081818181818
#615651 LEUKOENCEPHALOPATHY WITH ATAXIA; LKPAT	0.0232558	1.057081818181818
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.0232558	1.057081818181818
#604387 NEPHRONOPHTHISIS 3; NPHP3;;NPH3	0.0232558	1.057081818181818
#611390 SPASTIC ATAXIA 3, AUTOSOMAL RECESSIVE; SPAX3;;AUTOSOMAL RECESSIVE SPASTIC ATAXIA WITH LEUKOENCEPHALOPATHY; ARSAL	0.0232558	1.057081818181818
LEUKOENCEPHALOPATHY WITH DYSTONIA AND MOTOR NEUROPATHY	0.0232558	1.057081818181818
#615281 HYPOMYELINATION WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LEGSPASTICITY; HBSL;;ASPARTYL-tRNA SYNTHETASE DEFICIENCY	0.0232558	1.057081818181818
ANGIOPATHY, HEREDITARY, WITH NEPHROPATHY, ANEURYSMS, AND MUSCLE CRAMPS	0.0232558	1.057081818181818
PORPHYRIA CUTANEA TARDA, TYPE I	0.0232558	1.057081818181818
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.023066082	1.0484582727272727
HEMOCHROMATOSIS, TYPE 3; HFE3	0.022964	1.0438181818181818
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.02294953	1.0431604545454545
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.02294953	1.0431604545454545
GRANULOMAS, CONGENITAL CEREBRAL	0.02294953	1.0431604545454545
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.02294953	1.0431604545454545
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.02294953	1.0431604545454545
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.022533573	1.024253318181818
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.0223053	1.0138772727272727
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.022275882	1.012540090909091
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.022275882	1.012540090909091
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.022275882	1.012540090909091
EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6	0.0222222	1.0101
EPILEPSY, HOT WATER, 1	0.0222222	1.0101
MENTAL RETARDATION, X-LINKED 77	0.0222222	1.0101
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.0222222	1.0101
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.0222222	1.0101
#610951 CEROID LIPOFUSCINOSIS, NEURONAL, 7; CLN7	0.022081762	1.0037164545454547
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 34; COXPD34	0.02205261	1.0023913636363635
#615238 LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 5; FPLD5;;LIPODYSTROPHY, FAMILIAL PARTIAL, ASSOCIATED WITH CIDEC MUTATIONS	0.02205261	1.0023913636363635
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2	0.02205261	1.0023913636363635
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.02205261	1.0023913636363635
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIe; CDG2E	0.021912961	0.9960436818181819
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.021494012	0.9770005454545453
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.021494012	0.9770005454545453
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.021494012	0.9770005454545453
ALPHA-METHYLACYL-CoA RACEMASE DEFICIENCY; AMACRD	0.021432	0.9741818181818181
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.021277563	0.9671619545454544
PELGER-HUET ANOMALY; PHA	0.021231602	0.9650728181818181
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.021162662	0.9619391818181817
MITOCHONDRIAL DNA DEPLETION SYNDROME 16 (HEPATIC TYPE); MTDPS16	0.020997210000000002	0.9544186363636363
#613987 DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE, 2; DKCB2	0.02083332	0.9469690909090908
SEA-BLUE HISTIOCYTE DISEASE	0.02083332	0.9469690909090908
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.020627533	0.9376151363636364
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.020627533	0.9376151363636364
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.020574912	0.9352232727272727
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.019948733	0.9067605909090908
#214500 CHEDIAK-HIGASHI SYNDROME; CHS	0.019782281	0.8991945909090908
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.019711782	0.8959900909090909
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.019711782	0.8959900909090909
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.019711782	0.8959900909090909
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.019711782	0.8959900909090909
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.019711782	0.8959900909090909
BETA-UREIDOPROPIONASE DEFICIENCY	0.019711782	0.8959900909090909
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.019711782	0.8959900909090909
RING CHROMOSOME 14 SYNDROME	0.019711782	0.8959900909090909
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.019711782	0.8959900909090909
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.019711782	0.8959900909090909
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.019711782	0.8959900909090909
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ij; CDG1J	0.019572133	0.889642409090909
#300848 MENTAL RETARDATION, X-LINKED 89; MRX89	0.019517662	0.8871664545454546
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.019517661999999998	0.8871664545454544
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.019301213	0.8773278636363636
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.019104851	0.8684023181818181
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.019104851	0.8684023181818181
SPASTIC PSEUDOSCLEROSIS	0.0188679	0.8576318181818181
JUMPING FRENCHMAN OF MAINE	0.0188679	0.8576318181818181
COGNITIVE FUNCTION 1, SOCIAL	0.0188679	0.8576318181818181
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0188679	0.8576318181818181
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 6; FPLD6	0.0188679	0.8576318181818181
DIASTEMATOMYELIA	0.0188679	0.8576318181818181
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 2; CEMCOX2	0.0188679	0.8576318181818181
CERVICAL RIB	0.0188679	0.8576318181818181
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0188679	0.8576318181818181
#610189 SENIOR-LOKEN SYNDROME 6; SLSN6	0.0188679	0.8576318181818181
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0188679	0.8576318181818181
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0188679	0.8576318181818181
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0188679	0.8576318181818181
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0188679	0.8576318181818181
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.0188679	0.8576318181818181
PERONEAL NERVE, ACCESSORY DEEP	0.0188679	0.8576318181818181
PHOSPHOENOLPYRUVATE CARBOXYKINASE 2, MITOCHONDRIAL	0.0188679	0.8576318181818181
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0188679	0.8576318181818181
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0188679	0.8576318181818181
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0188679	0.8576318181818181
ANDROSTENONE, ABILITY TO SMELL	0.0188679	0.8576318181818181
MYOPATHY, CONGENITAL	0.0188679	0.8576318181818181
CARDIAC ARRHYTHMIA	0.0188679	0.8576318181818181
ERYTHERMALGIA, PRIMARY	0.0188679	0.8576318181818181
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.0188679	0.8576318181818181
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0188679	0.8576318181818181
#220100 CYSTINURIA;;CSNU;;CYSTINURIA, TYPE I, FORMERLY; CSNU1, FORMERLY;;CYSTINURIA, TYPE II, FORMERLY;;CYSTINURIA, TYPE III, FORMERLY; CSNU3, FORMERLY;;CYSTINURIA, TYPE NON-I, FORMERLYCYSTINURIA, TYPE A, INCLUDED;;CYSTINURIA, TYPE B, INCLUDED;;CYSTINURIA, TYPE A/B, INCLUDED	0.0188679	0.8576318181818181
ALCOHOL DEPENDENCE	0.0188679	0.8576318181818181
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0188679	0.8576318181818181
SPATIAL VISUALIZATION, APTITUDE FOR	0.0188679	0.8576318181818181
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0188679	0.8576318181818181
#615703 MORBID OBESITY AND SPERMATOGENIC FAILURE; MOSPGF	0.0188679	0.8576318181818181
PALMOMENTAL REFLEX	0.0188679	0.8576318181818181
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0188679	0.8576318181818181
ENDOCARDIAL FIBROELASTOSIS	0.0188679	0.8576318181818181
MERALGIA PARAESTHETICA, FAMILIAL	0.0188679	0.8576318181818181
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0188679	0.8576318181818181
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0188679	0.8576318181818181
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0188679	0.8576318181818181
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0188679	0.8576318181818181
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0188679	0.8576318181818181
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0188679	0.8576318181818181
141405 HEMIFACIAL SPASM, FAMILIAL	0.0188679	0.8576318181818181
PATENT DUCTUS VENOSUS	0.0188679	0.8576318181818181
TRANSSEXUALITY	0.0188679	0.8576318181818181
#615595 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 19; COXPD19	0.0188679	0.8576318181818181
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.0188679	0.8576318181818181
%613387 FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 2; NAFLD2	0.0188679	0.8576318181818181
THUMBS, CONGENITAL CLASPED	0.0188679	0.8576318181818181
%613282 FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1; NAFLD1LIVER DISEASE, ALCOHOLIC, SUSCEPTIBILITY TO, 1, INCLUDED	0.0188679	0.8576318181818181
NOVELTY SEEKING PERSONALITY TRAIT	0.0188679	0.8576318181818181
MOTION SICKNESS	0.0188679	0.8576318181818181
269800 SENILE PLAQUE FORMATION	0.0188679	0.8576318181818181
#613877 LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 4; FPLD4;;LIPODYSTROPHY, FAMILIAL PARTIAL, ASSOCIATED WITH PLIN1 MUTATIONS	0.0188679	0.8576318181818181
#259420 OSTEOGENESIS IMPERFECTA, TYPE III;;OI, TYPE III;;OI3;;OSTEOGENESIS IMPERFECTA, PROGRESSIVELY DEFORMING, WITH NORMAL SCLERAE	0.0188679	0.8576318181818181
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.018816533	0.8552969545454545
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.01878753	0.8539786363636362
INFANTILE LIVER FAILURE SYNDROME 2	0.018728251	0.8512841363636364
NOONAN SYNDROME 6; NS6	0.018385461999999998	0.8357028181818181
HEMOCHROMATOSIS, TYPE 2A	0.01833621	0.8334640909090908
GALACTOSEMIA	0.01833621	0.8334640909090908
#614706 CEROID LIPOFUSCINOSIS, NEURONAL, 11; CLN11	0.0181891	0.8267772727272726
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.017900782	0.813671909090909
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.01775468	0.8070309090909089
PSEUDO-TORCH SYNDROME 2	0.017594780999999997	0.7997627727272725
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.017594780999999997	0.7997627727272725
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.017522912	0.796496
#121300 COPROPORPHYRIA, HEREDITARY; HCP;;COPROPORPHYRINOGEN OXIDASE DEFICIENCY;;CPOX DEFICIENCY;;CPO DEFICIENCY;;CPX DEFICIENCYHARDEROPORPHYRIA, INCLUDED	0.01726634	0.7848336363636363
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.017161363	0.7800619545454545
GALACTOSE EPIMERASE DEFICIENCY	0.017077372	0.7762441818181818
#614457 ICHTHYOSIS, SPASTIC QUADRIPLEGIA, AND MENTAL RETARDATION; ISQMR	0.016468882	0.7485855454545454
ROIFMAN-CHITAYAT SYNDROME	0.016468882	0.7485855454545454
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.016468882	0.7485855454545454
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.016468882	0.7485855454545454
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.016468882	0.7485855454545454
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.016468882	0.7485855454545454
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.016252433	0.7387469545454545
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.015995382	0.7270628181818181
AICARDI-GOUTIERES SYNDROME 7	0.015651293	0.711422409090909
PAINE SYNDROME	0.015625	0.7102272727272727
MYOCLONIC EPILEPSY, HARTUNG TYPE	0.015625	0.7102272727272727
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.015625	0.7102272727272727
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.015625	0.7102272727272727
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.015625	0.7102272727272727
#609304 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 3; EIEE3	0.015625	0.7102272727272727
310370 MYOCLONIC EPILEPSY, PROGRESSIVE	0.015625	0.7102272727272727
MICROHYDRANENCEPHALY; MHAC	0.015625	0.7102272727272727
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.015625	0.7102272727272727
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.015625	0.7102272727272727
HYDROXYLYSINURIA	0.015625	0.7102272727272727
CARNOSINEMIA	0.015625	0.7102272727272727
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.015625	0.7102272727272727
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.015621650999999999	0.7100750454545454
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.015621650999999999	0.7100750454545454
#616351 MENTAL RETARDATION, AUTOSOMAL DOMINANT 34; MRD34	0.015549782	0.7068082727272726
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.015549782	0.7068082727272726
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.015549782	0.7068082727272726
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.015549782	0.7068082727272726
PAPILLORENAL SYNDROME	0.015408551	0.7003886818181817
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.015408551	0.7003886818181817
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.015408551	0.7003886818181817
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ig; CDG1G	0.015336682	0.6971219090909091
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.015336682	0.6971219090909091
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.015320943	0.6964064999999999
CRANIOECTODERMAL DYSPLASIA 3	0.015151499999999998	0.6887045454545453
ICHTHYOSIFORM ERYTHRODERMA, CORNEAL INVOLVEMENT, AND DEAFNESS	0.015151499999999998	0.6887045454545453
PULMONARY FIBROSIS, IDIOPATHIC; IPF	0.015151499999999998	0.6887045454545453
PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 2; PFBMFT2	0.015151499999999998	0.6887045454545453
PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 1; PFBMFT1	0.015151499999999998	0.6887045454545453
EPILEPSY, BENIGN NEONATAL, 3	0.0147059	0.66845
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.0147059	0.66845
269720 SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;BFNS, AUTOSOMAL RECESSIVE;;CONVULSIONS, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;EPILEPSY, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	0.0147059	0.66845
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.0147059	0.66845
#607876 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 2; FAME2;;BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY 2; BAFME2;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 2; FCMTE2;;CORTICAL MYOCLONUS AND EPILEPSY, AUTOSOMAL DOMINANT; ADCME	0.0147059	0.66845
#104290 ALTERNATING HEMIPLEGIA OF CHILDHOOD 1; AHC1	0.0147059	0.66845
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.0147059	0.66845
HALLERMANN-STREIFF SYNDROME; HSS	0.0147059	0.66845
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.0147059	0.66845
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.0147059	0.66845
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.0147059	0.66845
SEIZURES, BENIGN FAMILIAL INFANTILE, 5	0.0147059	0.66845
MYOCLONIC EPILEPSY, JUVENILE, 2	0.0147059	0.66845
DEAFNESS, UNILATERAL, WITH DELAYED ENDOLYMPHATIC HYDROPS	0.0144928	0.6587636363636363
LIPEDEMA	0.0144928	0.6587636363636363
%610158 CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 2; FECD2;;FCD1 LOCUS;;CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, LATE-ONSET	0.0144928	0.6587636363636363
CARDIOMYOPATHY, DILATED, WITH WOOLLY HAIR AND KERATODERMA; DCWHK	0.0144928	0.6587636363636363
KAPOSI SARCOMA, SUSCEPTIBILITY TO	0.0144928	0.6587636363636363
FOCAL SEGMENTAL GLOMERULOSCLEROSIS 1	0.0144928	0.6587636363636363
#253290 MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE; LMPS;;PTERYGIUM SYNDROME, MULTIPLE, LETHAL TYPE	0.0144928	0.6587636363636363
GLAUCOMA 3, PRIMARY CONGENITAL, E; GLC3E	0.0144928	0.6587636363636363
#600995 NEPHROTIC SYNDROME, TYPE 2; NPHS2;;NEPHROTIC SYNDROME, STEROID-RESISTANT, AUTOSOMAL RECESSIVE; SRN1	0.0144928	0.6587636363636363
ENTEROPATHY, FAMILIAL, WITH VILLOUS EDEMA AND IMMUNOGLOBULIN G2 DEFICIENCY	0.0144928	0.6587636363636363
KNIEST-LIKE DYSPLASIA, LETHAL	0.0144928	0.6587636363636363
CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 3; FECD3	0.0144928	0.6587636363636363
CLUSTER HEADACHE, FAMILIAL	0.0144928	0.6587636363636363
MASTOCYTOSIS, CUTANEOUS; MASTC	0.0144928	0.6587636363636363
#610725 NEPHROTIC SYNDROME, TYPE 3; NPHS3;;NEPHROTIC SYNDROME, EARLY-ONSET, TYPE 3	0.0144928	0.6587636363636363
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.0144928	0.6587636363636363
PIERSON SYNDROME	0.0144928	0.6587636363636363
NEPHROTIC SYNDROME, TYPE 1; NPHS1	0.0144928	0.6587636363636363
INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 2; NISBD2	0.0144928	0.6587636363636363
OPSISMODYSPLASIA; OPSMD	0.0144928	0.6587636363636363
NEPHROTIC SYNDROME, TYPE 9; NPHS9	0.0144928	0.6587636363636363
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	0.0144928	0.6587636363636363
KERATOENDOTHELIITIS FUGAX HEREDITARIA; KEFH	0.0144928	0.6587636363636363
#614131 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 6; FSGS6;;GLOMERULOSCLEROSIS, FOCAL SEGMENTAL, 6	0.0144928	0.6587636363636363
#614196 NEPHROTIC SYNDROME, TYPE 6; NPHS6	0.0144928	0.6587636363636363
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.0144928	0.6587636363636363
CHILBLAIN LUPUS 2; CHBL2	0.0144928	0.6587636363636363
WHITE SPONGE NEVUS 2; WSN2	0.0144928	0.6587636363636363
PITUITARY ADENOMA 4, ACTH-SECRETING; PITA4	0.0144928	0.6587636363636363
LETHAL CONGENITAL CONTRACTURE SYNDROME 2	0.0144928	0.6587636363636363
#253310 LETHAL CONGENITAL CONTRACTURE SYNDROME 1; LCCS1;;LCCS;;MULTIPLE CONTRACTURE SYNDROME, FINNISH TYPE	0.0144928	0.6587636363636363
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.014477061	0.6580482272727272
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.014100461	0.6409300454545453
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.014100461	0.6409300454545453
#612714 EXOCRINE PANCREATIC INSUFFICIENCY, DYSERYTHROPOIETIC ANEMIA, AND CALVARIALHYPEROSTOSIS	0.014028592000000001	0.6376632727272727
#613977 CYANOSIS, TRANSIENT NEONATAL; TNCY	0.01318471	0.599305
DEHYDRATED HEREDITARY STOMATOCYTOSIS 2; DHS2	0.01318471	0.599305
HYPERBILIRUBINEMIA, SHUNT, PRIMARY; PSHB	0.01318471	0.599305
#615631 ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE Ib; CDAN1B;;CDA, TYPE Ib	0.01318471	0.599305
#185000 OVERHYDRATED HEREDITARY STOMATOCYTOSIS; OHS;;POTASSIUM-SODIUM DISORDER OF ERYTHROCYTE	0.01318471	0.599305
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.012756843	0.5798565
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.012586611000000001	0.5721186818181818
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.012466583	0.5666628636363636
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.012397643	0.5635292272727273
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.012136233	0.5516469545454544
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.011912961	0.5414982272727272
#614582 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 9; COXPD9	0.011841092000000001	0.5382314545454545
#606777 GLUT1 DEFICIENCY SYNDROME 1; GLUT1DS1;;GLUCOSE TRANSPORT DEFECT, BLOOD-BRAIN BARRIERGLUT1 DEFICIENCY SYNDROME 1, AUTOSOMAL RECESSIVE, INCLUDED	0.011454143	0.5206428636363636
SALLA DISEASE	0.011454143	0.5206428636363636
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.011294700000000001	0.5133954545454545
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.011292350999999999	0.5132886818181817
ASPARTYLGLUCOSAMINURIA; AGU	0.011230871	0.5104941363636363
POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY; PGBM1	0.01099721	0.49987318181818174
#613561 MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 2; MLASA2	0.01099721	0.49987318181818174
GLYCINE N-METHYLTRANSFERASE DEFICIENCY	0.01099721	0.49987318181818174
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.01099721	0.49987318181818174
GLYCOGEN STORAGE DISEASE IXA	0.01099721	0.49987318181818174
ACTH DEFICIENCY, ISOLATED; IAD	0.010915751	0.49617049999999996
224250 DYSMYELINATION WITH JAUNDICE	0.010915751	0.49617049999999996
BARDET-BIEDL SYNDROME 21; BBS21	0.010861280000000001	0.4936945454545455
PROPIONIC ACIDEMIA	0.010626163	0.48300740909090906
GAUCHER DISEASE, TYPE II	0.010626163	0.48300740909090906
METHYLMALONIC ACIDURIA, CBLA TYPE	0.010626163	0.48300740909090906
#249270 THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME; TRMA;;THIAMINE METABOLISM DYSFUNCTION SYNDROME 1 (MEGALOBLASTIC ANEMIA,DIABETES MELLITUS, AND DEAFNESS TYPE); THMD1;;MEGALOBLASTIC ANEMIA, THIAMINE-RESPONSIVE, WITH DIABETES MELLITUSAND SENSORINEURAL DEAFNESS;;ROGERS SYNDROME;;THIAMINE-RESPONSIVE ANEMIA SYNDROME;;THIAMINE-RESPONSIVE MYELODYSPLASIA	0.010005553	0.45479786363636365
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIf; CDG2F	0.010005553	0.45479786363636365
FOLATE MALABSORPTION, HEREDITARY	0.010005553	0.45479786363636365
CRIGLER-NAJJAR SYNDROME, TYPE II	0.01	0.45454545454545453
ELLIPTOCYTOSIS 1; EL1	0.01	0.45454545454545453
HEMOLYTIC ANEMIA, CONGENITAL, X-LINKED	0.01	0.45454545454545453
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, POSSIBLY DUE TO DEFECT IN PORPHYRINMETABOLISM	0.01	0.45454545454545453
#218800 CRIGLER-NAJJAR SYNDROME, TYPE I;;HYPERBILIRUBINEMIA, CRIGLER-NAJJAR TYPE I; HBLRCN1;;CRIGLER-NAJJAR SYNDROME	0.01	0.45454545454545453
HYPERBILIRUBINEMIA, CONJUGATED, TYPE III	0.01	0.45454545454545453
ANEMIA, DYSERYTHROPOIETIC CONGENITAL, TYPE III	0.01	0.45454545454545453
SPECTRIN, BETA, ERYTHROCYTIC	0.01	0.45454545454545453
#612653 SPHEROCYTOSIS, TYPE 4; SPH4;;SPHEROCYTOSIS, HEREDITARY, 4; HS4	0.01	0.45454545454545453
HYPERBILIRUBINEMIA, TRANSIENT FAMILIAL NEONATALBREASTFEEDING JAUNDICE, INCLUDED	0.01	0.45454545454545453
ACETAMINOPHEN METABOLISM	0.01	0.45454545454545453
RH-NULL, REGULATOR TYPE; RHNR	0.01	0.45454545454545453
SPHEROCYTOSIS, TYPE 2	0.01	0.45454545454545453
SOLUTE CARRIER FAMILY 4 (ANION EXCHANGER), MEMBER 1; SLC4A1	0.01	0.45454545454545453
#612690 SPHEROCYTOSIS, TYPE 5; SPH5;;SPHEROCYTOSIS, HEREDITARY, 5; HS5	0.01	0.45454545454545453
JAUNDICE, FAMILIAL OBSTRUCTIVE, OF INFANCY	0.01	0.45454545454545453
GILBERT SYNDROME	0.01	0.45454545454545453
HYPERBILIRUBINEMIA, ROTOR TYPE	0.01	0.45454545454545453
NEUROFIBROMATOSIS-PHEOCHROMOCYTOMA-DUODENAL CARCINOID SYNDROME	0.01	0.45454545454545453
EDINBURGH MALFORMATION SYNDROME	0.01	0.45454545454545453
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.009833543	0.44697922727272726
CHROMOSOME 16p13.2 DELETION SYNDROME	0.009833543	0.44697922727272726
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.009713341	0.44151549999999995
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.009710412	0.44138236363636363
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.009710412	0.44138236363636363
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.009710412	0.44138236363636363
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.009710412	0.44138236363636363
METHYLMALONIC ACIDURIA, CBLB TYPE	0.009710412	0.44138236363636363
CORNELIA DE LANGE SYNDROME 1	0.009646351000000001	0.4384705
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIg; CDG2G	0.009574481999999999	0.43520372727272716
FORSYTHE-WAKELING SYNDROME; FWS	0.009574481999999999	0.43520372727272716
LIG4 SYNDROME	0.009574481999999999	0.43520372727272716
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.009572133	0.4350969545454545
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIq; CDG2Q	0.009572133	0.4350969545454545
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.009572133	0.4350969545454545
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.009572133	0.4350969545454545
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iu; CDG1U	0.009572133	0.4350969545454545
CHROMOSOME 1p35 DELETION SYNDROME	0.009348862999999999	0.4249483181818181
MENTAL RETARDATION, X-LINKED 104; MRX104	0.009348862999999999	0.4249483181818181
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.009348862999999999	0.4249483181818181
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.009348862999999999	0.4249483181818181
#301835 ARTS SYNDROME; ARTS;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARTS TYPE; MRXSARTS;;ATAXIA, FATAL X-LINKED, WITH DEAFNESS AND LOSS OF VISION;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 18; MRXS18	0.009348862999999999	0.4249483181818181
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.009348862999999999	0.4249483181818181
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.009348862999999999	0.4249483181818181
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.009348862999999999	0.4249483181818181
#222300 WOLFRAM SYNDROME 1; WFS1;;WFS;;DIABETES INSIPIDUS AND MELLITUS WITH OPTIC ATROPHY AND DEAFNESS; DIDMOAD	0.009161671	0.4164395909090909
#252940 MUCOPOLYSACCHARIDOSIS, TYPE IIID; MPS3D;;MPS IIID;;SANFILIPPO SYNDROME D;;N-ACETYLGLUCOSAMINE-6-SULFATASE DEFICIENCY	0.009125590999999999	0.4147995909090908
#269921 SIALURIA;;SIALURIA, FRENCH TYPE	0.009025973	0.4102715
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.009025973	0.4102715
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.008989661	0.4086209545454545
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.008917792	0.40535418181818184
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.008890043	0.40409286363636365
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.008890043	0.40409286363636365
EMANUEL SYNDROME	0.008890043	0.40409286363636365
CHROMOSOME 10Q26 DELETION SYNDROME	0.008890043	0.40409286363636365
#615085 OSTEOPETROSIS, AUTOSOMAL RECESSIVE 8; OPTB8	0.00886653	0.40302409090909086
GAUCHER DISEASE, TYPE I	0.00886653	0.40302409090909086
ERYTHROLEUKEMIA, FAMILIAL, SUSCEPTIBILITY TO; FERLK	0.00886653	0.40302409090909086
#613011 LYMPHOPROLIFERATIVE SYNDROME 1; LPFS1	0.00886653	0.40302409090909086
IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA; IMD59	0.00886653	0.40302409090909086
#603554 OMENN SYNDROME;;RETICULOENDOTHELIOSIS, FAMILIAL, WITH EOSINOPHILIA;;SEVERE COMBINED IMMUNODEFICIENCY WITH HYPEREOSINOPHILIA	0.00886653	0.40302409090909086
#608233 HERMANSKY-PUDLAK SYNDROME 2; HPS2	0.00886653	0.40302409090909086
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.008504981	0.3865900454545454
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.008504981	0.3865900454545454
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.008433112	0.3833232727272727
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.008433112	0.3833232727272727
YOU-HOOVER-FONG SYNDROME; YHFS	0.008433112	0.3833232727272727
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.008433112	0.3833232727272727
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.008405362999999999	0.3820619545454545
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.008405362999999999	0.3820619545454545
GAPO SYNDROME; GAPOS	0.008182090999999999	0.3719132272727272
RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	0.0078125	0.35511363636363635
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.0078125	0.35511363636363635
XFE PROGEROID SYNDROME; XFEPS	0.0078125	0.35511363636363635
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 15; MDDGC15	0.0078125	0.35511363636363635
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 6; MC3DN6	0.0078125	0.35511363636363635
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 5; MC3DN5	0.0078125	0.35511363636363635
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30	0.0078125	0.35511363636363635
INTERSTITIAL NEPHRITIS, KARYOMEGALIC	0.0078125	0.35511363636363635
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.007508443	0.34129286363636363
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.007508443	0.34129286363636363
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.007508443	0.34129286363636363
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.007508443	0.34129286363636363
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.007508443	0.34129286363636363
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.007508443	0.34129286363636363
Glycosylphosphatidylinositol biosynthesis defect 18	0.007508443	0.34129286363636363
REVESZ SYNDROME	0.007489612	0.34043690909090907
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.007441453	0.33824786363636355
#243500 ISOVALERIC ACIDEMIA; IVA;;ISOVALERIC ACID CoA DEHYDROGENASE DEFICIENCY;;IVD DEFICIENCY	0.007441453	0.33824786363636355
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE; MAHCC	0.007441453	0.33824786363636355
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.007441453	0.33824786363636355
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.007441453	0.33824786363636355
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ix; CDG1X	0.007441453	0.33824786363636355
MIRAGE SYNDROME; MIRAGE	0.007441453	0.33824786363636355
Cerebral creatine deficiency syndrome 2	0.007372513	0.3351142272727272
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.007372513	0.3351142272727272
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.007372513	0.3351142272727272
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.007372513	0.3351142272727272
PELIZAEUS-MERZBACHER DISEASE	0.007372513	0.3351142272727272
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.007372513	0.3351142272727272
#300653 PHOSPHOGLYCERATE KINASE 1 DEFICIENCY;;PGK1 DEFICIENCY	0.007372513	0.3351142272727272
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.007372513	0.3351142272727272
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.007372513	0.3351142272727272
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.007372513	0.3351142272727272
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.007372513	0.3351142272727272
#309548 MENTAL RETARDATION, X-LINKED, ASSOCIATED WITH FRAGILE SITE FRAXE;;FRAXE MENTAL RETARDATION SYNDROME	0.00713041	0.32410954545454546
#609152 HYPERTHYROIDISM, NONAUTOIMMUNE;;HYPERTHYROIDISM, CONGENITAL NONAUTOIMMUNE;;HYPERTHYROIDISM, NONAUTOIMMUNE, AUTOSOMAL DOMINANT;;TOXIC THYROID HYPERPLASIA, AUTOSOMAL DOMINANT	0.00713041	0.32410954545454546
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.006784763	0.3083983181818182
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.006784763	0.3083983181818182
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.006784763	0.3083983181818182
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.006784763	0.3083983181818182
RAYNAUD-CLAES SYNDROME; MRXSRC	0.006784763	0.3083983181818182
LISSENCEPHALY 8; LIS8	0.006784763	0.3083983181818182
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.006784763	0.3083983181818182
#300886 MENTAL RETARDATION, X-LINKED, SYNDROMIC 32; MRXS32	0.006784763	0.3083983181818182
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.006784763	0.3083983181818182
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.006784763	0.3083983181818182
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.006784763	0.3083983181818182
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.006784763	0.3083983181818182
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.006784763	0.3083983181818182
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.006784763	0.3083983181818182
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.006784763	0.3083983181818182
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.006784763	0.3083983181818182
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.006784763	0.3083983181818182
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.006784763	0.3083983181818182
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.006784763	0.3083983181818182
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.006784763	0.3083983181818182
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.006784763	0.3083983181818182
#300894 NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 5; NBIA5;;BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION; BPAN;;STATIC ENCEPHALOPATHY OF CHILDHOOD WITH NEURODEGENERATION IN ADULTHOOD;SENDA	0.006784763	0.3083983181818182
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.006784763	0.3083983181818182
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.006784763	0.3083983181818182
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.006784763	0.3083983181818182
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.006784763	0.3083983181818182
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.006784763	0.3083983181818182
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.006784763	0.3083983181818182
MENTAL RETARDATION, X-LINKED 103	0.006784763	0.3083983181818182
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.006784763	0.3083983181818182
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.006784763	0.3083983181818182
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.006784763	0.3083983181818182
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.006784763	0.3083983181818182
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.006784763	0.3083983181818182
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.006784763	0.3083983181818182
CHROMOSOME 19q13.11 DELETION SYNDROME, PROXIMAL	0.006784763	0.3083983181818182
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.006784763	0.3083983181818182
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.006784763	0.3083983181818182
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.006784763	0.3083983181818182
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.006784763	0.3083983181818182
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.006784763	0.3083983181818182
IMMUNODEFICIENCY 49; IMD49	0.006784763	0.3083983181818182
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ip; CDG1P	0.006784763	0.3083983181818182
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.006784763	0.3083983181818182
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.006784763	0.3083983181818182
CHROMOSOME 3pter-p25 DELETION SYNDROME	0.006784763	0.3083983181818182
COFFIN-SIRIS SYNDROME 5	0.006784763	0.3083983181818182
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.006784763	0.3083983181818182
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.006784763	0.3083983181818182
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.006784763	0.3083983181818182
SCHAAF-YANG SYNDROME; SHFYNG	0.006784763	0.3083983181818182
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.006784763	0.3083983181818182
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.006784763	0.3083983181818182
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.006784763	0.3083983181818182
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.006784763	0.3083983181818182
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.006784763	0.3083983181818182
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.006784763	0.3083983181818182
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.006784763	0.3083983181818182
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.006784763	0.3083983181818182
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.006784763	0.3083983181818182
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.006784763	0.3083983181818182
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.006784763	0.3083983181818182
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.006784763	0.3083983181818182
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.006784763	0.3083983181818182
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.006784763	0.3083983181818182
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.006784763	0.3083983181818182
Xq28 (MECP2) duplication	0.006784763	0.3083983181818182
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.006784763	0.3083983181818182
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.006784763	0.3083983181818182
MENTAL RETARDATION, X-LINKED 101; MRX101	0.006784763	0.3083983181818182
Pontine tegmental cap dysplasia	0.006784763	0.3083983181818182
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.006784763	0.3083983181818182
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.006784763	0.3083983181818182
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.006784763	0.3083983181818182
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.006784763	0.3083983181818182
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.006784763	0.3083983181818182
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.006784763	0.3083983181818182
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.006784763	0.3083983181818182
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.006784763	0.3083983181818182
MENTAL RETARDATION, X-LINKED 91; MRX91	0.006784763	0.3083983181818182
ANGELMAN SYNDROME	0.006784763	0.3083983181818182
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.006784763	0.3083983181818182
COCKAYNE SYNDROME A; CSA	0.006664560999999999	0.30293459090909086
#133540 COCKAYNE SYNDROME, TYPE B; CSB;;CKN2	0.006664560999999999	0.30293459090909086
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.006664560999999999	0.30293459090909086
CEREBELLOPARENCHYMAL DISORDER V	0.00664573	0.30207863636363635
#212840 CEREBELLAR ATAXIA AND HYPOGONADOTROPIC HYPOGONADISM; CAHH;;GORDON HOLMES SYNDROME;;LUTEINIZING HORMONE-RELEASING HORMONE, DEFICIENCY OF, WITH ATAXIA;;LHRH DEFICIENCY AND ATAXIA	0.00664573	0.30207863636363635
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3	0.00664573	0.30207863636363635
SPINOCEREBELLAR DEGENERATION AND CORNEAL DYSTROPHY	0.00664573	0.30207863636363635
TREMOR OF INTENTION, ATAXIA, AND LIPOFUSCINOSIS	0.00664573	0.30207863636363635
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.006597571	0.2998895909090909
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.006597571	0.2998895909090909
#235400 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1; AHUS1;;AHUS, SUSCEPTIBILITY TO, 1HEMOLYTIC UREMIC SYNDROME, TYPICAL, INCLUDED	0.006597571	0.2998895909090909
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.006597571	0.2998895909090909
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.006597571	0.2998895909090909
SMITH-KINGSMORE SYNDROME; SKS	0.006597571	0.2998895909090909
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.006592691999999999	0.2996678181818181
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.006528631	0.2967559545454545
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.006528631	0.2967559545454545
#612438 LEUKODYSTROPHY, HYPOMYELINATING, 6; HLD6;;LEUKODYSTROPHY, HYPOMYELINATING, WITH ATROPHY OF THE BASAL GANGLIAAND CEREBELLUM; HABC	0.006528631	0.2967559545454545
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.0065257019999999995	0.2966228181818181
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.0065257019999999995	0.2966228181818181
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.0065257019999999995	0.2966228181818181
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.0065257019999999995	0.2966228181818181
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.0065257019999999995	0.2966228181818181
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.0065257019999999995	0.2966228181818181
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.006456762	0.2934891818181818
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.006456762	0.2934891818181818
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.005940881	0.27004004545454546
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.005940881	0.27004004545454546
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.005940881	0.27004004545454546
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.005940881	0.27004004545454546
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.005940881	0.27004004545454546
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.005940881	0.27004004545454546
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.005940881	0.27004004545454546
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.005940881	0.27004004545454546
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.005940881	0.27004004545454546
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.005940881	0.27004004545454546
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.005940881	0.27004004545454546
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.005940881	0.27004004545454546
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.005940881	0.27004004545454546
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.005940881	0.27004004545454546
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.005940881	0.27004004545454546
PITT-HOPKINS SYNDROME	0.005940881	0.27004004545454546
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.005940881	0.27004004545454546
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.005940881	0.27004004545454546
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.005940881	0.27004004545454546
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.005940881	0.27004004545454546
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.005869012	0.2667732727272727
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.005869012	0.2667732727272727
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.005869012	0.2667732727272727
JOUBERT SYNDROME 24	0.005869012	0.2667732727272727
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.005869012	0.2667732727272727
AL-RAQAD SYNDROME; ARS	0.005869012	0.2667732727272727
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.005869012	0.2667732727272727
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.005869012	0.2667732727272727
OROFACIODIGITAL SYNDROME XIV; OFD14	0.005869012	0.2667732727272727
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.005869012	0.2667732727272727
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.005869012	0.2667732727272727
#614970 JOUBERT SYNDROME 20; JBTS20	0.005869012	0.2667732727272727
HADZISELIMOVIC SYNDROME	0.005869012	0.2667732727272727
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.005869012	0.2667732727272727
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.005869012	0.2667732727272727
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.005869012	0.2667732727272727
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.005869012	0.2667732727272727
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.005841263	0.2655119545454545
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.005841263	0.2655119545454545
BARAITSER-WINTER SYNDROME 1; BRWS1	0.005841263	0.2655119545454545
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.005841263	0.2655119545454545
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.005841263	0.2655119545454545
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.00574881	0.26130954545454543
ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE	0.00574881	0.26130954545454543
VON WILLEBRAND DISEASE, TYPE 3; VWD3	0.00568182	0.2582645454545454
HERMANSKY-PUDLAK SYNDROME 9	0.00568182	0.2582645454545454
#608404 PLATELET GLYCOPROTEIN IV DEFICIENCY;;BLEEDING DISORDER, PLATELET-TYPE, 10; BDPLT10;;CD36 DEFICIENCY	0.00568182	0.2582645454545454
MACROTHROMBOCYTOPENIA AND GRANULOCYTE INCLUSIONS WITH OR WITHOUT NEPHRITIS OR SENSORINEURAL HEARING LOSS; MATINS	0.00568182	0.2582645454545454
BLEEDING DISORDER, PLATELET-TYPE, 15; BDPLT15	0.00568182	0.2582645454545454
HERMANSKY-PUDLAK SYNDROME 5; HPS5	0.00568182	0.2582645454545454
AMEGAKARYOCYTIC THROMBOCYTOPENIA, CONGENITAL	0.00568182	0.2582645454545454
#139090 GRAY PLATELET SYNDROME; GPS;;BLEEDING DISORDER, PLATELET-TYPE, 4; BDPLT4;;PLATELET ALPHA-GRANULE DEFICIENCY	0.00568182	0.2582645454545454
#231095 GHOSAL HEMATODIAPHYSEAL DYSPLASIA; GHDD;;GHOSAL SYNDROME	0.00568182	0.2582645454545454
FANCONI ANEMIA, COMPLEMENTATION GROUP B; FANCB	0.00568182	0.2582645454545454
OSTEOCHONDRODYSPLASIA, RHIZOMELIC, WITH CALLOSAL AGENESIS, THROMBOCYTOPENIA,HYDROCEPHALUS, AND HYPERTENSION	0.00568182	0.2582645454545454
%614200 BLEEDING DISORDER, PLATELET-TYPE, 9; BDPLT9;;GLYCOPROTEIN Ia DEFICIENCY;;GP Ia DEFICIENCY;;COLLAGEN PLATELET RECEPTOR DEFICIENCY	0.00568182	0.2582645454545454
Bernard-Soulier syndrome	0.00568182	0.2582645454545454
#188025 THROMBOCYTOPENIA, PARIS-TROUSSEAU TYPE; TCPT;;CHROMOSOME 11q23 DELETION SYNDROME	0.00568182	0.2582645454545454
IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED; IPEX	0.00568182	0.2582645454545454
167850 PANCYTOPENIA AND OCCLUSIVE VASCULAR DISEASE	0.00568182	0.2582645454545454
#612926 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 6; AHUS6;;AHUS, SUSCEPTIBILITY TO, 6	0.00568182	0.2582645454545454
FANCONI ANEMIA	0.00568182	0.2582645454545454
#601709 QUEBEC PLATELET DISORDER; QPD;;BLEEDING DISORDER, PLATELET-TYPE, 5; BDPLT5;;FACTOR V QUEBEC	0.00568182	0.2582645454545454
#615715 BONE MARROW FAILURE SYNDROME 2; BMFS2	0.00568182	0.2582645454545454
FANCONI ANEMIA, COMPLEMENTATION GROUP V	0.00568182	0.2582645454545454
IMMUNODEFICIENCY 52; IMD52	0.00568182	0.2582645454545454
600903 WISKOTT-ALDRICH SYNDROME, AUTOSOMAL DOMINANT FORM	0.00568182	0.2582645454545454
#612924 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 4; AHUS4;;AHUS, SUSCEPTIBILITY TO, 4	0.00568182	0.2582645454545454
EOSINOPHILIA, FAMILIAL	0.00568182	0.2582645454545454
JACOBSEN SYNDROME	0.00568182	0.2582645454545454
SEBASTIAN SYNDROME	0.00568182	0.2582645454545454
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	0.00568182	0.2582645454545454
HEMANGIOMA-THROMBOCYTOPENIA SYNDROME	0.00568182	0.2582645454545454
IMMUNODEFICIENCY, COMMON VARIABLE, 12; CVID12	0.00568182	0.2582645454545454
VON WILLEBRAND DISEASE, TYPE 2; VWD2	0.00568182	0.2582645454545454
IMMUNODEFICIENCY 10; IMD10	0.00568182	0.2582645454545454
IVIC SYNDROME	0.00568182	0.2582645454545454
GIANT PLATELET SYNDROME WITH THROMBOCYTOPENIA	0.00568182	0.2582645454545454
#314050 THROMBOCYTOPENIA WITH BETA-THALASSEMIA, X-LINKED; XLTT;;THROMBOCYTOPENIA, PLATELET DYSFUNCTION, HEMOLYSIS, AND IMBALANCEDGLOBIN SYNTHESIS	0.00568182	0.2582645454545454
THROMBOCYTOPENIA, CYCLIC	0.00568182	0.2582645454545454
WT LIMB-BLOOD SYNDROME	0.00568182	0.2582645454545454
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA 2	0.00568182	0.2582645454545454
BLEEDING DISORDER, PLATELET-TYPE, 20	0.00568182	0.2582645454545454
AUTOINFLAMMATORY SYNDROME, FAMILIAL, BEHCET-LIKE	0.00568182	0.2582645454545454
PLATELET DISORDER, FAMILIAL, WITH ASSOCIATED MYELOID MALIGNANCY	0.00568182	0.2582645454545454
#612925 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 5; AHUS5;;AHUS, SUSCEPTIBILITY TO, 5	0.00568182	0.2582645454545454
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.00568182	0.2582645454545454
THROMBOCYTOPENIA 2	0.00568182	0.2582645454545454
#263300 POLYCYTHEMIA VERA;;PV;;POLYCYTHEMIA RUBRA VERA; PRV	0.00568182	0.2582645454545454
Diamond-Blackfan anemia 1	0.00568182	0.2582645454545454
SENGERS SYNDROME	0.00568182	0.2582645454545454
THROMBOCYTOPENIA 3	0.00568182	0.2582645454545454
#614493 WISKOTT-ALDRICH SYNDROME 2; WAS2;;WIPF1 DEFICIENCY	0.00568182	0.2582645454545454
#614700 IMMUNODEFICIENCY, COMMON VARIABLE, 8, WITH AUTOIMMUNITY; CVID8	0.00568182	0.2582645454545454
#612004 THROMBOCYTOPENIA 4; THC4;;THROMBOCYTOPENIA, AUTOSOMAL DOMINANT, 4	0.00568182	0.2582645454545454
BLEEDING DISORDER, PLATELET-TYPE, 17; BDPLT17	0.00568182	0.2582645454545454
THROMBOCYTOPENIA 6	0.00568182	0.2582645454545454
FANCONI ANEMIA, COMPLEMENTATION GROUP T; FANCT	0.00568182	0.2582645454545454
#612923 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 3; AHUS3;;AHUS, SUSCEPTIBILITY TO, 3	0.00568182	0.2582645454545454
STORMORKEN SYNDROME; STRMK	0.00568182	0.2582645454545454
THROMBOCYTOPENIA 5; THC5	0.00568182	0.2582645454545454
#612922 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 2; AHUS2;;AHUS, SUSCEPTIBILITY TO, 2	0.00568182	0.2582645454545454
188030 THROMBOCYTOPENIC PURPURA, AUTOIMMUNE; AITP;;IMMUNE THROMBOCYTOPENIC PURPURA; ITP;;IDIOPATHIC THROMBOCYTOPENIC PURPURA	0.00568182	0.2582645454545454
PLATELET ABNORMALITIES WITH EOSINOPHILIA AND IMMUNE-MEDIATED INFLAMMATORY DISEASE; PLTEID	0.00568182	0.2582645454545454
BEEMER LETHAL MALFORMATION SYNDROME	0.00568182	0.2582645454545454
THROMBOCYTOPENIA, ANEMIA, AND MYELOFIBROSIS; THAMY	0.00568182	0.2582645454545454
#614082 FANCONI ANEMIA, COMPLEMENTATION GROUP G; FANCG	0.00568182	0.2582645454545454
BLEEDING DISORDER, PLATELET-TYPE, 21; BDPLT21	0.00568182	0.2582645454545454
MONOSOMY 7 OF BONE MARROW	0.00568182	0.2582645454545454
PLATELET DISORDER, UNDEFINED	0.00568182	0.2582645454545454
DEAFNESS, AUTOSOMAL DOMINANT 1	0.00568182	0.2582645454545454
PLATELET SIGNAL PROCESSING DEFECT	0.00568182	0.2582645454545454
#227646 FANCONI ANEMIA, COMPLEMENTATION GROUP D2; FANCD2;;FAD2;;FANCONI ANEMIA, COMPLEMENTATION GROUP D; FANCD; FACD;;FANCONI PANCYTOPENIA, TYPE 4; FA4	0.00568182	0.2582645454545454
#300835 ANEMIA, X-LINKED, WITH OR WITHOUT NEUTROPENIA AND/OR PLATELET ABNORMALITIES;XLANP	0.00568182	0.2582645454545454
NIJMEGEN BREAKAGE SYNDROME	0.00568182	0.2582645454545454
#227645 FANCONI ANEMIA, COMPLEMENTATION GROUP C; FANCC;;FACC; FAC;;FANCONI PANCYTOPENIA, TYPE 3; FA3	0.00568182	0.2582645454545454
#301000 WISKOTT-ALDRICH SYNDROME; WAS;;WISKOTT-ALDRICH SYNDROME 1; WAS1;;ALDRICH SYNDROME;;ECZEMA-THROMBOCYTOPENIA-IMMUNODEFICIENCY SYNDROME;;IMMUNODEFICIENCY 2; IMD2	0.00568182	0.2582645454545454
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.00561288	0.255130909090909
MALE PSEUDOHERMAPHRODITISM/MENTAL RETARDATION SYNDROME, VERLOES TYPE	0.00502513	0.228415
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4	0.00502513	0.228415
WARBURG MICRO SYNDROME 2; WARBM2	0.00502513	0.228415
OPTICOCOCHLEODENTATE DEGENERATION	0.00502513	0.228415
MENTAL RETARDATION, X-LINKED 105; MRX105	0.00502513	0.228415
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.00502513	0.228415
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.00502513	0.228415
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 29	0.00502513	0.228415
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.00502513	0.228415
MICROCEPHALY 21, PRIMARY, AUTOSOMAL RECESSIVE; MCPH21	0.00502513	0.228415
HYPERURICEMIA, INFANTILE, WITH ABNORMAL BEHAVIOR AND NORMAL HYPOXANTHINEGUANINE PHOSPHORIBOSYLTRANSFERASE	0.00502513	0.228415
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13; COXPD13	0.00502513	0.228415
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.00502513	0.228415
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.004997381	0.2271536818181818
#215100 RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 1; RCDP1;;PEROXISOME BIOGENESIS DISORDER 9; PBD9;;CHONDRODYSPLASIA PUNCTATA, RHIZOMELIC FORM; CDPR;;CHONDRODYSTROPHIA CALCIFICANS PUNCTATA	0.004997381	0.2271536818181818
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.004997381	0.2271536818181818
HYPERLEUCINE-ISOLEUCINEMIA	0.004997381	0.2271536818181818
ICHTHYOSIS AND MALE HYPOGONADISM	0.004997381	0.2271536818181818
#309801 MICROPHTHALMIA, SYNDROMIC 7; MCOPS7;;MICROPHTHALMIA WITH LINEAR SKIN DEFECTS; MLS;;MICROPHTHALMIA, DERMAL APLASIA, AND SCLEROCORNEA;;MIDAS SYNDROME	0.004997381	0.2271536818181818
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.004997381	0.2271536818181818
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.004997381	0.2271536818181818
#300337 HYPOMELANOSIS OF ITO; HMI;;INCONTINENTIA PIGMENTI ACHROMIANS; IPA;;ITO HYPOMELANOSIS; ITO;;INCONTINENTIA PIGMENTI, TYPE I, FORMERLY; IP1, FORMERLY	0.004997381	0.2271536818181818
EPILEPSY-TELANGIECTASIA	0.004997381	0.2271536818181818
XYLOSIDASE DEFICIENCY	0.004997381	0.2271536818181818
PYRUVATE CARBOXYLASE DEFICIENCY	0.004944343	0.22474286363636364
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ii; CDG1I	0.004944343	0.22474286363636364
#613730 HEMORRHAGIC DESTRUCTION OF THE BRAIN, SUBEPENDYMAL CALCIFICATION,AND CATARACTS; HDBSCC	0.004944343	0.22474286363636364
#231050 GELEOPHYSIC DYSPLASIA 1; GPHYSD1	0.004944343	0.22474286363636364
C SYNDROME	0.004944343	0.22474286363636364
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.004944343	0.22474286363636364
#615182 COMBINED D-2- AND L-2-HYDROXYGLUTARIC ACIDURIA; D2L2AD	0.004944343	0.22474286363636364
KAGAMI-OGATA SYNDROME	0.004944343	0.22474286363636364
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.004944343	0.22474286363636364
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.004925512	0.22388690909090908
LARSEN-LIKE SYNDROME	0.004925512	0.22388690909090908
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.004808413	0.21856422727272723
XQ25 DUPLICATION SYNDROME	0.004808413	0.21856422727272723
GLASS SYNDROME	0.004808413	0.21856422727272723
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.004808413	0.21856422727272723
LUSCAN-LUMISH SYNDROME; LLS	0.004808413	0.21856422727272723
SHUKLA-VERNON SYNDROME; SHUVER	0.004808413	0.21856422727272723
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.004808413	0.21856422727272723
KLEEFSTRA SYNDROME 2; KLEFS2	0.004808413	0.21856422727272723
WEAVER SYNDROME	0.004808413	0.21856422727272723
PRADER-WILLI SYNDROME; PWS	0.004808413	0.21856422727272723
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.004808413	0.21856422727272723
#136570 CHROMOSOME 16p12.1 DELETION SYNDROME, 520-KBFRAGILE SITE 16p12, INCLUDED	0.004808413	0.21856422727272723
MEHMO SYNDROME; MEHMO	0.004808413	0.21856422727272723
Pierpont syndrome	0.004808413	0.21856422727272723
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.004808413	0.21856422727272723
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.004808413	0.21856422727272723
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.004808413	0.21856422727272723
CHROMOSOME 19p13.13 DELETION SYNDROME	0.004808413	0.21856422727272723
SHASHI-PENA SYNDROME; SHAPNS	0.004808413	0.21856422727272723
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.004808413	0.21856422727272723
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.004808413	0.21856422727272723
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.004808413	0.21856422727272723
#604317 MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT CORTICALMALFORMATIONS; MCPH2	0.004808413	0.21856422727272723
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.004808413	0.21856422727272723
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.004808413	0.21856422727272723
WIEACKER-WOLFF SYNDROME	0.004808413	0.21856422727272723
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.004808413	0.21856422727272723
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.004808413	0.21856422727272723
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.004808413	0.21856422727272723
CHROMOSOME 5Q12 DELETION SYNDROME	0.004808413	0.21856422727272723
MENTAL RETARDATION, X-LINKED 90	0.004808413	0.21856422727272723
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.004808413	0.21856422727272723
CHROMOSOME 16p11.2 DELETION SYNDROME, 593-KB	0.004808413	0.21856422727272723
COFFIN-SIRIS SYNDROME 2; CSS2	0.004808413	0.21856422727272723
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.004808413	0.21856422727272723
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.004808413	0.21856422727272723
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.004808413	0.21856422727272723
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.004808413	0.21856422727272723
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.004808413	0.21856422727272723
LANDAU-KLEFFNER SYNDROME	0.004808413	0.21856422727272723
WIEDEMANN-STEINER SYNDROME; WDSTS	0.004808413	0.21856422727272723
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.004808413	0.21856422727272723
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.004808413	0.21856422727272723
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.004808413	0.21856422727272723
DESANTO-SHINAWI SYNDROME	0.004808413	0.21856422727272723
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.004808413	0.21856422727272723
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.004808413	0.21856422727272723
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.004808413	0.21856422727272723
MENTAL RETARDATION, X-LINKED 9	0.004808413	0.21856422727272723
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.004808413	0.21856422727272723
ADENYLOSUCCINASE DEFICIENCY	0.004808413	0.21856422727272723
#300831 CK SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH THIN BODY HABITUS AND CORTICALMALFORMATION	0.004808413	0.21856422727272723
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.004808413	0.21856422727272723
WITTEVEEN-KOLK SYNDROME	0.004808413	0.21856422727272723
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.004808413	0.21856422727272723
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.004808413	0.21856422727272723
AL KAISSI SYNDROME; ALKAS	0.004808413	0.21856422727272723
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.004808413	0.21856422727272723
JOUBERT SYNDROME 30; JBTS30	0.004808413	0.21856422727272723
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.004808413	0.21856422727272723
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.004808413	0.21856422727272723
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.004808413	0.21856422727272723
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.004323733	0.19653331818181818
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.004323733	0.19653331818181818
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.004323733	0.19653331818181818
#608804 LEUKODYSTROPHY, HYPOMYELINATING, 2; HLD2;;PELIZAEUS-MERZBACHER-LIKE DISEASE, 1; PMLD1	0.004323733	0.19653331818181818
#245400 MITOCHONDRIAL DNA DEPLETION SYNDROME 9 (ENCEPHALOMYOPATHIC TYPE WITHMETHYLMALONIC ACIDURIA); MTDPS9;;LACTIC ACIDOSIS, FATAL INFANTILE, FORMERLY	0.004323733	0.19653331818181818
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.004323733	0.19653331818181818
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.004323733	0.19653331818181818
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.004323733	0.19653331818181818
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.004323733	0.19653331818181818
SULFOCYSTEINURIA	0.004323733	0.19653331818181818
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.004323733	0.19653331818181818
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.004323733	0.19653331818181818
#612716 DYSTONIA, DOPA-RESPONSIVE, DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY;;SEPIAPTERIN REDUCTASE DEFICIENCY;;SPR DEFICIENCY	0.004323733	0.19653331818181818
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.004323733	0.19653331818181818
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.004323733	0.19653331818181818
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.004323733	0.19653331818181818
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.004323733	0.19653331818181818
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.004323733	0.19653331818181818
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.004323733	0.19653331818181818
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.004323733	0.19653331818181818
ELEJALDE DISEASE	0.004323733	0.19653331818181818
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.004323733	0.19653331818181818
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.004323733	0.19653331818181818
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.004323733	0.19653331818181818
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.004323733	0.19653331818181818
#226750 KOHLSCHUTTER-TONZ SYNDROME; KTZS;;EPILEPSY AND YELLOW TEETH;;EPILEPSY, DEMENTIA, AND AMELOGENESIS IMPERFECTA;;KOHLSCHUTTER SYNDROME	0.004323733	0.19653331818181818
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.004323733	0.19653331818181818
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.004323733	0.19653331818181818
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.004323733	0.19653331818181818
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.004323733	0.19653331818181818
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.004323733	0.19653331818181818
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.004323733	0.19653331818181818
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.004100461	0.18638459090909087
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.004100461	0.18638459090909087
MUCOPOLYSACCHARIDOSIS, TYPE II	0.004100461	0.18638459090909087
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.004100461	0.18638459090909087
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.004100461	0.18638459090909087
#252930 MUCOPOLYSACCHARIDOSIS TYPE IIIC;;MPS IIIC; MPS3C;;SANFILIPPO SYNDROME C;;ACETYL-CoA:ALPHA-GLUCOSAMINIDE N-ACETYLTRANSFERASE DEFICIENCY	0.004100461	0.18638459090909087
ZIMMERMANN-LABAND SYNDROME 1	0.004100461	0.18638459090909087
GAUCHER DISEASE, TYPE IIIC	0.004100461	0.18638459090909087
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.004100461	0.18638459090909087
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.004100461	0.18638459090909087
GLUTARIC ACIDEMIA I; GA1	0.004100461	0.18638459090909087
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.004100461	0.18638459090909087
#230000 FUCOSIDOSIS;;ALPHA-L-FUCOSIDASE DEFICIENCY	0.004100461	0.18638459090909087
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.004100461	0.18638459090909087
T-SUBSTANCE ANOMALY	0.00408163	0.18552863636363634
VASCULITIS, LYMPHOCYTIC, NODULAR	0.00408163	0.18552863636363634
COLLAGENOSIS, FAMILIAL REACTIVE PERFORATING	0.00408163	0.18552863636363634
HYPOGONADOTROPIC HYPOGONADISM 23 WITHOUT ANOSMIA; HH23	0.00408163	0.18552863636363634
PLATELET PROSTACYCLIN RECEPTOR DEFECT	0.00408163	0.18552863636363634
OSTEOGENESIS IMPERFECTA, TYPE V	0.00408163	0.18552863636363634
ETHANOLAMINOSIS	0.00408163	0.18552863636363634
PARALYSIS AGITANS, JUVENILE, OF HUNT	0.00408163	0.18552863636363634
NORMOKALEMIC PERIODIC PARALYSIS	0.00408163	0.18552863636363634
PROPERDIN DEFICIENCY, X-LINKED	0.00408163	0.18552863636363634
SPINAL ARACHNOIDITIS	0.00408163	0.18552863636363634
PREMATURE OVARIAN FAILURE 1	0.00408163	0.18552863636363634
OSTEOGENIC SARCOMA	0.00408163	0.18552863636363634
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00408163	0.18552863636363634
METAPHYSEAL CHONDRODYSPLASIA, PENA TYPE	0.00408163	0.18552863636363634
METHEMOGLOBINEMIA AND AMBIGUOUS GENITALIA; METAG	0.00408163	0.18552863636363634
103230 ADRENOCORTICAL HYPOFUNCTION, CHRONIC PRIMARY CONGENITAL;;ADDISON DISEASE, CONGENITAL	0.00408163	0.18552863636363634
#185020 CRYOHYDROCYTOSIS; CHC;;STOMATOCYTOSIS, COLD-SENSITIVE	0.00408163	0.18552863636363634
LISSENCEPHALY TYPE III AND BONE DYSPLASIA	0.00408163	0.18552863636363634
EHLERS-DANLOS SYNDROME, TYPE VI	0.00408163	0.18552863636363634
CORONARY ARTERY DISSECTION, SPONTANEOUS	0.00408163	0.18552863636363634
#217095 CONOTRUNCAL HEART MALFORMATIONS; CTHMTRUNCUS ARTERIOSUS COMMUNIS, INCLUDED;;CONOTRUNCAL ANOMALY FACE SYNDROME, INCLUDED; CAFS, INCLUDED;;DOUBLE-OUTLET RIGHT VENTRICLE, INCLUDED; DORV, INCLUDED;;PERSISTENT TRUNCUS ARTERIOSUS, INCLUDED; PTA, INCLUDED;;INTERRUPTED AORTIC ARCH, INCLUDED	0.00408163	0.18552863636363634
WHITE SPONGE NEVUS OF CANNON	0.00408163	0.18552863636363634
PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PPSH	0.00408163	0.18552863636363634
NEUTROPHIL ACTIN DYSFUNCTION	0.00408163	0.18552863636363634
MYOPATHY, GRANULOVACUOLAR LOBULAR, WITH ELECTRICAL MYOTONIA	0.00408163	0.18552863636363634
LUTHERAN SUPPRESSOR, X-LINKED	0.00408163	0.18552863636363634
THIOPURINE S-METHYLTRANSFERASE DEFICIENCY	0.00408163	0.18552863636363634
URATE-BINDING GLOBULIN, DECREASE IN	0.00408163	0.18552863636363634
XM SYSTEM	0.00408163	0.18552863636363634
GONADOBLASTOMA	0.00408163	0.18552863636363634
HOOFT DISEASE	0.00408163	0.18552863636363634
238800 HYPERMETABOLISM DUE TO DEFECT IN MITOCHONDRIA	0.00408163	0.18552863636363634
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.00408163	0.18552863636363634
#608747 INSULIN-LIKE GROWTH FACTOR I DEFICIENCY;;IGF1 DEFICIENCY;;GROWTH RETARDATION WITH SENSORINEURAL DEAFNESS AND MENTAL RETARDATION	0.00408163	0.18552863636363634
LYMPHOBLASTIC TRANSFORMATION, INHIBITION OF	0.00408163	0.18552863636363634
EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 1; EV1	0.00408163	0.18552863636363634
PACMAN DYSPLASIA	0.00408163	0.18552863636363634
MACROCYTOSIS, FAMILIAL	0.00408163	0.18552863636363634
SCHIZOPHRENIA 4	0.00408163	0.18552863636363634
PENDRED SYNDROME	0.00408163	0.18552863636363634
MYOTONIC MYOPATHY WITH CYLINDRICAL SPIRALS	0.00408163	0.18552863636363634
256720 NEUROLOGIC DISEASE, INFANTILE MULTISYSTEM, WITH OSSEOUS FRAGILITY	0.00408163	0.18552863636363634
SPASTIC PARAPLEGIA WITH PRECOCIOUS PUBERTY	0.00408163	0.18552863636363634
GLOMUVENOUS MALFORMATIONS	0.00408163	0.18552863636363634
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.00408163	0.18552863636363634
MAGNESIUM, ELEVATED RED CELL	0.00408163	0.18552863636363634
601195 IRON OVERLOAD IN AFRICA;;AFRICAN IRON OVERLOAD;;BANTU SIDEROSIS	0.00408163	0.18552863636363634
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.00408163	0.18552863636363634
%608572 BURN-MCKEOWN SYNDROME	0.00408163	0.18552863636363634
MITOCHONDRIAL MYOPATHY WITH A DEFECT IN MITOCHONDRIAL-PROTEIN TRANSPORT	0.00408163	0.18552863636363634
CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVD1	0.00408163	0.18552863636363634
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 2; LGMDD2	0.00408163	0.18552863636363634
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.00408163	0.18552863636363634
LIPASE DEFICIENCY, COMBINED	0.00408163	0.18552863636363634
OVARIAN CANCER	0.00408163	0.18552863636363634
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.00408163	0.18552863636363634
#301830 SPINAL MUSCULAR ATROPHY, X-LINKED 2; SMAX2;;SPINAL MUSCULAR ATROPHY, X-LINKED LETHAL INFANTILE;;SPINAL MUSCULAR ATROPHY, INFANTILE X-LINKED; XLSMA;;ARTHROGRYPOSIS MULTIPLEX CONGENITA, DISTAL, X-LINKED;;AMC, DISTAL, X-LINKED;;ARTHROGRYPOSIS, X-LINKED, TYPE I; AMCX1	0.00408163	0.18552863636363634
PSEUDOURIDINURIA AND MENTAL DEFECT	0.00408163	0.18552863636363634
CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY	0.00408163	0.18552863636363634
FLOOD FACTOR DEFICIENCY	0.00408163	0.18552863636363634
OCULORENOCEREBELLAR SYNDROME	0.00408163	0.18552863636363634
ICHTHYOSIS, X-LINKED	0.00408163	0.18552863636363634
#270300 PEELING SKIN SYNDROME 1; PSS1;;PSS;;SKIN PEELING, FAMILIAL CONTINUOUS GENERALIZED;;KERATOLYSIS EXFOLIATIVA CONGENITA;;DECIDUOUS SKIN	0.00408163	0.18552863636363634
VENTRICULAR TACHYCARDIA, FAMILIAL	0.00408163	0.18552863636363634
SPONDYLOEPIPHYSEAL DYSPLASIA WITH PUNCTATE CORNEAL DYSTROPHY	0.00408163	0.18552863636363634
LYMPHOBLASTIC TRANSFORMATION, INTRINSIC DEFECT IN	0.00408163	0.18552863636363634
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00408163	0.18552863636363634
CITRULLINE TRANSPORT DEFECT	0.00408163	0.18552863636363634
SUCROSURIA, HIATUS HERNIA AND MENTAL RETARDATION	0.00408163	0.18552863636363634
CATECHOL-O-METHYLTRANSFERASE	0.00408163	0.18552863636363634
THYROID CANCER, NONMEDULLARY, 2; NMTC2	0.00408163	0.18552863636363634
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.00408163	0.18552863636363634
ANEMIA, AUTOIMMUNE HEMOLYTIC	0.00408163	0.18552863636363634
%193090 TRANSCOBALAMIN I DEFICIENCY;;TCN1 DEFICIENCY;;COBALAMIN PSEUDODEFICIENCY DUE TO TRANSCOBALAMIN DEFICIENCY;;COBALAMIN R BINDER PROTEIN DEFICIENCYTRANSCOBALAMIN I DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED;;R BINDER DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED	0.00408163	0.18552863636363634
POLYCYSTIC OVARY SYNDROME 1	0.00408163	0.18552863636363634
DRUG METABOLISM, POOR, CYP2D6-RELATEDDRUG METABOLISM, ULTRARAPID, CYP2D6-RELATED, INCLUDED	0.00408163	0.18552863636363634
EPOXIDE HYDROLASE 1, MICROSOMAL	0.00408163	0.18552863636363634
ADRENAL HYPOPLASIA, CONGENITAL, WITH ABSENT PITUITARY LUTEINIZINGHORMONE	0.00408163	0.18552863636363634
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00408163	0.18552863636363634
%253240 MUCUS INSPISSATION OF RESPIRATORY TRACT	0.00408163	0.18552863636363634
ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA	0.00408163	0.18552863636363634
PARAOXONASE 1	0.00408163	0.18552863636363634
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.00408163	0.18552863636363634
KERATOSIS, FAMILIAL ACTINIC	0.00408163	0.18552863636363634
SERTOLI CELL-ONLY SYNDROME	0.00408163	0.18552863636363634
ACETYLATION, SLOW	0.00408163	0.18552863636363634
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.00408163	0.18552863636363634
GLUTATHIONE REDUCTASE	0.00408163	0.18552863636363634
245650 LARSEN-LIKE SYNDROME, LETHAL TYPE	0.00408163	0.18552863636363634
APOLIPOPROTEIN(A)	0.00408163	0.18552863636363634
DERMATOLEUKODYSTROPHY	0.00408163	0.18552863636363634
PROGESTERONE RESISTANCE	0.00408163	0.18552863636363634
ZINC, ELEVATED PLASMA	0.00408163	0.18552863636363634
PSEUDOCHOLINESTERASE, INCREASE IN PLASMA LEVEL OF	0.00408163	0.18552863636363634
VERTEBRAL FUSION, POSTERIOR LUMBOSACRAL, WITH BLEPHAROPTOSIS	0.00408163	0.18552863636363634
ONCOCYTOMA	0.00408163	0.18552863636363634
COUMARIN RESISTANCE	0.00408163	0.18552863636363634
TRISOMY 18-LIKE SYNDROME	0.00408163	0.18552863636363634
%257600 OCULAR MYOPATHY WITH CURARE SENSITIVITY	0.00408163	0.18552863636363634
SPERMATOGENIC FAILURE, X-LINKED, 2; SPGFX2	0.00408163	0.18552863636363634
DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, WITH OR WITHOUT OTHER CONGENITAL ANOMALIES	0.00408163	0.18552863636363634
AMOBARBITAL, DEFICIENT N-HYDROXYLATION OF	0.00408163	0.18552863636363634
17-@BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY	0.00408163	0.18552863636363634
SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 2	0.00408163	0.18552863636363634
GLUTATHIONURIA	0.00408163	0.18552863636363634
600459 ARTERIAL DISSECTION WITH LENTIGINOSIS	0.00408163	0.18552863636363634
HYPERPROGLUCAGONEMIA	0.00408163	0.18552863636363634
NEPHROSIALIDOSIS	0.00408163	0.18552863636363634
MUSCULAR DYSTROPHY, CONGENITAL, PRODUCING ARTHROGRYPOSIS	0.00408163	0.18552863636363634
253320 MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPICHYPOGONADISM;;CHUDLEY SYNDROME	0.00408163	0.18552863636363634
HYPOASCORBEMIA	0.00408163	0.18552863636363634
MACULAR DYSTROPHY, CORNEAL, 1	0.00408163	0.18552863636363634
AREDYLD	0.00408163	0.18552863636363634
NEURONAL INTESTINAL DYSPLASIA, TYPE B	0.00408163	0.18552863636363634
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, ASSOCIATED WITH ABNORMALITY OF REDCELL MEMBRANE	0.00408163	0.18552863636363634
LARON SYNDROME	0.00408163	0.18552863636363634
%270150 SJOGREN SYNDROME;;SICCA SYNDROME	0.00408163	0.18552863636363634
#225250 HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 5; CHNG5	0.00408163	0.18552863636363634
#301200 AMELOGENESIS IMPERFECTA, TYPE IE; AI1E;;AMELOGENESIS IMPERFECTA, HYPOPLASTIC/HYPOMATURATION, X-LINKED 1;;AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, WITH SNOW-CAPPED TEETH;;AMELOGENESIS IMPERFECTA, X-LINKED 1; AIH1;;ENAMEL HYPOPLASIA, X-LINKED	0.00408163	0.18552863636363634
CILIARY DISCOORDINATION DUE TO RANDOM CILIARY ORIENTATION	0.00408163	0.18552863636363634
TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN	0.00408163	0.18552863636363634
#192600 CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1; CMH1;;CMH;;VENTRICULAR HYPERTROPHY, HEREDITARY;;ASYMMETRIC SEPTAL HYPERTROPHY; ASH;;HYPERTROPHIC SUBAORTIC STENOSIS, IDIOPATHIC	0.00408163	0.18552863636363634
MYOPATHY, SPHEROID BODY	0.00408163	0.18552863636363634
600333 MOTOR NEURON DISEASE WITH DEMENTIA AND OPHTHALMOPLEGIA	0.00408163	0.18552863636363634
HEINZ BODY ANEMIAS	0.00408163	0.18552863636363634
CYTOCHROME P450, SUBFAMILY I, POLYPEPTIDE 2	0.00408163	0.18552863636363634
DERMATITIS, ATOPIC	0.00408163	0.18552863636363634
SHORT STATURE SYNDROME, BRUSSELS TYPE	0.00408163	0.18552863636363634
CONE-ROD DYSTROPHY 1; CORD1	0.00408163	0.18552863636363634
ALAND ISLAND EYE DISEASE	0.00408163	0.18552863636363634
ALPHA-2-DEFICIENT COLLAGEN DISEASE	0.00408163	0.18552863636363634
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.00408163	0.18552863636363634
#256050 ATELOSTEOGENESIS, TYPE II; AOII;;AO2;;NEONATAL OSSEOUS DYSPLASIA IDE LA CHAPELLE DYSPLASIA, INCLUDED; DLCD, INCLUDED	0.00408163	0.18552863636363634
CHOROIDAL OSTEOMA, BILATERAL	0.00408163	0.18552863636363634
NEURAL TUBE DEFECTS, FOLATE-SENSITIVE	0.00408163	0.18552863636363634
PERRY SYNDROME	0.00408163	0.18552863636363634
CONE DYSTROPHY, X-LINKED, WITH TAPETAL-LIKE SHEEN	0.00408163	0.18552863636363634
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2A	0.00408163	0.18552863636363634
INTERSTITIAL PNEUMONITIS, DESQUAMATIVE, FAMILIAL; DIP	0.00408163	0.18552863636363634
HYPOGONADOTROPIC HYPOGONADISM 24 WITHOUT ANOSMIA; HH24	0.00408163	0.18552863636363634
LYMPHOKINE DEFICIENCY	0.00408163	0.18552863636363634
DIABETES INSIPIDUS, NEUROHYPOPHYSEAL TYPE	0.00408163	0.18552863636363634
PREMATURE CENTROMERE DIVISION; PCD	0.00408163	0.18552863636363634
FINGERPRINT BODY MYOPATHY	0.00408163	0.18552863636363634
VISCERAL MYOPATHY, FAMILIAL, WITH EXTERNAL OPHTHALMOPLEGIA	0.00408163	0.18552863636363634
SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1; SMDP1	0.00408163	0.18552863636363634
MYASTHENIA, CONGENITAL, REFRACTORY TO ACETYLCHOLINESTERASE INHIBITORS	0.00408163	0.18552863636363634
BEETURIA	0.00408163	0.18552863636363634
TESTICULAR GERM CELL TUMOR; TGCT	0.00408163	0.18552863636363634
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 5	0.00408163	0.18552863636363634
257960 OCULOTRICHODYSPLASIA; OTD	0.00408163	0.18552863636363634
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.00408163	0.18552863636363634
CARBOXYLESTERASE 1	0.00408163	0.18552863636363634
#203655 ALOPECIA UNIVERSALIS CONGENITA; ALUNC;;ATRICHIA, GENERALIZED	0.00408163	0.18552863636363634
LACTOSE INTOLERANCE, ADULT TYPE	0.00408163	0.18552863636363634
PYGMY	0.00408163	0.18552863636363634
PHAGOCYTOSIS, PLASMA-RELATED DEFECT IN	0.00408163	0.18552863636363634
FETAL IODINE DEFICIENCY DISORDER	0.00408163	0.18552863636363634
SODIUM-POTASSIUM-ATPASE ACTIVITY OF RED CELL	0.00408163	0.18552863636363634
GAMMA-GLUTAMYLCYSTEINE SYNTHETASE DEFICIENCY, HEMOLYTIC ANEMIA DUETO	0.00408163	0.18552863636363634
CALVARIAL HYPEROSTOSIS	0.00408163	0.18552863636363634
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.00408163	0.18552863636363634
CARDIAC LIPIDOSIS, FAMILIAL	0.00408163	0.18552863636363634
SUCRASE-ISOMALTASE DEFICIENCY, CONGENITAL	0.00408163	0.18552863636363634
SPERMATOGENIC FAILURE 1; SPGF1	0.00408163	0.18552863636363634
#143860 HYPERCHLORHIDROSIS, ISOLATED	0.00408163	0.18552863636363634
ORNITHINE AMINOTRANSFERASE DEFICIENCY	0.00408163	0.18552863636363634
DOPAMINE BETA-HYDROXYLASE, PLASMA, THERMOLABILITY OF	0.00408163	0.18552863636363634
ICHTHYOSIS HYSTRIX, CURTH-MACKLIN TYPE	0.00408163	0.18552863636363634
PITUITARY DWARFISM IV	0.00408163	0.18552863636363634
DELETED IN AZOOSPERMIA	0.00408163	0.18552863636363634
TINEA IMBRICATA, SUSCEPTIBILITY TO	0.00408163	0.18552863636363634
#270960 SPERMATOGENIC FAILURE 4; SPGF4;;AZOOSPERMIA DUE TO PERTURBATIONS OF MEIOSIS;;AZOOSPERMIA WITH MATURATION ARREST;;SPERMATOGENESIS ARRESTPREGNANCY LOSS, RECURRENT, SUSCEPTIBILITY TO, 4; RPRGL4	0.00408163	0.18552863636363634
OCULOSKELETODENTAL SYNDROME; OCSKD	0.004028592	0.1831178181818182
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.004028592	0.1831178181818182
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.004028592	0.1831178181818182
ROIFMAN SYNDROME; RFMN	0.004028592	0.1831178181818182
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.004028592	0.1831178181818182
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.004028592	0.1831178181818182
MACROCEPHALY/AUTISM SYNDROME	0.004028592	0.1831178181818182
PEROXISOME BIOGENESIS DISORDER 3B	0.004028592	0.1831178181818182
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.003964531	0.18020595454545454
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.003964531	0.18020595454545454
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.003964531	0.18020595454545454
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.003964531	0.18020595454545454
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.003964531	0.18020595454545454
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.003964531	0.18020595454545454
COFFIN-SIRIS SYNDROME 8; CSS8	0.003964531	0.18020595454545454
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.003964531	0.18020595454545454
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.003964531	0.18020595454545454
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.003964531	0.18020595454545454
#309510 PARTINGTON X-LINKED MENTAL RETARDATION SYNDROME; PRTS;;PARTINGTON SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 1; MRXS1;;MENTAL RETARDATION, X-LINKED, WITH DYSTONIC MOVEMENTS, ATAXIA, ANDSEIZURES;;MENTAL RETARDATION, X-LINKED 36; MRX36	0.003964531	0.18020595454545454
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.003964531	0.18020595454545454
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.003964531	0.18020595454545454
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.003964531	0.18020595454545454
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.003964531	0.18020595454545454
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.003964531	0.18020595454545454
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.003964531	0.18020595454545454
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.003964531	0.18020595454545454
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.003964531	0.18020595454545454
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.003964531	0.18020595454545454
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.003964531	0.18020595454545454
#300558 MENTAL RETARDATION, X-LINKED 30; MRX30;;MENTAL RETARDATION, X-LINKED 47; MRX47	0.003964531	0.18020595454545454
TENORIO SYNDROME; TNORS	0.003964531	0.18020595454545454
AUTISM	0.003964531	0.18020595454545454
#602541 MUSCULAR DYSTROPHY, CONGENITAL, MEGACONIAL TYPE; MDCMC;;MUSCULAR DYSTROPHY, CONGENITAL, WITH MITOCHONDRIAL STRUCTURAL ABNORMALITIES	0.003964531	0.18020595454545454
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.003964531	0.18020595454545454
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.003964531	0.18020595454545454
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.003964531	0.18020595454545454
SPINOCEREBELLAR ATAXIA 47; SCA47	0.003964531	0.18020595454545454
KLEEFSTRA SYNDROME	0.003964531	0.18020595454545454
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.003964531	0.18020595454545454
CHROMOSOME 15q11-q13 DUPLICATION SYNDROME	0.003964531	0.18020595454545454
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.003964531	0.18020595454545454
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.003892662	0.1769391818181818
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.003892662	0.1769391818181818
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.003892662	0.1769391818181818
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.003892662	0.1769391818181818
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.003892662	0.1769391818181818
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.003892662	0.1769391818181818
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.003892662	0.1769391818181818
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.003892662	0.1769391818181818
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.003892662	0.1769391818181818
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.003892662	0.1769391818181818
LAMB-SHAFFER SYNDROME	0.003892662	0.1769391818181818
TONNE-KALSCHEUER SYNDROME; TOKAS	0.003892662	0.1769391818181818
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.003892662	0.1769391818181818
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.003892662	0.1769391818181818
Retinitis pigmentosa with or without skeletal anomalies	0.003892662	0.1769391818181818
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.003892662	0.1769391818181818
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.003892662	0.1769391818181818
COHEN-GIBSON SYNDROME; COGIS	0.003892662	0.1769391818181818
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.003892662	0.1769391818181818
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.003892662	0.1769391818181818
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.003892662	0.1769391818181818
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.003892662	0.1769391818181818
#615541 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 39; MRT39	0.003892662	0.1769391818181818
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.003892662	0.1769391818181818
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.003892662	0.1769391818181818
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.003892662	0.1769391818181818
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.003892662	0.1769391818181818
BARATELA-SCOTT SYNDROME	0.003892662	0.1769391818181818
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.003892662	0.1769391818181818
SAUL-WILSON SYNDROME; SWILS	0.003892662	0.1769391818181818
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.003892662	0.1769391818181818
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.003892662	0.1769391818181818
Cerebral creatine deficiency syndrome 3	0.003892662	0.1769391818181818
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.003892662	0.1769391818181818
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.003892662	0.1769391818181818
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.003892662	0.1769391818181818
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.003892662	0.1769391818181818
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.003892662	0.1769391818181818
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.003892662	0.1769391818181818
COFFIN-SIRIS SYNDROME 6; CSS6	0.003892662	0.1769391818181818
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.003892662	0.1769391818181818
#614728 SECKEL SYNDROME 6; SCKL6	0.003892662	0.1769391818181818
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.003892662	0.1769391818181818
CHROMOSOME 9P DELETION SYNDROME	0.003892662	0.1769391818181818
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.003892662	0.1769391818181818
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.003892662	0.1769391818181818
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.003892662	0.1769391818181818
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.003892662	0.1769391818181818
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.003892662	0.1769391818181818
DESBUQUOIS DYSPLASIA 2; DBQD2	0.003892662	0.1769391818181818
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.003892662	0.1769391818181818
COFFIN-SIRIS SYNDROME 7; CSS7	0.003892662	0.1769391818181818
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.003892662	0.1769391818181818
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.003892662	0.1769391818181818
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.003892662	0.1769391818181818
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.003892662	0.1769391818181818
#610185 CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME2; CAMRQ2;;CEREBELLAR ATAXIA AND MENTAL RETARDATION WITH OR WITHOUT QUADRUPEDALLOCOMOTION 2	0.003892662	0.1769391818181818
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.003892662	0.1769391818181818
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.003892662	0.1769391818181818
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.003892662	0.1769391818181818
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.003892662	0.1769391818181818
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.003892662	0.1769391818181818
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.003892662	0.1769391818181818
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.003892662	0.1769391818181818
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.003892662	0.1769391818181818
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.003479851	0.15817504545454544
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.003479851	0.15817504545454544
ALEXANDER DISEASE	0.003479851	0.15817504545454544
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.003479851	0.15817504545454544
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.003479851	0.15817504545454544
CYCLIC VOMITING SYNDROME	0.003479851	0.15817504545454544
LISSENCEPHALY 3; LIS3	0.003479851	0.15817504545454544
NEUROFIBROMATOSIS, TYPE II	0.003479851	0.15817504545454544
#615705 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 15; SCAR15;;SALIH ATAXIA	0.003479851	0.15817504545454544
PERRAULT SYNDROME 5; PRLTS5	0.003479851	0.15817504545454544
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.003479851	0.15817504545454544
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.003479851	0.15817504545454544
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.003479851	0.15817504545454544
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.003479851	0.15817504545454544
GITELMAN SYNDROME	0.003479851	0.15817504545454544
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.003479851	0.15817504545454544
#208900 ATAXIA-TELANGIECTASIA; AT;;AT1;;LOUIS-BAR SYNDROMEAT, COMPLEMENTATION GROUP A, INCLUDED; ATA, INCLUDED;;AT, COMPLEMENTATION GROUP C, INCLUDED; ATC, INCLUDED;;AT, COMPLEMENTATION GROUP D, INCLUDED; ATD, INCLUDED;;AT, COMPLEMENTATION GROUP E, INCLUDED; ATE, INCLUDED;;ATAXIA-TELANGIECTASIA VARIANT, INCLUDED	0.003479851	0.15817504545454544
CEREBELLOPARENCHYMAL DISORDER II	0.003479851	0.15817504545454544
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.003479851	0.15817504545454544
FLYNN-AIRD SYNDROME	0.003479851	0.15817504545454544
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.003479851	0.15817504545454544
KNOBLOCH SYNDROME 1; KNO1	0.003479851	0.15817504545454544
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.003479851	0.15817504545454544
#256731 CEROID LIPOFUSCINOSIS, NEURONAL, 5; CLN5;;CEROID LIPOFUSCINOSIS, NEURONAL, 5, VARIABLE AGE AT ONSETNEURONAL CEROID LIPOFUSCINOSIS, LATE INFANTILE, FINNISH VARIANT, INCLUDED;;FINNISH vLINCL, INCLUDED	0.003479851	0.15817504545454544
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.003479851	0.15817504545454544
#604004 MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 1; MLC1;;VACUOLATING MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS;;LVM;;VL;;LEUKOENCEPHALOPATHY WITH SWELLING AND CYSTS;;VAN DER KNAAP DISEASE	0.003479851	0.15817504545454544
KUFOR-RAKEB SYNDROME	0.003479851	0.15817504545454544
#141500 MIGRAINE, FAMILIAL HEMIPLEGIC, 1; FHM1;;FHM;;MHP1MIGRAINE, FAMILIAL HEMIPLEGIC 1, WITH PROGRESSIVE CEREBELLAR ATAXIA,INCLUDED;;MIGRAINE, SPORADIC HEMIPLEGIC, INCLUDED	0.003479851	0.15817504545454544
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.003479851	0.15817504545454544
GLUTATHIONE SYNTHETASE DEFICIENCY	0.003479851	0.15817504545454544
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.003479851	0.15817504545454544
LISSENCEPHALY, X-LINKED, 1; LISX1	0.003479851	0.15817504545454544
KEARNS-SAYRE SYNDROME; KSS	0.003479851	0.15817504545454544
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.003479851	0.15817504545454544
Myhre syndrome	0.003479851	0.15817504545454544
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.003479851	0.15817504545454544
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.003479851	0.15817504545454544
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.003479851	0.15817504545454544
DIAMINOPENTANURIA	0.003479851	0.15817504545454544
#252011 MITOCHONDRIAL COMPLEX II DEFICIENCY;;SUCCINATE CoQ REDUCTASE DEFICIENCY	0.003479851	0.15817504545454544
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.0034079819999999995	0.1549082727272727
PELLAGRA-LIKE SYNDROME	0.0034079819999999995	0.1549082727272727
JOUBERT SYNDROME 8	0.0034079819999999995	0.1549082727272727
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.0034079819999999995	0.1549082727272727
BAKER-GORDON SYNDROME; BAGOS	0.0034079819999999995	0.1549082727272727
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.0034079819999999995	0.1549082727272727
OROFACIODIGITAL SYNDROME XVI; OFD16	0.0034079819999999995	0.1549082727272727
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.0034079819999999995	0.1549082727272727
JOUBERT SYNDROME 33; JBTS33	0.0034079819999999995	0.1549082727272727
JOUBERT SYNDROME 14	0.0034079819999999995	0.1549082727272727
JOUBERT SYNDROME 27	0.0034079819999999995	0.1549082727272727
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.0034079819999999995	0.1549082727272727
RICHARDS-RUNDLE SYNDROME; RRNS	0.0034079819999999995	0.1549082727272727
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.0034079819999999995	0.1549082727272727
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.0034079819999999995	0.1549082727272727
#231550 ACHALASIA-ADDISONIANISM-ALACRIMA SYNDROME; AAAS;;TRIPLE-A SYNDROME;;ALACRIMA-ACHALASIA-ADRENAL INSUFFICIENCY NEUROLOGIC DISORDER;;GLUCOCORTICOID DEFICIENCY AND ACHALASIA;;ALLGROVE SYNDROME;;ADDISONIAN-ACHALASIA SYNDROME;;HYPOADRENALISM WITH ACHALASIA;;ALACRIMA-ACHALASIA-ADDISONIANISM;;ACTH-RESISTANT ADRENAL INSUFFICIENCY, ACHALASIA AND ALACRIMAACHALASIA-ALACRIMA SYNDROME, INCLUDED	0.0034079819999999995	0.1549082727272727
JOUBERT SYNDROME 21	0.0034079819999999995	0.1549082727272727
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.0034079819999999995	0.1549082727272727
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.0034079819999999995	0.1549082727272727
JOUBERT SYNDROME 25	0.0034079819999999995	0.1549082727272727
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.0034079819999999995	0.1549082727272727
WAARDENBURG-SHAH SYNDROME	0.0034079819999999995	0.1549082727272727
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.0034079819999999995	0.1549082727272727
JOUBERT SYNDROME 7	0.0034079819999999995	0.1549082727272727
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.0034079819999999995	0.1549082727272727
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.0034079819999999995	0.1549082727272727
MECKEL SYNDROME 13; MKS13	0.0034079819999999995	0.1549082727272727
JOUBERT SYNDROME 32; JBTS32	0.0034079819999999995	0.1549082727272727
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.0034079819999999995	0.1549082727272727
JOUBERT SYNDROME 15	0.0034079819999999995	0.1549082727272727
JOUBERT SYNDROME 17; JBTS17	0.0034079819999999995	0.1549082727272727
MARINESCO-SJOGREN SYNDROME; MSS	0.0034079819999999995	0.1549082727272727
JOUBERT SYNDROME 35; JBTS35	0.0034079819999999995	0.1549082727272727
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.0034079819999999995	0.1549082727272727
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.0034079819999999995	0.1549082727272727
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.0034079819999999995	0.1549082727272727
JOUBERT SYNDROME 28	0.0034079819999999995	0.1549082727272727
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.0034079819999999995	0.1549082727272727
#609016 LONG-CHAIN 3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY;;LCHAD DEFICIENCY	0.00318471	0.14475954545454542
LEBER CONGENITAL AMAUROSIS, TYPE I	0.00318471	0.14475954545454542
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 2; AHMIO2	0.00318471	0.14475954545454542
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE-2 DEFICIENCY	0.00318471	0.14475954545454542
#607196 MICROCEPHALY, AMISH TYPE; MCPHA;;AMISH LETHAL MICROCEPHALY;;THIAMINE METABOLISM DYSFUNCTION SYNDROME 3 (MICROCEPHALY TYPE); THMD3	0.00318471	0.14475954545454542
APOLIPOPROTEIN C-II DEFICIENCY	0.00318471	0.14475954545454542
FAMILIAL MEDITERRANEAN FEVER; FMF	0.00318471	0.14475954545454542
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.00318471	0.14475954545454542
SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1	0.00318471	0.14475954545454542
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 3; MC3DN3	0.00318471	0.14475954545454542
SARCOIDOSIS, SUSCEPTIBILITY TO, 2; SS2	0.00318471	0.14475954545454542
#614185 GELEOPHYSIC DYSPLASIA 2; GPHYSD2	0.00318471	0.14475954545454542
PERSISTENT POLYCLONAL B-CELL LYMPHOCYTOSIS; PPBL	0.00318471	0.14475954545454542
HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	0.00318471	0.14475954545454542
HURLER-SCHEIE SYNDROME	0.00318471	0.14475954545454542
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE V; ALPS5	0.00318471	0.14475954545454542
#500009 MITOCHONDRIAL MYOPATHY, INFANTILE, TRANSIENT; MMIT;;MITOCHONDRIAL MYOPATHY, INFANTILE, TRANSIENT, DUE TO RESPIRATORY CHAINDEFICIENCY;;COX DEFICIENCY MYOPATHY, INFANTILE, TRANSIENT;;RESPIRATORY CHAIN DEFICIENCY, INFANTILE, TRANSIENT	0.00318471	0.14475954545454542
#253250 MULIBREY NANISM;;MUSCLE-LIVER-BRAIN-EYE NANISM;;PERICARDIAL CONSTRICTION AND GROWTH FAILURE;;PERHEENTUPA SYNDROME	0.00318471	0.14475954545454542
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.00318471	0.14475954545454542
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.00318471	0.14475954545454542
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE	0.00318471	0.14475954545454542
#253010 MUCOPOLYSACCHARIDOSIS TYPE IVB;;MORQUIO SYNDROME B;;MPS IVB; MPS4B	0.00318471	0.14475954545454542
#269840 SELECTIVE T-CELL DEFECT; STCD	0.00318471	0.14475954545454542
TANGIER DISEASE; TGD	0.00318471	0.14475954545454542
POIKILODERMA, HEREDITARY FIBROSING, WITH TENDON CONTRACTURES, MYOPATHY, AND PULMONARY FIBROSIS; POIKTMP	0.00318471	0.14475954545454542
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY	0.00318471	0.14475954545454542
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	0.00318471	0.14475954545454542
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.00318471	0.14475954545454542
RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER; RALD	0.00318471	0.14475954545454542
HYPERLIPOPROTEINEMIA, TYPE ID	0.00318471	0.14475954545454542
HYPERZINCEMIA WITH FUNCTIONAL ZINC DEPLETION	0.00318471	0.14475954545454542
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.00318471	0.14475954545454542
#614034 HEME OXYGENASE 1 DEFICIENCY; HMOX1D	0.00318471	0.14475954545454542
SEVERE COMBINED IMMUNODEFICIENCY, X-LINKED	0.00318471	0.14475954545454542
FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG; FRTS4	0.00318471	0.14475954545454542
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.00318471	0.14475954545454542
IMMUNODEFICIENCY 63 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY; IMD63	0.00318471	0.14475954545454542
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE; SEMDSH	0.00318471	0.14475954545454542
#607594 IMMUNODEFICIENCY, COMMON VARIABLE, 1; CVID1;;ANTIBODY DEFICIENCY DUE TO ICOS DEFECTIMMUNODEFICIENCY, COMMON VARIABLE, INCLUDED; CVID, INCLUDED	0.00318471	0.14475954545454542
THROMBOCYTOSIS, FAMILIAL X-LINKED	0.00318471	0.14475954545454542
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 1	0.00318471	0.14475954545454542
CYSTINOSIS, NEPHROPATHIC; CTNS	0.00318471	0.14475954545454542
OSTEOPETROSIS, AUTOSOMAL DOMINANT 3; OPTA3	0.00318471	0.14475954545454542
GLYCOGEN STORAGE DISEASE II	0.00318471	0.14475954545454542
LYMPHOPROLIFERATIVE SYNDROME 3; LPFS3	0.00318471	0.14475954545454542
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.00318471	0.14475954545454542
AUTOINFLAMMATION WITH ARTHRITIS AND DYSKERATOSIS; AIADK	0.00318471	0.14475954545454542
GELEOPHYSIC DYSPLASIA 3; GPHYSD3	0.00318471	0.14475954545454542
MORQUIO SYNDROME A	0.00318471	0.14475954545454542
#613978 HEMOGLOBIN H DISEASE; HBH;;ALPHA-THALASSEMIA, HEMOGLOBIN H TYPE;;HEMOGLOBIN H DISEASE, DELETIONALHEMOGLOBIN H DISEASE, NONDELETIONAL, INCLUDED	0.00318471	0.14475954545454542
IMMUNODEFICIENCY, COMMON VARIABLE, 2; CVID2	0.00318471	0.14475954545454542
NIEMANN-PICK DISEASE, TYPE B	0.00318471	0.14475954545454542
129540 ECTODERMAL DYSPLASIA SYNDROME WITH DISTINCTIVE FACIAL APPEARANCE ANDPREAXIAL POLYDACTYLY OF FEET	0.00304878	0.1385809090909091
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.00304878	0.1385809090909091
DEAFNESS, AUTOSOMAL RECESSIVE 79; DFNB79	0.00304878	0.1385809090909091
MENTAL RETARDATION, X-LINKED 95	0.00304878	0.1385809090909091
DYSTONIA 16; DYT16	0.00304878	0.1385809090909091
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.00304878	0.1385809090909091
MOEBIUS SYNDROME; MBS	0.00304878	0.1385809090909091
22q13 deletion syndrome (Phelan-Mcdermid syndrome)	0.00304878	0.1385809090909091
OSTEOGENESIS IMPERFECTA, TYPE XVII; OI17	0.00304878	0.1385809090909091
MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4	0.00304878	0.1385809090909091
SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE; SPAX4	0.00304878	0.1385809090909091
224550 DYSTONIA WITH RINGBINDEN	0.00304878	0.1385809090909091
#614438 CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIB; ARCL3B;;DE BARSY SYNDROME B	0.00304878	0.1385809090909091
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.00304878	0.1385809090909091
SPEECH-LANGUAGE DISORDER 1	0.00304878	0.1385809090909091
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 25	0.00304878	0.1385809090909091
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 8; NBIA8	0.00304878	0.1385809090909091
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.00304878	0.1385809090909091
#166250 OSTEOGLOPHONIC DYSPLASIA; OGD;;OSTEOGLOPHONIC DWARFISM	0.00304878	0.1385809090909091
SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME; MRXSSD	0.00304878	0.1385809090909091
CHROMOSOME 13q14 DELETION SYNDROME	0.00304878	0.1385809090909091
VERVERI-BRADY SYNDROME; VERBRAS	0.00304878	0.1385809090909091
SPINOCEREBELLAR ATAXIA 44; SCA44	0.00304878	0.1385809090909091
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.00304878	0.1385809090909091
Orofaciodigital syndrome XVII	0.00304878	0.1385809090909091
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.00304878	0.1385809090909091
MEIER-GORLIN SYNDROME 3; MGORS3	0.00304878	0.1385809090909091
GERODERMA OSTEODYSPLASTICUM; GO	0.00304878	0.1385809090909091
#300705 MENTAL RETARDATION, X-LINKED 17; MRX17;;MENTAL RETARDATION, X-LINKED 31; MRX31	0.00304878	0.1385809090909091
THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT	0.00304878	0.1385809090909091
MENTAL RETARDATION, X-LINKED 97; MRX97	0.00304878	0.1385809090909091
%606772 MENTAL RETARDATION, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKINANOMALIES;;MOMES SYNDROME	0.00304878	0.1385809090909091
8p23.1 duplication syndrome	0.00304878	0.1385809090909091
CRANIOSYNOSTOSIS 7	0.00304878	0.1385809090909091
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 54	0.00304878	0.1385809090909091
FG SYNDROME 2; FGS2	0.00304878	0.1385809090909091
DUBOWITZ SYNDROME	0.00304878	0.1385809090909091
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.00304878	0.1385809090909091
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 8; MDDGC8	0.00304878	0.1385809090909091
OSTEOGENESIS IMPERFECTA, TYPE XVIII; OI18	0.00304878	0.1385809090909091
HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME; HADDTS	0.00304878	0.1385809090909091
HYPOGLOSSIA WITH SITUS INVERSUS	0.00304878	0.1385809090909091
#278250 WRINKLY SKIN SYNDROME; WSS	0.00304878	0.1385809090909091
#615328 SHAHEEN SYNDROME; SHNS	0.00304878	0.1385809090909091
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.00304878	0.1385809090909091
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.00304878	0.1385809090909091
TEMPLE SYNDROME	0.00304878	0.1385809090909091
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.00304878	0.1385809090909091
SOTOS SYNDROME 2	0.00304878	0.1385809090909091
ABLEPHARON-MACROSTOMIA SYNDROME	0.00304878	0.1385809090909091
SPECIFIC LANGUAGE IMPAIRMENT 1; SLI1	0.00304878	0.1385809090909091
CHITAYAT SYNDROME	0.00304878	0.1385809090909091
STRIATONIGRAL DEGENERATION, CHILDHOOD-ONSET	0.00304878	0.1385809090909091
MENTAL RETARDATION, X-LINKED 93	0.00304878	0.1385809090909091
MENTAL RETARDATION, X-LINKED 19	0.00304878	0.1385809090909091
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.00304878	0.1385809090909091
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 14	0.00304878	0.1385809090909091
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 24	0.00304878	0.1385809090909091
MEIER-GORLIN SYNDROME 6; MGORS6	0.00304878	0.1385809090909091
MAXILLOFACIAL DYSOSTOSIS	0.00304878	0.1385809090909091
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 28	0.00304878	0.1385809090909091
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 7; NBIA7	0.00304878	0.1385809090909091
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00304878	0.1385809090909091
BRACHYDACTYLY, TYPE A1, D	0.00304878	0.1385809090909091
SPEECH DEVELOPMENT, DELAYED, WITH FACIAL ASYMMETRY, STRABISMUS, ANDTRANSVERSE EARLOBE CREASE	0.00304878	0.1385809090909091
Recurrent 16p12.1 microdeletion (neurodevelopmental susceptibility locus)	0.00304878	0.1385809090909091
CHROMOSOME 3q13.31 DELETION SYNDROME	0.00304878	0.1385809090909091
22q11 deletion syndrome (Velocardiofacial / DiGeorge syndrome)	0.00304878	0.1385809090909091
#605407 SEGAWA SYNDROME, AUTOSOMAL RECESSIVE;;PARKINSONISM, INFANTILE, AUTOSOMAL RECESSIVE;;DYSTONIA, DOPA-RESPONSIVE, AUTOSOMAL RECESSIVE;;DOPA-RESPONSIVE DYSTONIA, AUTOSOMAL RECESSIVE;;TYROSINE HYDROXYLASE DEFICIENCY	0.00304878	0.1385809090909091
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.00304878	0.1385809090909091
HYPERPARATHYROIDISM, TRANSIENT NEONATAL; HRPTTN	0.00304878	0.1385809090909091
7q11.23 duplication syndrome	0.00304878	0.1385809090909091
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2	0.00304878	0.1385809090909091
MENTAL RETARDATION, TRUNCAL OBESITY, RETINAL DYSTROPHY, AND MICROPENIS SYNDROME; MORMS	0.00304878	0.1385809090909091
#615633 SHORT-RIB THORACIC DYSPLASIA 11 WITH OR WITHOUT POLYDACTYLY; SRTD11	0.00304878	0.1385809090909091
NYSTAGMUS, HEREDITARY VERTICAL	0.0025640999999999997	0.11654999999999999
NEUROBLASTOMA, SUSCEPTIBILITY TO	0.0025640999999999997	0.11654999999999999
%601992 FRIEDREICH ATAXIA 2; FRDA2	0.0025640999999999997	0.11654999999999999
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K; CMT4K	0.0025640999999999997	0.11654999999999999
ENCEPHALOPATHY WITH INTRACRANIAL CALCIFICATION, GROWTH HORMONE DEFICIENCY, MICROCEPHALY, AND RETINAL DEGENERATION	0.0025640999999999997	0.11654999999999999
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG	0.0025640999999999997	0.11654999999999999
#612674 POLYNEUROPATHY, HEARING LOSS, ATAXIA, RETINITIS PIGMENTOSA, AND CATARACT;PHARC	0.0025640999999999997	0.11654999999999999
SPASTIC PARAPLEGIA, ATAXIA, AND MENTAL RETARDATION	0.0025640999999999997	0.11654999999999999
CEREBELLAR HYPOPLASIA	0.0025640999999999997	0.11654999999999999
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2	0.0025640999999999997	0.11654999999999999
#600072 FATAL FAMILIAL INSOMNIA; FFI;;INSOMNIA, FATAL FAMILIAL	0.0025640999999999997	0.11654999999999999
ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA; EAOH	0.0025640999999999997	0.11654999999999999
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 2; FTDALS2	0.0025640999999999997	0.11654999999999999
#270700 SPASTIC PARAPLEGIA 15, AUTOSOMAL RECESSIVE; SPG15;;SPASTIC PARAPLEGIA AND RETINAL DEGENERATION;;KJELLIN SYNDROME	0.0025640999999999997	0.11654999999999999
BIRK-LANDAU-PEREZ SYNDROME; BILAPES	0.0025640999999999997	0.11654999999999999
HYPOGONADOTROPIC HYPOGONADISM 1 WITH OR WITHOUT ANOSMIA; HH1	0.0025640999999999997	0.11654999999999999
PERIPHERAL NEUROPATHY, ATAXIA, FOCAL NECROTIZING ENCEPHALOPATHY, AND	0.0025640999999999997	0.11654999999999999
MUSCULAR ATROPHY, ATAXIA, RETINITIS PIGMENTOSA, AND DIABETES MELLITUS	0.0025640999999999997	0.11654999999999999
SPINOCEREBELLAR ATAXIA 37; SCA37	0.0025640999999999997	0.11654999999999999
SPASTIC ATAXIA 9, AUTOSOMAL RECESSIVE; SPAX9	0.0025640999999999997	0.11654999999999999
SPINOCEREBELLAR ATAXIA 41; SCA41	0.0025640999999999997	0.11654999999999999
%300703 SPINOCEREBELLAR ATAXIA, X-LINKED 5; SCAX5	0.0025640999999999997	0.11654999999999999
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.0025640999999999997	0.11654999999999999
OLIVOPONTOCEREBELLAR ATROPHY II, AUTOSOMAL RECESSIVE	0.0025640999999999997	0.11654999999999999
#276880 UROCANASE DEFICIENCY	0.0025640999999999997	0.11654999999999999
#275350 TRANSCOBALAMIN II DEFICIENCY;;TC II DEFICIENCY;;TCN2 DEFICIENCY	0.0025640999999999997	0.11654999999999999
OPTIC ATROPHY 10 WITH OR WITHOUT ATAXIA, MENTAL RETARDATION, AND SEIZURES	0.0025640999999999997	0.11654999999999999
SPINOCEREBELLAR ATAXIA, X-LINKED 1; SCAX1	0.0025640999999999997	0.11654999999999999
MACHADO-JOSEPH DISEASE; MJD	0.0025640999999999997	0.11654999999999999
#609270 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 7; SCAR7	0.0025640999999999997	0.11654999999999999
ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.0025640999999999997	0.11654999999999999
SPINOCEREBELLAR ATAXIA 31	0.0025640999999999997	0.11654999999999999
FRIEDREICH ATAXIA, SO-CALLED, WITH OPTIC ATROPHY AND SENSORINEURALDEAFNESS	0.0025640999999999997	0.11654999999999999
SPINOCEREBELLAR ATAXIA, X-LINKED 2	0.0025640999999999997	0.11654999999999999
PIEBALD TRAIT WITH NEUROLOGIC DEFECTS	0.0025640999999999997	0.11654999999999999
BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA	0.0025640999999999997	0.11654999999999999
CHIARI MALFORMATION TYPE II	0.0025640999999999997	0.11654999999999999
#613227 CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME3; CAMRQ3;;CEREBELLAR ATAXIA AND MENTAL RETARDATION WITH OR WITHOUT QUADRUPEDALLOCOMOTION 3	0.0025640999999999997	0.11654999999999999
ACERULOPLASMINEMIA	0.0025640999999999997	0.11654999999999999
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.0025640999999999997	0.11654999999999999
KALLMANN SYNDROME WITH SPASTIC PARAPLEGIA	0.0025640999999999997	0.11654999999999999
MITOCHONDRIAL MYOPATHY WITH DIABETES	0.0025640999999999997	0.11654999999999999
POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	0.0025640999999999997	0.11654999999999999
229310 FRIEDREICH ATAXIA AND CONGENITAL GLAUCOMA	0.0025640999999999997	0.11654999999999999
MYOCLONUS, FAMILIAL CORTICAL; FCM	0.0025640999999999997	0.11654999999999999
ATAXIA, DEAFNESS, AND CARDIOMYOPATHY	0.0025640999999999997	0.11654999999999999
JOUBERT SYNDROME 3; JBTS3	0.0025640999999999997	0.11654999999999999
#258501 3-@METHYLGLUTACONIC ACIDURIA, TYPE III; MGCA3;;MGA, TYPE III; MGA3;;OPTIC ATROPHY PLUS SYNDROME;;OPTIC ATROPHY, INFANTILE, WITH CHOREA AND SPASTIC PARAPLEGIA;;IRAQI-JEWISH 'OPTIC ATROPHY PLUS';;COSTEFF SYNDROME;;OPTIC ATROPHY 3, AUTOSOMAL RECESSIVE;;OPA3, AUTOSOMAL RECESSIVE	0.0025640999999999997	0.11654999999999999
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	0.0025640999999999997	0.11654999999999999
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE G; CMTDIG	0.0025640999999999997	0.11654999999999999
GILLESPIE SYNDROME; GLSP	0.0025640999999999997	0.11654999999999999
SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE	0.0025640999999999997	0.11654999999999999
JOUBERT SYNDROME 5	0.0025640999999999997	0.11654999999999999
#604360 SPASTIC PARAPLEGIA 11, AUTOSOMAL RECESSIVE; SPG11;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, WITH MENTAL IMPAIRMENT ANDTHIN CORPUS CALLOSUM;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, COMPLICATED, WITH THIN CORPUSCALLOSUM;;HSP-TCC	0.0025640999999999997	0.11654999999999999
#615558 HYPOBETALIPOPROTEINEMIA, FAMILIAL, 1; FHBL1;;HYPOBETALIPOPROTEINEMIA, FAMILIAL; FHBL;;ACANTHOCYTOSIS WITH HYPOBETALIPOPROTEINEMIA;;HYPOBETALIPOPROTEINEMIA, NORMOTRIGLYCERIDEMIC	0.0025640999999999997	0.11654999999999999
245800 LAURENCE-MOON SYNDROME	0.0025640999999999997	0.11654999999999999
CATARACT, ATAXIA, SHORT STATURE, AND MENTAL RETARDATION	0.0025640999999999997	0.11654999999999999
#604187 SPASTIC PARAPLEGIA 10, AUTOSOMAL DOMINANT; SPG10;;SPASTIC PARAPLEGIA 10 WITH OR WITHOUT PERIPHERAL NEUROPATHY	0.0025640999999999997	0.11654999999999999
#613078 NIJMEGEN BREAKAGE SYNDROME-LIKE DISORDER; NBSLD;;NBS-LIKE DISORDER;;RAD50 DEFICIENCY;;MICROCEPHALY AND SPONTANEOUS CHROMOSOME INSTABILITY WITHOUT IMMUNODEFICIENCY	0.0025640999999999997	0.11654999999999999
SPASTIC PARAPLEGIA 80, AUTOSOMAL DOMINANT; SPG80	0.0025640999999999997	0.11654999999999999
ATONIC-ASTATIC SYNDROME OF FOERSTER	0.0025640999999999997	0.11654999999999999
ATAXIA-OCULOMOTOR APRAXIA 4; AOA4	0.0025640999999999997	0.11654999999999999
#612020 SPASTIC PARAPLEGIA 39, AUTOSOMAL RECESSIVE; SPG39;;NTE-RELATED MOTOR NEURON DISORDER; NTEMND	0.0025640999999999997	0.11654999999999999
NEUROPATHY, HEREDITARY SENSORY, ATYPICAL	0.0025640999999999997	0.11654999999999999
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.0025640999999999997	0.11654999999999999
POSTERIOR COLUMN ATAXIA	0.0025640999999999997	0.11654999999999999
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.0025640999999999997	0.11654999999999999
CATARACT-ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.0025640999999999997	0.11654999999999999
ATAXIA-MICROCEPHALY-CATARACT SYNDROME	0.0025640999999999997	0.11654999999999999
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	0.0025640999999999997	0.11654999999999999
MULTIPLE SYSTEM ATROPHY 1, SUSCEPTIBILITY TO; MSA1	0.0025640999999999997	0.11654999999999999
VITAMIN E, FAMILIAL ISOLATED DEFICIENCY OF	0.0025640999999999997	0.11654999999999999
272600 TAPETORETINAL DEGENERATION WITH ATAXIA	0.0025640999999999997	0.11654999999999999
LEUKOENCEPHALOPATHY, ACUTE REVERSIBLE, WITH INCREASED URINARY ALPHA-KETOGLUTARATE; ARLIAK	0.0025640999999999997	0.11654999999999999
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.0025640999999999997	0.11654999999999999
SPINOCEREBELLAR ATAXIA 30; SCA30	0.0025640999999999997	0.11654999999999999
ATAXIA WITH FASCICULATIONS	0.0025640999999999997	0.11654999999999999
LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE; LKENP	0.0025640999999999997	0.11654999999999999
Boucher-Neuhauser syndrome	0.0025640999999999997	0.11654999999999999
EPISODIC ATAXIA, TYPE 8	0.0025640999999999997	0.11654999999999999
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.0025640999999999997	0.11654999999999999
164700 OLIVOPONTOCEREBELLAR ATROPHY V; OPCA V;;OPCA WITH DEMENTIA AND EXTRAPYRAMIDAL SIGNS	0.0025640999999999997	0.11654999999999999
MYOCLONUS, CEREBELLAR ATAXIA, AND DEAFNESS	0.0025640999999999997	0.11654999999999999
#611943 RIDDLE SYNDROME;;RADIOSENSITIVITY, IMMUNODEFICIENCY, DYSMORPHIC FEATURES, AND LEARNINGDIFFICULTIES	0.0025640999999999997	0.11654999999999999
302900 CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY AND FRIEDREICH ATAXIA,COMBINED	0.0025640999999999997	0.11654999999999999
SPINOCEREBELLAR ATAXIA, X-LINKED 4	0.0025640999999999997	0.11654999999999999
JOUBERT SYNDROME 4	0.0025640999999999997	0.11654999999999999
165200 OPTIC ATROPHY WITH DEMYELINATING DISEASE OF CNS	0.0025640999999999997	0.11654999999999999
DE SANCTIS-CACCHIONE SYNDROME	0.0025640999999999997	0.11654999999999999
WERNICKE-KORSAKOFF SYNDROME	0.0025640999999999997	0.11654999999999999
ALLAN-HERNDON-DUDLEY SYNDROME	0.0025640999999999997	0.11654999999999999
#535000 LEBER OPTIC ATROPHY;;LEBER HEREDITARY OPTIC NEUROPATHY; LHON	0.0025640999999999997	0.11654999999999999
POLYMYOCLONUS, INFANTILE	0.0025640999999999997	0.11654999999999999
DEMENTIA, FAMILIAL DANISH	0.0025640999999999997	0.11654999999999999
PEROXISOME BIOGENESIS DISORDER 9B; PBD9B	0.0025640999999999997	0.11654999999999999
212835 CEREBELLAR ATAXIA AND ECTODERMAL DYSPLASIA	0.0025640999999999997	0.11654999999999999
CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT; ADCADN	0.0025640999999999997	0.11654999999999999
SPINOCEREBELLAR ATAXIA WITH RIGIDITY AND PERIPHERAL NEUROPATHY	0.0025640999999999997	0.11654999999999999
OPTIC ATROPHY 1; OPA1	0.0025640999999999997	0.11654999999999999
ATAXIA-TELANGIECTASIA WITH GENERALIZED SKIN PIGMENTATION AND EARLY DEATH	0.0025640999999999997	0.11654999999999999
ABETALIPOPROTEINEMIA	0.0025640999999999997	0.11654999999999999
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.0025640999999999997	0.11654999999999999
CEREBELLAR ATAXIA AND NEUROSENSORY DEAFNESS	0.0025640999999999997	0.11654999999999999
SPINOCEREBELLAR ATAXIA 32; SCA32	0.0025640999999999997	0.11654999999999999
POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1	0.0025640999999999997	0.11654999999999999
TRYPTOPHANURIA WITH DWARFISM	0.0025640999999999997	0.11654999999999999
BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1	0.0025640999999999997	0.11654999999999999
KURU, SUSCEPTIBILITY TO	0.0025640999999999997	0.11654999999999999
DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES; DYTOABG	0.0025640999999999997	0.11654999999999999
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 3	0.0025640999999999997	0.11654999999999999
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B	0.0025640999999999997	0.11654999999999999
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.001759633	0.07998331818181817
#613180 POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.001759633	0.07998331818181817
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.001759633	0.07998331818181817
PALLISTER-HALL SYNDROME	0.001759633	0.07998331818181817
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.001759633	0.07998331818181817
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.001759633	0.07998331818181817
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.001759633	0.07998331818181817
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.001759633	0.07998331818181817
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.001759633	0.07998331818181817
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.001759633	0.07998331818181817
BOHRING-OPITZ SYNDROME	0.001759633	0.07998331818181817
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.001759633	0.07998331818181817
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.001759633	0.07998331818181817
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.001759633	0.07998331818181817
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.001759633	0.07998331818181817
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.001759633	0.07998331818181817
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.001759633	0.07998331818181817
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.001759633	0.07998331818181817
PETTIGREW SYNDROME	0.001759633	0.07998331818181817
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.001759633	0.07998331818181817
#614845 NEPHRONOPHTHISIS 15; NPHP15	0.001759633	0.07998331818181817
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.001759633	0.07998331818181817
#615279 CARDIOFACIOCUTANEOUS SYNDROME 3; CFC3	0.001759633	0.07998331818181817
GM2-GANGLIOSIDOSIS, AB VARIANT	0.001759633	0.07998331818181817
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.001759633	0.07998331818181817
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.001759633	0.07998331818181817
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.001759633	0.07998331818181817
CODAS SYNDROME	0.001759633	0.07998331818181817
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.001759633	0.07998331818181817
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.001759633	0.07998331818181817
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.001759633	0.07998331818181817
ZTTK SYNDROME; ZTTKS	0.001759633	0.07998331818181817
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Id; CDG1D	0.001759633	0.07998331818181817
3-METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.001759633	0.07998331818181817
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.001759633	0.07998331818181817
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.001759633	0.07998331818181817
#218000 AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY; ACCPN;;CHARLEVOIX DISEASE;;ANDERMANN SYNDROME;;POLYNEUROPATHY, SENSORIMOTOR, WITH OR WITHOUT AGENESIS OF THE CORPUSCALLOSUM;;CORPUS CALLOSUM, AGENESIS OF, WITH NEURONOPATHY	0.001759633	0.07998331818181817
N-ACETYLASPARTATE DEFICIENCY; NACED	0.001759633	0.07998331818181817
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.001759633	0.07998331818181817
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.001759633	0.07998331818181817
#236250 HOMOCYSTINURIA DUE TO DEFICIENCY OF N(5,10)-METHYLENETETRAHYDROFOLATEREDUCTASE ACTIVITY;;METHYLENETETRAHYDROFOLATE REDUCTASE DEFICIENCY;;MTHFR DEFICIENCYMTHFR DEFICIENCY, THERMOLABILE TYPE, INCLUDED	0.001759633	0.07998331818181817
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.001759633	0.07998331818181817
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.001759633	0.07998331818181817
#220120 D-GLYCERIC ACIDURIA;;D-GLYCERIC ACIDEMIA;;GLYCERATE KINASE DEFICIENCY	0.001759633	0.07998331818181817
CHROMOSOME 1q41-q42 DELETION SYNDROME	0.001759633	0.07998331818181817
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.001759633	0.07998331818181817
CHROMOSOME 2q37 DELETION SYNDROME	0.001759633	0.07998331818181817
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.001759633	0.07998331818181817
VICI SYNDROME; VICIS	0.001759633	0.07998331818181817
2,4-DIENOYL-CoA REDUCTASE DEFICIENCY; DECRD	0.001759633	0.07998331818181817
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.001759633	0.07998331818181817
#222448 DONNAI-BARROW SYNDROME;;FACIOOCULOACOUSTICORENAL SYNDROME;;DBS/FOAR SYNDROME;;DIAPHRAGMATIC HERNIA, EXOMPHALOS, ABSENT CORPUS CALLOSUM, HYPERTELORISM,MYOPIA, SENSORINEURAL DEAFNESS, AND PROTEINURIA	0.001759633	0.07998331818181817
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.001759633	0.07998331818181817
#305450 OPITZ-KAVEGGIA SYNDROME; OKS;;FG SYNDROME 1; FGS1;;FG SYNDROME; FGS;;MENTAL RETARDATION, LARGE HEAD, IMPERFORATE ANUS, CONGENITAL HYPOTONIA,AND PARTIAL AGENESIS OF CORPUS CALLOSUM;;KELLER SYNDROME	0.001759633	0.07998331818181817
#300867 KABUKI SYNDROME 2; KABUK2	0.001759633	0.07998331818181817
#611718 HYPOMAGNESEMIA 4, RENAL; HOMG4;;HYPOMAGNESEMIA, RENAL, NORMOCALCIURIC	0.001759633	0.07998331818181817
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.001759633	0.07998331818181817
LISSENCEPHALY 4	0.001759633	0.07998331818181817
MENTAL RETARDATION, X-LINKED 72	0.001759633	0.07998331818181817
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.001759633	0.07998331818181817
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.001759633	0.07998331818181817
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.001759633	0.07998331818181817
HEART AND BRAIN MALFORMATION SYNDROME	0.001759633	0.07998331818181817
WEBB-DATTANI SYNDROME; WEDAS	0.001759633	0.07998331818181817
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.001759633	0.07998331818181817
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.001759633	0.07998331818181817
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.001759633	0.07998331818181817
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.001759633	0.07998331818181817
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.001759633	0.07998331818181817
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.001759633	0.07998331818181817
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.001759633	0.07998331818181817
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.001759633	0.07998331818181817
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.001759633	0.07998331818181817
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.001759633	0.07998331818181817
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.001759633	0.07998331818181817
HOLOPROSENCEPHALY 2; HPE2	0.001759633	0.07998331818181817
TEMTAMY SYNDROME; TEMTYS	0.001759633	0.07998331818181817
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iw; CDG1W	0.001759633	0.07998331818181817
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.001759633	0.07998331818181817
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.001759633	0.07998331818181817
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIm; CDG2M	0.001759633	0.07998331818181817
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.001759633	0.07998331818181817
TIMOTHY SYNDROME; TS	0.001759633	0.07998331818181817
KBG SYNDROME	0.001759633	0.07998331818181817
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.001759633	0.07998331818181817
#614483 PORENCEPHALY 2; POREN2	0.001759633	0.07998331818181817
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.001759633	0.07998331818181817
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.001759633	0.07998331818181817
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.001759633	0.07998331818181817
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.001759633	0.07998331818181817
#612938 GROWTH RETARDATION, DEVELOPMENTAL DELAY, COARSE FACIES, AND EARLYDEATH; GDFD	0.001759633	0.07998331818181817
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.001759633	0.07998331818181817
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.001759633	0.07998331818181817
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.001759633	0.07998331818181817
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.001759633	0.07998331818181817
PHACE ASSOCIATION	0.001759633	0.07998331818181817
RECOMBINANT CHROMOSOME 8 SYNDROME	0.001759633	0.07998331818181817
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.001759633	0.07998331818181817
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.001759633	0.07998331818181817
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iy; CDG1Y	0.001759633	0.07998331818181817
MEND SYNDROME; MEND	0.001759633	0.07998331818181817
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.001759633	0.07998331818181817
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.001759633	0.07998331818181817
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.001759633	0.07998331818181817
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.001759633	0.07998331818181817
KABUKI SYNDROME 1	0.001759633	0.07998331818181817
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.001759633	0.07998331818181817
#613657 D-2-@HYDROXYGLUTARIC ACIDURIA 2;;D2HGA2	0.001759633	0.07998331818181817
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.001759633	0.07998331818181817
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.001759633	0.07998331818181817
HYPEREKPLEXIA 4; HKPX4	0.001759633	0.07998331818181817
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.001759633	0.07998331818181817
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.001759633	0.07998331818181817
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.001759633	0.07998331818181817
HOLOPROSENCEPHALY 1; HPE1	0.001759633	0.07998331818181817
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.001759633	0.07998331818181817
CORNELIA DE LANGE SYNDROME 3	0.001759633	0.07998331818181817
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.001759633	0.07998331818181817
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.001759633	0.07998331818181817
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.001759633	0.07998331818181817
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.001759633	0.07998331818181817
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.001759633	0.07998331818181817
#602398 DESMOSTEROLOSIS	0.001759633	0.07998331818181817
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.001759633	0.07998331818181817
#300673 ENCEPHALOPATHY, NEONATAL SEVERE, DUE TO MECP2 MUTATIONS	0.001759633	0.07998331818181817
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.001759633	0.07998331818181817
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.001759633	0.07998331818181817
#614322 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 12; SCAR12;;SPINOCEREBELLAR ATAXIA WITH MENTAL RETARDATION AND EPILEPSY	0.001759633	0.07998331818181817
Muenke syndrome	0.001759633	0.07998331818181817
COFFIN-SIRIS SYNDROME 4; CSS4	0.001759633	0.07998331818181817
GABA-TRANSAMINASE DEFICIENCY	0.001759633	0.07998331818181817
#614202 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 15; MRT15	0.001759633	0.07998331818181817
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.001759633	0.07998331818181817
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.001759633	0.07998331818181817
CATEL-MANZKE SYNDROME; CATMANS	0.001759633	0.07998331818181817
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.001759633	0.07998331818181817
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.001759633	0.07998331818181817
#300004 CORPUS CALLOSUM, AGENESIS OF, WITH ABNORMAL GENITALIA;;ACC WITH ABNORMAL GENITALIA;;PROUD SYNDROME	0.001759633	0.07998331818181817
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.001759633	0.07998331818181817
GRISCELLI SYNDROME, TYPE 1	0.001759633	0.07998331818181817
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.001759633	0.07998331818181817
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.001759633	0.07998331818181817
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.001759633	0.07998331818181817
JABERI-ELAHI SYNDROME; JABELS	0.001759633	0.07998331818181817
COFFIN-SIRIS SYNDROME 3; CSS3	0.001759633	0.07998331818181817
#269000 SC PHOCOMELIA SYNDROME;;SC PSEUDOTHALIDOMIDE SYNDROME	0.001759633	0.07998331818181817
BAND HETEROTOPIA; BH	0.001759633	0.07998331818181817
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.001759633	0.07998331818181817
CHROMOSOME 22q13 DUPLICATION SYNDROME	0.001759633	0.07998331818181817
CHROMOSOME 14q11-q22 DELETION SYNDROME	0.001759633	0.07998331818181817
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.001759633	0.07998331818181817
#608027 PONTOCEREBELLAR HYPOPLASIA, TYPE 3; PCH3;;CEREBELLAR ATROPHY WITH PROGRESSIVE MICROCEPHALY; CLAM;;PCH WITH OPTIC ATROPHY	0.001759633	0.07998331818181817
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.001759633	0.07998331818181817
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.001759633	0.07998331818181817
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.001759633	0.07998331818181817
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.001759633	0.07998331818181817
ADAMS-OLIVER SYNDROME 1; AOS1	0.001759633	0.07998331818181817
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.001759633	0.07998331818181817
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.001759633	0.07998331818181817
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.001759633	0.07998331818181817
HOLOPROSENCEPHALY 7	0.001759633	0.07998331818181817
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.001759633	0.07998331818181817
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.001759633	0.07998331818181817
Helsmoortel-van der Aa syndrome	0.001759633	0.07998331818181817
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.001759633	0.07998331818181817
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.001759633	0.07998331818181817
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.001759633	0.07998331818181817
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.001759633	0.07998331818181817
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.001759633	0.07998331818181817
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.001759633	0.07998331818181817
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.001759633	0.07998331818181817
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.001759633	0.07998331818181817
MELANOSIS, NEUROCUTANEOUS; NCMS	0.001759633	0.07998331818181817
#613668 MICROCEPHALY, POSTNATAL PROGRESSIVE, WITH SEIZURES AND BRAIN ATROPHY	0.001759633	0.07998331818181817
#610829 HOLOPROSENCEPHALY 9; HPE9;;PITUITARY ANOMALIES WITH HOLOPROSENCEPHALY-LIKE FEATURES;;HOLOPROSENCEPHALY WITH MICROPHTHALMIA AND FIRST BRANCHIAL ARCH ANOMALIES	0.001759633	0.07998331818181817
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.001759633	0.07998331818181817
GLYCEROL KINASE DEFICIENCY; GKD	0.001759633	0.07998331818181817
WAISMAN SYNDROME; WSMN	0.001759633	0.07998331818181817
HARTNUP DISORDER	0.001759633	0.07998331818181817
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.001759633	0.07998331818181817
#300422 FG SYNDROME 4; FGS4MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT NYSTAGMUS, INCLUDED	0.001759633	0.07998331818181817
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.001759633	0.07998331818181817
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.001759633	0.07998331818181817
#603387 MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME;MPPH;;MEGALENCEPHALY, POLYMICROGYRIA, MEGA CORPUS CALLOSUM SYNDROME;;MEG-PMG-MEGACC SYNDROME;;MEGALENCEPHALY, MEGA CORPUS CALLOSUM, AND COMPLETE LACK OF MOTOR DEVELOPMENT	0.001759633	0.07998331818181817
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.001759633	0.07998331818181817
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.001759633	0.07998331818181817
SCHINDLER DISEASE, TYPE I	0.001759633	0.07998331818181817
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.001759633	0.07998331818181817
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.001759633	0.07998331818181817
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.001759633	0.07998331818181817
#613744 SPASTIC PARAPLEGIA 51, AUTOSOMAL RECESSIVE; SPG51;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 4, FORMERLY; CPSQ4, FORMERLY	0.001759633	0.07998331818181817
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.001759633	0.07998331818181817
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.001759633	0.07998331818181817
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.001759633	0.07998331818181817
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.001759633	0.07998331818181817
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.001759633	0.07998331818181817
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.001759633	0.07998331818181817
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.001759633	0.07998331818181817
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.001759633	0.07998331818181817
MENTAL RETARDATION, X-LINKED 88	0.001759633	0.07998331818181817
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.001759633	0.07998331818181817
#612936 SPASTIC PARAPLEGIA 50, AUTOSOMAL RECESSIVE; SPG50;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3, FORMERLY; CPSQ3, FORMERLY	0.001759633	0.07998331818181817
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.001759633	0.07998331818181817
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.001759633	0.07998331818181817
MACDERMOT-WINTER SYNDROME	0.001759633	0.07998331818181817
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.001759633	0.07998331818181817
GRACILE BONE DYSPLASIA; GCLEB	0.001759633	0.07998331818181817
#300845 MOYAMOYA DISEASE 4 WITH SHORT STATURE, HYPERGONADOTROPIC HYPOGONADISM,AND FACIAL DYSMORPHISM; MYMY4;;CHROMOSOME XQ28 DELETION SYNDROME, 3.4-KB;;SYNDROMIC MOYAMOYA DISEASE	0.001759633	0.07998331818181817
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.001759633	0.07998331818181817
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.001759633	0.07998331818181817
TEMPLE-BARAITSER SYNDROME; TMBTS	0.001759633	0.07998331818181817
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.001759633	0.07998331818181817
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.001759633	0.07998331818181817
611961 STEVENSON-CAREY SYNDROME	0.001759633	0.07998331818181817
ADAMS-OLIVER SYNDROME 2; AOS2	0.001759633	0.07998331818181817
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.001759633	0.07998331818181817
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.001759633	0.07998331818181817
#207800 ARGININEMIA;;ARGINASE DEFICIENCY;;HYPERARGININEMIA;;ARG1 DEFICIENCY	0.001759633	0.07998331818181817
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.001759633	0.07998331818181817
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.001759633	0.07998331818181817
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.001759633	0.07998331818181817
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.001759633	0.07998331818181817
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.001759633	0.07998331818181817
#177980 PTERYGIA, MENTAL RETARDATION, AND DISTINCTIVE CRANIOFACIAL FEATURES;;HASPESLAGH SYNDROME	0.000915751	0.04162504545454545
#128200 EPISODIC KINESIGENIC DYSKINESIA 1; EKD1;;PAROXYSMAL KINESIGENIC CHOREOATHETOSIS; PKC;;PAROXYSMAL KINESIGENIC DYSKINESIA; PKD;;DYSTONIA, FAMILIAL PAROXYSMAL;;DYSTONIA 10; DYT10	0.000915751	0.04162504545454545
ALZHEIMER DISEASE 3; AD	0.000915751	0.04162504545454545
SJOGREN-LARSSON SYNDROME; SLS	0.000915751	0.04162504545454545
#612475 CHROMOSOME 1q21.1 DUPLICATION SYNDROME	0.000915751	0.04162504545454545
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.000915751	0.04162504545454545
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000915751	0.04162504545454545
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.000915751	0.04162504545454545
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.000915751	0.04162504545454545
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.000915751	0.04162504545454545
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.000915751	0.04162504545454545
#604213 CHUDLEY-MCCULLOUGH SYNDROME; CMCS;;DEAFNESS, SENSORINEURAL, WITH PARTIAL AGENESIS OF THE CORPUS CALLOSUMAND ARACHNOID CYSTS;;DEAFNESS, AUTOSOMAL RECESSIVE 82; DFNB82	0.000915751	0.04162504545454545
#300607 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 8; EIEE8;;HYPEREKPLEXIA AND EPILEPSY	0.000915751	0.04162504545454545
ZUNICH NEUROECTODERMAL SYNDROME	0.000915751	0.04162504545454545
#300534 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CLAES-JENSEN TYPE; MRXSCJ;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, JARID1C-RELATED; MRXSJ	0.000915751	0.04162504545454545
HYPOPARATHYROIDISM, X-LINKED	0.000915751	0.04162504545454545
HYPOPHOSPHATASIA, INFANTILE	0.000915751	0.04162504545454545
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.000915751	0.04162504545454545
#248250 HYPOMAGNESEMIA 3, RENAL; HOMG3;;HYPOMAGNESEMIA, PRIMARY, DUE TO DEFECT IN RENAL TUBULAR TRANSPORTOF MAGNESIUM;;HYPOMAGNESEMIA, ISOLATED RENAL;;HYPOMAGNESEMIA, FAMILIAL, WITH HYPERCALCIURIA AND NEPHROCALCINOSISHYPERCALCIURIA, CHILDHOOD, SELF-LIMITING, INCLUDED	0.000915751	0.04162504545454545
CROUZON SYNDROME	0.000915751	0.04162504545454545
THREONINEMIA	0.000915751	0.04162504545454545
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.000915751	0.04162504545454545
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.000915751	0.04162504545454545
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.000915751	0.04162504545454545
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.000915751	0.04162504545454545
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.000915751	0.04162504545454545
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.000915751	0.04162504545454545
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.000915751	0.04162504545454545
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.000915751	0.04162504545454545
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.000915751	0.04162504545454545
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.000915751	0.04162504545454545
CHOREOATHETOSIS, FAMILIAL INVERTED	0.000915751	0.04162504545454545
#612580 MENTAL RETARDATION, AUTOSOMAL DOMINANT 3; MRD3	0.000915751	0.04162504545454545
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.000915751	0.04162504545454545
POTOCKI-SHAFFER SYNDROME	0.000915751	0.04162504545454545
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000915751	0.04162504545454545
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000915751	0.04162504545454545
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.000915751	0.04162504545454545
ADAMS-OLIVER SYNDROME 5; AOS5	0.000915751	0.04162504545454545
MENKES DISEASE	0.000915751	0.04162504545454545
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.000915751	0.04162504545454545
RETINAL DEGENERATION AND EPILEPSY	0.000915751	0.04162504545454545
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.000915751	0.04162504545454545
EPILEPSY, READING	0.000915751	0.04162504545454545
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.000915751	0.04162504545454545
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.000915751	0.04162504545454545
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.000915751	0.04162504545454545
#612285 JOUBERT SYNDROME 9; JBTS9JOUBERT SYNDROME 9/15, DIGENIC, INCLUDED	0.000915751	0.04162504545454545
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.000915751	0.04162504545454545
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.000915751	0.04162504545454545
RETT SYNDROME, CONGENITAL VARIANT	0.000915751	0.04162504545454545
MENTAL RETARDATION, FRA12A TYPE	0.000915751	0.04162504545454545
#612462 PSEUDOHYPOPARATHYROIDISM, TYPE IC; PHP1C;;PHP IC	0.000915751	0.04162504545454545
CHROMOSOME 15q13.3 MICRODELETION SYNDROME	0.000915751	0.04162504545454545
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000915751	0.04162504545454545
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.000915751	0.04162504545454545
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.000915751	0.04162504545454545
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.000915751	0.04162504545454545
RAMON SYNDROME	0.000915751	0.04162504545454545
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.000915751	0.04162504545454545
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000915751	0.04162504545454545
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.000915751	0.04162504545454545
#236600 HYDROCEPHALUS, NONSYNDROMIC, AUTOSOMAL RECESSIVE 1; HYC1;;HYDROCEPHALY;;VENTRICULOMEGALY	0.000915751	0.04162504545454545
#613707 LEOPARD SYNDROME 3; LPRD3	0.000915751	0.04162504545454545
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.000915751	0.04162504545454545
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.000915751	0.04162504545454545
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.000915751	0.04162504545454545
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.000915751	0.04162504545454545
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.000915751	0.04162504545454545
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.000915751	0.04162504545454545
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000915751	0.04162504545454545
311450 PALLISTER W SYNDROME;;W SYNDROME	0.000915751	0.04162504545454545
MENTAL RETARDATION, X-LINKED 100	0.000915751	0.04162504545454545
HYPER-BETA-ALANINEMIA	0.000915751	0.04162504545454545
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.000915751	0.04162504545454545
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000915751	0.04162504545454545
MENTAL RETARDATION, X-LINKED 82	0.000915751	0.04162504545454545
EPISODIC ATAXIA, TYPE 6	0.000915751	0.04162504545454545
#300143 MENTAL RETARDATION, X-LINKED 21; MRX21;;MENTAL RETARDATION, X-LINKED 34; MRX34	0.000915751	0.04162504545454545
CRANIOSYNOSTOSIS 2	0.000915751	0.04162504545454545
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIa; CDG2A	0.000915751	0.04162504545454545
#614650 COENZYME Q10 DEFICIENCY, PRIMARY, 6; COQ10D6	0.000915751	0.04162504545454545
#200150 CHOREOACANTHOCYTOSIS; CHAC;;LEVINE-CRITCHLEY SYNDROME;;ACANTHOCYTOSIS WITH NEUROLOGIC DISORDER;;NEUROACANTHOCYTOSIS;;CHOREA-ACANTHOCYTOSIS	0.000915751	0.04162504545454545
CROME SYNDROME	0.000915751	0.04162504545454545
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000915751	0.04162504545454545
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.000915751	0.04162504545454545
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.000915751	0.04162504545454545
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.000915751	0.04162504545454545
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.000915751	0.04162504545454545
GLUTAMINE DEFICIENCY, CONGENITAL	0.000915751	0.04162504545454545
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.000915751	0.04162504545454545
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.000915751	0.04162504545454545
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.000915751	0.04162504545454545
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000915751	0.04162504545454545
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.000915751	0.04162504545454545
NEUROFIBROMATOSIS, TYPE I	0.000915751	0.04162504545454545
#615663 WARBURG MICRO SYNDROME 4; WARBM4	0.000915751	0.04162504545454545
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000915751	0.04162504545454545
MENTAL RETARDATION, X-LINKED 1	0.000915751	0.04162504545454545
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.000915751	0.04162504545454545
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.000915751	0.04162504545454545
#615937 MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 2;MPPH2	0.000915751	0.04162504545454545
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.000915751	0.04162504545454545
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.000915751	0.04162504545454545
ATKIN-FLAITZ SYNDROME	0.000915751	0.04162504545454545
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.000915751	0.04162504545454545
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.000915751	0.04162504545454545
#615752 POLYMICROGYRIA, BILATERAL PERISYLVIAN, AUTOSOMAL RECESSIVE; BPPR ;;PMGR	0.000915751	0.04162504545454545
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, cblX TYPE	0.000915751	0.04162504545454545
COHEN SYNDROME	0.000915751	0.04162504545454545
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.000915751	0.04162504545454545
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.000915751	0.04162504545454545
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.000915751	0.04162504545454545
GURRIERI SYNDROME	0.000915751	0.04162504545454545
RETT SYNDROME; RTT	0.000915751	0.04162504545454545
RENPENNING SYNDROME 1; RENS1	0.000915751	0.04162504545454545
#605375 EPILEPSY, NOCTURNAL FRONTAL LOBE, 3; ENFL3	0.000915751	0.04162504545454545
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.000915751	0.04162504545454545
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.000915751	0.04162504545454545
DARIER-WHITE DISEASE; DAR	0.000915751	0.04162504545454545
MICROPHTHALMIA, SYNDROMIC 1	0.000915751	0.04162504545454545
#611755 LEBER CONGENITAL AMAUROSIS 10; LCA10	0.000915751	0.04162504545454545
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.000915751	0.04162504545454545
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.000915751	0.04162504545454545
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.000915751	0.04162504545454545
AUTISM, SUSCEPTIBILITY TO, 18	0.000915751	0.04162504545454545
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.000915751	0.04162504545454545
GLYCOGEN STORAGE DISEASE 0, LIVER	0.000915751	0.04162504545454545
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.000915751	0.04162504545454545
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.000915751	0.04162504545454545
COFFIN-LOWRY SYNDROME; CLS	0.000915751	0.04162504545454545
#240900 HYPOINSULINEMIC HYPOGLYCEMIA WITH HEMIHYPERTROPHY; HIHGHH	0.000915751	0.04162504545454545
2q33.1 deletion syndrome	0.000915751	0.04162504545454545
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000915751	0.04162504545454545
#610768 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Im; CDG1M;;CDG Im; CDGIm;;DOLICHOL KINASE DEFICIENCY;;DK1 DEFICIENCY	0.000915751	0.04162504545454545
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.000915751	0.04162504545454545
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.000915751	0.04162504545454545
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.000915751	0.04162504545454545
HYPOMAGNESEMIA 2, RENAL	0.000915751	0.04162504545454545
15q13.3 microdeletion syndrome	0.000915751	0.04162504545454545
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.000915751	0.04162504545454545
FILIPPI SYNDROME; FLPIS	0.000915751	0.04162504545454545
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.000915751	0.04162504545454545
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.000915751	0.04162504545454545
HHHH SYNDROME	0.000915751	0.04162504545454545
SUDDEN CARDIAC FAILURE, INFANTILE	0.000915751	0.04162504545454545
HYPOPHOSPHATASIA, CHILDHOOD	0.000915751	0.04162504545454545
KIFAFA SEIZURE DISORDER	0.000915751	0.04162504545454545
OHDO SYNDROME	0.000915751	0.04162504545454545
MENTAL RETARDATION, X-LINKED 102	0.000915751	0.04162504545454545
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000915751	0.04162504545454545
STURGE-WEBER SYNDROME	0.000915751	0.04162504545454545
HUNTINGTON DISEASE; HD	0.000915751	0.04162504545454545
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.000915751	0.04162504545454545
LISSENCEPHALY, X-LINKED, 2	0.000915751	0.04162504545454545
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.000915751	0.04162504545454545
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.000915751	0.04162504545454545
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.000915751	0.04162504545454545
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.000915751	0.04162504545454545
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.000915751	0.04162504545454545
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.000915751	0.04162504545454545
#103580 PSEUDOHYPOPARATHYROIDISM, TYPE IA; PHP1A;;PHP IA;;ALBRIGHT HEREDITARY OSTEODYSTROPHY WITH MULTIPLE HORMONE RESISTANCE	0.000915751	0.04162504545454545
#603516 SPINOCEREBELLAR ATAXIA 10; SCA10	0.000915751	0.04162504545454545
#158900 FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1; FSHD1;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1;;FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; FSHD; FMD;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1A; FSHD1A;;LANDOUZY-DEJERINE MUSCULAR DYSTROPHYFACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY, INFANTILE, INCLUDED;;FACIOSCAPULOHUMERAL DYSTROPHY WITH SENSORINEURAL HEARING LOSS ANDTORTUOSITY OF RETINAL ARTERIOLES, INCLUDED	0.000915751	0.04162504545454545
GLYCINE ENCEPHALOPATHY; GCE	0.000915751	0.04162504545454545
EPILEPSY, BENIGN OCCIPITAL	0.000915751	0.04162504545454545
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.000915751	0.04162504545454545
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.000915751	0.04162504545454545
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.000915751	0.04162504545454545
Angelman syndrome (Type 1)	0.000915751	0.04162504545454545
KEUTEL SYNDROME; KTLS	0.000915751	0.04162504545454545
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000915751	0.04162504545454545
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.000915751	0.04162504545454545
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.000915751	0.04162504545454545
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.000915751	0.04162504545454545
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.000915751	0.04162504545454545
#300049 HETEROTOPIA, PERIVENTRICULAR, X-LINKED DOMINANT;;HETEROTOPIA, FAMILIAL NODULAR;;PERIVENTRICULAR NODULAR HETEROTOPIA 1; PVNH1;;NODULAR HETEROTOPIA, BILATERAL PERIVENTRICULAR; NHBP; BPNHHETEROTOPIA, PERIVENTRICULAR NODULAR, WITH FRONTOMETAPHYSEAL DYSPLASIA,INCLUDED	0.000915751	0.04162504545454545
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.000915751	0.04162504545454545
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.000915751	0.04162504545454545
TAY-SACHS DISEASE; TSD	0.000915751	0.04162504545454545
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.000915751	0.04162504545454545
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.000915751	0.04162504545454545
#244460 KENNY-CAFFEY SYNDROME, TYPE 1; KCS1;;KCS;;KENNY-CAFFEY SYNDROME, AUTOSOMAL RECESSIVE	0.000915751	0.04162504545454545
#300860 MENTAL RETARDATION, X-LINKED, SYNDROMIC, NASCIMENTO TYPE; MRXSN;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 30; MRXS30	0.000915751	0.04162504545454545
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.000915751	0.04162504545454545
PARIETAL FORAMINA	0.000915751	0.04162504545454545
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.000915751	0.04162504545454545
FRAGILE X MENTAL RETARDATION SYNDROME	0.000915751	0.04162504545454545
MECKEL SYNDROME, TYPE 10; MKS10	0.000915751	0.04162504545454545
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.000915751	0.04162504545454545
CLARK-BARAITSER SYNDROME	0.000915751	0.04162504545454545
IMMUNODEFICIENCY 37; IMD37	0.000915751	0.04162504545454545
MARDEN-WALKER SYNDROME	0.000915751	0.04162504545454545
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.000915751	0.04162504545454545
#223360 DOPAMINE BETA-HYDROXYLASE DEFICIENCY, CONGENITAL;;NOREPINEPHRINE DEFICIENCY;;NORADRENALINE DEFICIENCY	0.000915751	0.04162504545454545
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.000915751	0.04162504545454545
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.000915751	0.04162504545454545
#607136 SPINOCEREBELLAR ATAXIA 17; SCA17;;HUNTINGTON DISEASE-LIKE 4; HDL4	0.000915751	0.04162504545454545
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.000915751	0.04162504545454545
#310600 NORRIE DISEASE; ND;;ATROPHIA BULBORUM HEREDITARIA;;EPISKOPI BLINDNESS	0.000915751	0.04162504545454545
DYSOSTEOSCLEROSIS	0.000915751	0.04162504545454545
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.000915751	0.04162504545454545
KRABBE DISEASE	0.000915751	0.04162504545454545
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.000915751	0.04162504545454545
OCULOCEREBROCUTANEOUS SYNDROME	0.000915751	0.04162504545454545
SUPRABULBAR PARESIS, CONGENITAL	0.000915751	0.04162504545454545
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.000915751	0.04162504545454545
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.000915751	0.04162504545454545
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.000915751	0.04162504545454545
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.000915751	0.04162504545454545
BRANCHIOOCULOFACIAL SYNDROME	0.000915751	0.04162504545454545
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.000915751	0.04162504545454545
#119540 CLEFT PALATE, ISOLATED; CPI;;CLEFT PALATE; CPCLEFT PALATE, ISOLATED, AND MENTAL RETARDATION, INCLUDED	0.000915751	0.04162504545454545
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.000915751	0.04162504545454545
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.000915751	0.04162504545454545
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.000915751	0.04162504545454545
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.000915751	0.04162504545454545
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.000915751	0.04162504545454545
SNEDDON SYNDROME	0.000915751	0.04162504545454545
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000915751	0.04162504545454545
ACROCALLOSAL SYNDROME; ACLS	0.000915751	0.04162504545454545
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.000915751	0.04162504545454545
PALLISTER-KILLIAN SYNDROME	0.000915751	0.04162504545454545
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.000915751	0.04162504545454545
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.000915751	0.04162504545454545
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.000915751	0.04162504545454545
1p36 microdeletion syndrome	0.000915751	0.04162504545454545
MENTAL RETARDATION, X-LINKED 14	0.000915751	0.04162504545454545
#202200 GLUCOCORTICOID DEFICIENCY 1; GCCD1;;FAMILIAL GLUCOCORTICOID DEFICIENCY 1; FGD1;;ADRENAL UNRESPONSIVENESS TO ACTH;;ACTH RESISTANCE	0.000915751	0.04162504545454545
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000915751	0.04162504545454545
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000915751	0.04162504545454545
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.000915751	0.04162504545454545
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.000915751	0.04162504545454545
AYME-GRIPP SYNDROME; AYGRP	0.000915751	0.04162504545454545
#520000 DIABETES AND DEAFNESS, MATERNALLY INHERITED; MIDD;;DIABETES-DEAFNESS SYNDROME, MATERNALLY TRANSMITTED;;BALLINGER-WALLACE SYNDROME;;DIABETES MELLITUS, TYPE II, WITH DEAFNESS;;NONINSULIN-DEPENDENT DIABETES MELLITUS WITH DEAFNESS;;NIDDM WITH DEAFNESS	0.000915751	0.04162504545454545
SECKEL SYNDROME 7; SCKL7	0.000915751	0.04162504545454545
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.000915751	0.04162504545454545
SECKEL SYNDROME 1; SCKL1	0.000915751	0.04162504545454545
NOONAN SYNDROME 7; NS7	0.000915751	0.04162504545454545
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.000915751	0.04162504545454545
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.000915751	0.04162504545454545
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.000915751	0.04162504545454545
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.000915751	0.04162504545454545
HYPERPROLINEMIA, TYPE II	0.000915751	0.04162504545454545
PHENYLKETONURIA	0.000915751	0.04162504545454545
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.000915751	0.04162504545454545
#603285 CEREBRAL CAVERNOUS MALFORMATIONS 3; CCM3	0.000915751	0.04162504545454545
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.000915751	0.04162504545454545
LOWE OCULOCEREBRORENAL SYNDROME	0.000915751	0.04162504545454545
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.000915751	0.04162504545454545
BARAITSER-WINTER SYNDROME 2; BRWS2	0.000915751	0.04162504545454545
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.000915751	0.04162504545454545
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000915751	0.04162504545454545
PERRAULT SYNDROME 3	0.000915751	0.04162504545454545
INCONTINENTIA PIGMENTI; IP	0.000915751	0.04162504545454545
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.000915751	0.04162504545454545
COPPER DEFICIENCY, FAMILIAL BENIGN	0.000915751	0.04162504545454545
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.000915751	0.04162504545454545
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.000915751	0.04162504545454545
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.000915751	0.04162504545454545
PACHYGYRIA, FRONTOTEMPORAL	0.000915751	0.04162504545454545
#614399 MYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET;EMARDDMYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET,MILD VARIANT, INCLUDED	0.000915751	0.04162504545454545
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.000915751	0.04162504545454545
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.000915751	0.04162504545454545
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000915751	0.04162504545454545
#613150 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYEANOMALIES), TYPE A, 2; MDDGA2;;WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, POMT2-RELATED	0.000915751	0.04162504545454545
Wolf-Hirschhorn Syndrome	0.000915751	0.04162504545454545
PAPILLOMA OF CHOROID PLEXUS	0.000915751	0.04162504545454545
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.000915751	0.04162504545454545
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.000915751	0.04162504545454545
Angelman syndrome (Type 2)	0.000915751	0.04162504545454545
WARBURG MICRO SYNDROME 3; WARBM3	0.000915751	0.04162504545454545
#614923 BRANCHED-CHAIN KETOACID DEHYDROGENASE KINASE DEFICIENCY; BCKDKD;;BCKDK DEFICIENCY	0.000915751	0.04162504545454545
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.000843882	0.03835827272727273
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.000843882	0.03835827272727273
#610168 LOEYS-DIETZ SYNDROME 2; LDS2;;AORTIC ANEURYSM, FAMILIAL THORACIC 3; AAT3;;MARFAN SYNDROME, TYPE II, FORMERLY	0.000843882	0.03835827272727273
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.000843882	0.03835827272727273
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.000843882	0.03835827272727273
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.000843882	0.03835827272727273
JOUBERT SYNDROME 10	0.000843882	0.03835827272727273
SPINOCEREBELLAR ATAXIA 5; SCA5	0.000843882	0.03835827272727273
CURRY-JONES SYNDROME	0.000843882	0.03835827272727273
CHROMOSOME 18P DELETION SYNDROME	0.000843882	0.03835827272727273
CHROMOSOME 17q23.1-q23.2 DELETION SYNDROME	0.000843882	0.03835827272727273
NOONAN SYNDROME 9; NS9	0.000843882	0.03835827272727273
CEREBELLOFACIODENTAL SYNDROME	0.000843882	0.03835827272727273
WARSAW BREAKAGE SYNDROME; WABS	0.000843882	0.03835827272727273
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.000843882	0.03835827272727273
HYDROXYKYNURENINURIA	0.000843882	0.03835827272727273
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.000843882	0.03835827272727273
#275900 SPASTIC PARAPLEGIA 20, AUTOSOMAL RECESSIVE; SPG20;;TROYER SYNDROME;;SPASTIC PARAPARESIS, CHILDHOOD-ONSET, WITH DISTAL MUSCLE WASTING;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, TROYER TYPE	0.000843882	0.03835827272727273
OROTIC ACIDURIA	0.000843882	0.03835827272727273
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.000843882	0.03835827272727273
CHROMOSOME 4q21 DELETION SYNDROME	0.000843882	0.03835827272727273
#609528 CEREBRAL DYSGENESIS, NEUROPATHY, ICHTHYOSIS, AND PALMOPLANTAR KERATODERMASYNDROME;;CEDNIK SYNDROME	0.000843882	0.03835827272727273
HYDROCEPHALUS, NORMAL-PRESSURE	0.000843882	0.03835827272727273
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000843882	0.03835827272727273
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.000843882	0.03835827272727273
CULLER-JONES SYNDROME; CJS	0.000843882	0.03835827272727273
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.000843882	0.03835827272727273
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.000843882	0.03835827272727273
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.000843882	0.03835827272727273
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.000843882	0.03835827272727273
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.000843882	0.03835827272727273
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.000843882	0.03835827272727273
MITOCHONDRIAL SHORT-CHAIN ENOYL-CoA HYDRATASE 1 DEFICIENCY; ECHS1D	0.000843882	0.03835827272727273
#610758 CEREBROOCULOFACIOSKELETAL SYNDROME 4; COFS4	0.000843882	0.03835827272727273
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.000843882	0.03835827272727273
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.000843882	0.03835827272727273
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.000843882	0.03835827272727273
DYSTONIA 28, CHILDHOOD-ONSET	0.000843882	0.03835827272727273
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000843882	0.03835827272727273
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.000843882	0.03835827272727273
NOONAN SYNDROME 5; NS5	0.000843882	0.03835827272727273
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.000843882	0.03835827272727273
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000843882	0.03835827272727273
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.000843882	0.03835827272727273
BARDET-BIEDL SYNDROME 16; BBS16	0.000843882	0.03835827272727273
#614213 NEUROPATHY, HEREDITARY SENSORY, TYPE IIC; HSN2C	0.000843882	0.03835827272727273
OROFACIODIGITAL SYNDROME VI	0.000843882	0.03835827272727273
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.000843882	0.03835827272727273
GOLDBERG-SHPRINTZEN SYNDROME	0.000843882	0.03835827272727273
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.000843882	0.03835827272727273
FRIAS SYNDROME	0.000843882	0.03835827272727273
POPOV-CHANG SYNDROME; POPCHAS	0.000843882	0.03835827272727273
CHROMOSOME 17P13.1 DELETION SYNDROME	0.000843882	0.03835827272727273
#300257 DANON DISEASE;;VACUOLAR CARDIOMYOPATHY AND MYOPATHY, X-LINKED;;PSEUDOGLYCOGENOSIS II;;ANTOPOL DISEASE;;LYSOSOMAL GLYCOGEN STORAGE DISEASE WITHOUT ACID MALTASE DEFICIENCY,FORMERLY;;GLYCOGEN STORAGE DISEASE IIb; GSD2B, FORMERLY;;GSD IIb, FORMERLY	0.000843882	0.03835827272727273
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.000843882	0.03835827272727273
MENTAL RETARDATION, X-LINKED 107; MRX107	0.000843882	0.03835827272727273
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.000843882	0.03835827272727273
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.000843882	0.03835827272727273
BARDET-BIEDL SYNDROME 8; BBS8	0.000843882	0.03835827272727273
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.000843882	0.03835827272727273
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.000843882	0.03835827272727273
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000843882	0.03835827272727273
OROFACIODIGITAL SYNDROME VIII; OFD8	0.000843882	0.03835827272727273
Mental retardation, autosomal dominant 21	0.000843882	0.03835827272727273
#268310 ROBINOW SYNDROME, AUTOSOMAL RECESSIVE; RRS;;COSTOVERTEBRAL SEGMENTATION DEFECT WITH MESOMELIA, FORMERLY;;COVESDEM SYNDROME, FORMERLYROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH APLASIA/HYPOPLASIA OFPHALANGES AND METACARPALS/METATARSALS, INCLUDED;;ROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH BRACHY-SYN-POLYDACTYLY,INCLUDED	0.000843882	0.03835827272727273
CHAR SYNDROME	0.000843882	0.03835827272727273
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.000843882	0.03835827272727273
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.000843882	0.03835827272727273
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000843882	0.03835827272727273
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.000843882	0.03835827272727273
HYPERMANGANESEMIA WITH DYSTONIA 2	0.000843882	0.03835827272727273
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.000843882	0.03835827272727273
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.000843882	0.03835827272727273
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.000843882	0.03835827272727273
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.000843882	0.03835827272727273
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.000843882	0.03835827272727273
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.000843882	0.03835827272727273
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.000843882	0.03835827272727273
NOONAN SYNDROME 11; NS11	0.000843882	0.03835827272727273
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.000843882	0.03835827272727273
#615314 CRANIOSYNOSTOSIS 3; CRS3	0.000843882	0.03835827272727273
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.000843882	0.03835827272727273
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.000843882	0.03835827272727273
TOWNES-BROCKS SYNDROME 1; TBS1	0.000843882	0.03835827272727273
BARDET-BIEDL SYNDROME 13; BBS13	0.000843882	0.03835827272727273
#608443 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 3; MRT3	0.000843882	0.03835827272727273
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.000843882	0.03835827272727273
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.000843882	0.03835827272727273
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.000843882	0.03835827272727273
#300895 OHDO SYNDROME, X-LINKED; OHDOX;;BLEPHAROPHIMOSIS-MENTAL RETARDATION SYNDROME, MAAT-KIEVIT-BRUNNERTYPE	0.000843882	0.03835827272727273
XIA-GIBBS SYNDROME	0.000843882	0.03835827272727273
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.000843882	0.03835827272727273
JOUBERT SYNDROME 23; JBTS23	0.000843882	0.03835827272727273
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.000843882	0.03835827272727273
PEROXISOME BIOGENESIS DISORDER 5B	0.000843882	0.03835827272727273
#615280 CARDIOFACIOCUTANEOUS SYNDROME 4; CFC4	0.000843882	0.03835827272727273
#614732 INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIACONGENITA, AND GENITAL ANOMALIES;;IMAGE SYNDROME	0.000843882	0.03835827272727273
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.000843882	0.03835827272727273
#613076 MYOPATHY, MITOCHONDRIAL PROGRESSIVE, WITH CONGENITAL CATARACT, HEARINGLOSS, AND DEVELOPMENTAL DELAY;;MYOPATHY WITH CATARACT AND COMBINED RESPIRATORY CHAIN DEFICIENCY;;MITOCHONDRIAL COMPLEX DEFICIENCY, COMBINED	0.000843882	0.03835827272727273
#615432 SPECIFIC LANGUAGE IMPAIRMENT 5; SLI5	0.000843882	0.03835827272727273
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000843882	0.03835827272727273
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.000843882	0.03835827272727273
ELSAHY-WATERS SYNDROME; ESWS	0.000843882	0.03835827272727273
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.000843882	0.03835827272727273
GENITOPATELLAR SYNDROME; GTPTS	0.000843882	0.03835827272727273
3MC SYNDROME 2	0.000843882	0.03835827272727273
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.000843882	0.03835827272727273
Bardet-Biedl syndrome 2	0.000843882	0.03835827272727273
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.000843882	0.03835827272727273
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.000843882	0.03835827272727273
RAHMAN SYNDROME	0.000843882	0.03835827272727273
Aarskog-Scott syndrome	0.000843882	0.03835827272727273
THAUVIN-ROBINET-FAIVRE SYNDROME	0.000843882	0.03835827272727273
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.000843882	0.03835827272727273
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000843882	0.03835827272727273
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.000843882	0.03835827272727273
#614402 MICROPHTHALMIA, SYNDROMIC 11; MCOPS11	0.000843882	0.03835827272727273
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.000843882	0.03835827272727273
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.000843882	0.03835827272727273
CREE MENTAL RETARDATION SYNDROME	0.000843882	0.03835827272727273
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.000843882	0.03835827272727273
BARDET-BIEDL SYNDROME 17; BBS17	0.000843882	0.03835827272727273
NOONAN SYNDROME 3; NS3	0.000843882	0.03835827272727273
MEIER-GORLIN SYNDROME 7	0.000843882	0.03835827272727273
#611936 CHROMOSOME 3q29 DUPLICATION SYNDROME;;MICRODUPLICATION 3q29 SYNDROME	0.000843882	0.03835827272727273
#227810 FANCONI-BICKEL SYNDROME; FBS;;HEPATORENAL GLYCOGENOSIS WITH RENAL FANCONI SYNDROME;;HEPATIC GLYCOGENOSIS WITH FANCONI NEPHROPATHY;;HEPATIC GLYCOGENOSIS WITH AMINO ACIDURIA AND GLUCOSURIA;;FANCONI SYNDROME WITH INTESTINAL MALABSORPTION AND GALACTOSE INTOLERANCE;;PSEUDO-PHLORIZIN DIABETES;;GLYCOGENOSIS, FANCONI TYPE;;GLYCOGEN STORAGE DISEASE XI	0.000843882	0.03835827272727273
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.000843882	0.03835827272727273
MICROPHTHALMIA, SYNDROMIC 3	0.000843882	0.03835827272727273
CRANIOSYNOSTOSIS 6; CRS6	0.000843882	0.03835827272727273
ROSSELLI-GULIENETTI SYNDROME	0.000843882	0.03835827272727273
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.000843882	0.03835827272727273
#607694 LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OR WITHOUT OLIGODONTIA AND/ORHYPOGONADOTROPIC HYPOGONADISM; HLD7;;LEUKOENCEPHALOPATHY, HYPOMYELINATING, WITH ATAXIA AND DELAYED DENTITION;;ATAXIA, DELAYED DENTITION, AND HYPOMYELINATION; ADDH;;LEUKODYSTROPHY, HYPOMYELINATING, WITH HYPODONTIA AND HYPOGONADOTROPICHYPOGONADISM;;4H SYNDROME	0.000843882	0.03835827272727273
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.000843882	0.03835827272727273
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.000843882	0.03835827272727273
CDAGS SYNDROME	0.000843882	0.03835827272727273
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000843882	0.03835827272727273
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.000843882	0.03835827272727273
JOUBERT SYNDROME 26	0.000843882	0.03835827272727273
#612626 CHROMOSOME 15q26-qter DELETION SYNDROME;;DRAYER SYNDROME	0.000843882	0.03835827272727273
AU-KLINE SYNDROME; AUKS	0.000843882	0.03835827272727273
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.000843882	0.03835827272727273
Jawad syndrome	0.000843882	0.03835827272727273
OROFACIODIGITAL SYNDROME IX; OFD9	0.000843882	0.03835827272727273
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.000843882	0.03835827272727273
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.000843882	0.03835827272727273
#615220 OSTEOGENESIS IMPERFECTA, TYPE XV; OI15;;OI, TYPE XV	0.000843882	0.03835827272727273
#600638 FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3A, WITH OR WITHOUT EXTRAOCULARINVOLVEMENT; CFEOM3A;;FEOM3 LOCUS	0.000843882	0.03835827272727273
LOWRY-MACLEAN SYNDROME	0.000843882	0.03835827272727273
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.000843882	0.03835827272727273
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.000843882	0.03835827272727273
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000843882	0.03835827272727273
CRANIOTELENCEPHALIC DYSPLASIA	0.000843882	0.03835827272727273
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.000843882	0.03835827272727273
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.000843882	0.03835827272727273
RETINITIS PIGMENTOSA 80; RP80	0.000843882	0.03835827272727273
#614873 PEROXISOME BIOGENESIS DISORDER 7B; PBD7B	0.000843882	0.03835827272727273
HOLOPROSENCEPHALY 11	0.000843882	0.03835827272727273
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.000843882	0.03835827272727273
OGDEN SYNDROME; OGDNS	0.000843882	0.03835827272727273
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000843882	0.03835827272727273
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.000843882	0.03835827272727273
MENTAL RETARDATION, X-LINKED 106; MRX106	0.000843882	0.03835827272727273
ALAZAMI SYNDROME; ALAZS	0.000843882	0.03835827272727273
#180700 ROBINOW SYNDROME, AUTOSOMAL DOMINANT; DRS;;ROBINOW DWARFISM;;FETAL FACE SYNDROME;;ACRAL DYSOSTOSIS WITH FACIAL AND GENITAL ABNORMALITIES	0.000843882	0.03835827272727273
#613603 CHROMOSOME 4q32.1-q32.2 TRIPLICATION SYNDROME	0.000843882	0.03835827272727273
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.000843882	0.03835827272727273
MENTAL RETARDATION, X-LINKED 99	0.000843882	0.03835827272727273
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.000843882	0.03835827272727273
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.000843882	0.03835827272727273
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.000843882	0.03835827272727273
JOUBERT SYNDROME 31; JBTS31	0.000843882	0.03835827272727273
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000843882	0.03835827272727273
HOLOPROSENCEPHALY 5; HPE5	0.000843882	0.03835827272727273
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.000843882	0.03835827272727273
SWEENEY-COX SYNDROME; SWCOS	0.000843882	0.03835827272727273
CHROMOSOME 16Q22 DELETION SYNDROME	0.000843882	0.03835827272727273
RAINE SYNDROME	0.000843882	0.03835827272727273
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.000843882	0.03835827272727273
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.000843882	0.03835827272727273
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.000843882	0.03835827272727273
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.000843882	0.03835827272727273
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.000843882	0.03835827272727273
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.000843882	0.03835827272727273
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.000843882	0.03835827272727273
CHROMOSOME Xq27.3-q28 DUPLICATION SYNDROME	0.000843882	0.03835827272727273
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.000843882	0.03835827272727273
#607454 SPINOCEREBELLAR ATAXIA 21; SCA21	0.000843882	0.03835827272727273
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.000843882	0.03835827272727273
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.000843882	0.03835827272727273
#615033 SPASTIC PARAPLEGIA 54, AUTOSOMAL RECESSIVE; SPG54	0.000843882	0.03835827272727273
CRANIOFRONTONASAL SYNDROME; CFNS	0.000843882	0.03835827272727273
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.000843882	0.03835827272727273
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.000843882	0.03835827272727273
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000843882	0.03835827272727273
CHROMOSOME 22q11.2 DELETION SYNDROME, DISTAL	0.000843882	0.03835827272727273
RITSCHER-SCHINZEL SYNDROME 1	0.000843882	0.03835827272727273
#609054 FANCONI ANEMIA, COMPLEMENTATION GROUP J; FANCJ	0.000843882	0.03835827272727273
ADAMS-OLIVER SYNDROME 3; AOS3	0.000843882	0.03835827272727273
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000843882	0.03835827272727273
NOONAN SYNDROME 2; NS2	0.000843882	0.03835827272727273
HARTSFIELD SYNDROME; HRTFDS	0.000843882	0.03835827272727273
SEPTOOPTIC DYSPLASIA	0.000843882	0.03835827272727273
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000843882	0.03835827272727273
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.000843882	0.03835827272727273
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.000843882	0.03835827272727273
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.000843882	0.03835827272727273
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.000843882	0.03835827272727273
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.000843882	0.03835827272727273
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.000843882	0.03835827272727273
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.000843882	0.03835827272727273
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.000843882	0.03835827272727273
#615066 OSTEOGENESIS IMPERFECTA, TYPE XIV; OI14 ;;OI, TYPE XIV	0.000843882	0.03835827272727273
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.000843882	0.03835827272727273
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.000843882	0.03835827272727273
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.000843882	0.03835827272727273
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.000843882	0.03835827272727273
STEEL SYNDROME; STLS	0.000843882	0.03835827272727273
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.000843882	0.03835827272727273
#300555 DENT DISEASE 2	0.000843882	0.03835827272727273
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.000843882	0.03835827272727273
#613752 HYPERMETHIONINEMIA WITH S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.000843882	0.03835827272727273
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.000843882	0.03835827272727273
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.000843882	0.03835827272727273
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000843882	0.03835827272727273
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.000843882	0.03835827272727273
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.000843882	0.03835827272727273
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.000843882	0.03835827272727273
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000843882	0.03835827272727273
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.000843882	0.03835827272727273
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.000843882	0.03835827272727273
BARDET-BIEDL SYNDROME 3; BBS3	0.000843882	0.03835827272727273
#609425 CHROMOSOME 3q29 DELETION SYNDROME;;MICRODELETION 3q29 SYNDROME	0.000843882	0.03835827272727273
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.000843882	0.03835827272727273
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000843882	0.03835827272727273
THANATOPHORIC DYSPLASIA, TYPE I	0.000843882	0.03835827272727273
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.000843882	0.03835827272727273
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.000843882	0.03835827272727273
CURRARINO SYNDROME	0.000843882	0.03835827272727273
AUSTRALIA ANTIGEN	0.000843882	0.03835827272727273
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.000843882	0.03835827272727273
#615401 IMMUNODEFICIENCY 8; IMD8	0.000843882	0.03835827272727273
CHROMOSOME 15q25 DELETION SYNDROME	0.000843882	0.03835827272727273
Temtamy preaxial brachydactyly syndrome	0.000843882	0.03835827272727273
#610915 OSTEOGENESIS IMPERFECTA, TYPE VIII; OI8;;OI, TYPE VIII	0.000843882	0.03835827272727273
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.000843882	0.03835827272727273
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.000843882	0.03835827272727273
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 1; CEMCOX1	0.000843882	0.03835827272727273
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.000843882	0.03835827272727273
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.000843882	0.03835827272727273
#615665 JOUBERT SYNDROME 22; JBTS22	0.000843882	0.03835827272727273
#615583 VERHEIJ SYNDROME; VRJS;;CHROMOSOME 8q24.3 DELETION SYNDROME	0.000843882	0.03835827272727273
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.000843882	0.03835827272727273
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.000843882	0.03835827272727273
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.000843882	0.03835827272727273
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000843882	0.03835827272727273
FRONTOOCULAR SYNDROME	0.000843882	0.03835827272727273
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000843882	0.03835827272727273
#613641 CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE B; CMTRIB;;CHARCOT-MARIE-TOOTH NEUROPATHY, RECESSIVE INTERMEDIATE B; RI-CMTB	0.000843882	0.03835827272727273
TURNPENNY-FRY SYNDROME; TPFS	0.000843882	0.03835827272727273
SECKEL SYNDROME 8; SCKL8	0.000843882	0.03835827272727273
TARP SYNDROME; TARPS	0.000843882	0.03835827272727273
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000843882	0.03835827272727273
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.000843882	0.03835827272727273
#614976 CARPENTER SYNDROME 2; CRPT2	0.000843882	0.03835827272727273
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.000843882	0.03835827272727273
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.000843882	0.03835827272727273
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000843882	0.03835827272727273
Leukotriene C4 synthase deficiency	0.000843882	0.03835827272727273
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.000843882	0.03835827272727273
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.000843882	0.03835827272727273
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.000843882	0.03835827272727273
CHROMOSOME 15Q14 DELETION SYNDROME	0.000843882	0.03835827272727273
#615278 CARDIOFACIOCUTANEOUS SYNDROME 2; CFC2	0.000843882	0.03835827272727273
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.000843882	0.03835827272727273
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.000843882	0.03835827272727273
#303110 CHOROIDEREMIA, DEAFNESS, AND MENTAL RETARDATION;;CHROMOSOME Xq21 DELETION SYNDROME	0.000843882	0.03835827272727273
#614701 CORNELIA DE LANGE SYNDROME 4; CDLS4	0.000843882	0.03835827272727273
HYPERTRYPTOPHANEMIA; HYPTRP	0.000843882	0.03835827272727273
COSTELLO SYNDROME; CSTLO	0.000843882	0.03835827272727273
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.000843882	0.03835827272727273
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.000843882	0.03835827272727273
SECKEL SYNDROME 9; SCKL9	0.000843882	0.03835827272727273
BARDET-BIEDL SYNDROME 14; BBS14	0.000843882	0.03835827272727273
DIAMOND-BLACKFAN ANEMIA 5	0.000843882	0.03835827272727273
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.000843882	0.03835827272727273
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.000843882	0.03835827272727273
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.000843882	0.03835827272727273
AICARDI-GOUTIERES SYNDROME 6	0.000843882	0.03835827272727273
#604804 MICROCEPHALY 3, PRIMARY, AUTOSOMAL RECESSIVE; MCPH3	0.000843882	0.03835827272727273
CHOPS SYNDROME; CHOPS	0.000843882	0.03835827272727273
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.000843882	0.03835827272727273
#300123 MENTAL RETARDATION, X-LINKED, WITH PANHYPOPITUITARISMMENTAL RETARDATION, X-LINKED, WITH ISOLATED GROWTH HORMONE DEFICIENCY,INCLUDED; MRGH, INCLUDED	0.000843882	0.03835827272727273
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.000843882	0.03835827272727273
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.000843882	0.03835827272727273
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.000843882	0.03835827272727273
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.000843882	0.03835827272727273
TYSHCHENKO SYNDROME	0.000843882	0.03835827272727273
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.000843882	0.03835827272727273
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.000843882	0.03835827272727273
HYPOTONIA-CYSTINURIA SYNDROME	0.000843882	0.03835827272727273
EVEN-PLUS SYNDROME	0.000843882	0.03835827272727273
ALAZAMI-YUAN SYNDROME	0.000843882	0.03835827272727273
HOLOPROSENCEPHALY 3; HPE3	0.000843882	0.03835827272727273
